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Abstract 
Changes in the content and the composition of natural compounds always results from the 
balance of their biosynthesis, allocation, and degradation. These three processes could be 
influenced differentially by various developmental and environmental factors. In consequence, 
the overall impact of these influences on the spectrum and the content of the secondary 
metabolites might be very complex and multifarious. However, these considerations open novel 
doors for manifold and deliberate approaches to change and adapt the secondary metabolism, 
intended to improve and optimize the search for novel pharmacologically active compounds.  
With respect to environmental factors, the generation of various stress situations and the 
concomitant consideration of the developmental stage of the plant seems to be the most 
promising approaches. Since these conjunctures are governed by various signal transduction 
chains, the application of corresponding growth regulators or signal transducers should 
augment the capabilities for plant chemodiversity and phytochemical drug discovery. In this 
context, the most promising candidates are methyl jasmonate (MeJA), hydrogen peroxide 
(H2O2) and salicylic acid (SA), which are part of several signal transduction chains. 
This thesis was aimed to comprehend the effects of MeJA, H2O2 and SA on the pattern of 
monoterpenoid indole alkaloids (MIAs) in Vinca minor with the special emphasis on the 
appearance of the novel, so far unknown indole alkaloids. The intention was to investigate 
whether or not the application of growth regulators could be the basis for a novel strategy to 
modify the composition of active components in medicinal plants.  
To establish a solid basis for the identification of new, stress-induced alkaloids; firstly, the 
spectrum of MIAs of healthy, mature V. minor plants was recorded. For this, the MIAs were 
extracted from healthy leaves and fractionated by preparative HPLC. By means of HRMS and 
NMR, the main alkaloids were identified as vincamine, strictamine, 10-hydroxycathofoline, 
and vincadifformine.  
Treatment with MeJA and H2O2 extensively changed the pattern and composition of the indole 
alkaloids present in V. minor plants. While 10-hydroxycathofoline and strictamine concen-
trations remained unaltered, the contents of vincamine and vincadifformine were dramatically 
reduced. Moreover, treatment with both growth regulators resulted in the accumulation of four 
other MIAs, identified as minovincinine, minovincine, 9-methoxyvincamine and finally a 
related alkaloid thought to be kopsinine. Whereas minovincinine and minovincine are already 
known to occur - however only in trace amounts - in V. minor, 9-methoxyvincamine represents 
a novel natural product.  
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Based on the high similarities of vincamine and 9-methoxyvincamine and their inverse changes 
in concentrations, it was postulated that vincamine was transformed to 9-methoxyvincamine. 
Similarly, vincadifformine was thought to be converted first to minovincinine and finally to 
minovincine. These modifications require oxidative enzymes. Considering the corresponding 
enzymes involved in the MIAs biosynthesis in Catharanthus roseus, it seems to be very likely 
that these reactions are catalyzed by cytochrome P450 enzymes. In order to verify this 
assumption, in parallel to treatment with MeJA, also specific enzyme inhibitors, which are 
known to suppress or to modulate the alkaloid biosynthesis in C. roseus, have been applied to 
the V. minor plants. As expected, the application of resveratrol or naproxen respectively, as 
oxygenases enzyme inhibitors, prevented the conversion of vincamine to 9-methoxyvincamine 
as well as that of vincadifformine via minovincinine to minovincine. Accordingly, these results 
vividly confirmed the postulated stress-induced oxidative conversion of both major MIAs in V. 
minor plants, i.e., vincamine and vincadifformine, to 9-methoxyvincamine and to 
minovincinine and minovincine, respectively.  
The stress-induced conversions, and especially the discovery of 9-methoxyvincamine as a novel 
natural product, insistently outlines that even well-known, extensively studied plants such as V. 
minor, might be an auspicious source for the discovery of novel phytochemicals. Accordingly, 
in the future, the stress-induced changes in natural products conditions, preferably induced by 
the application of MeJA and other growth regulators have to be integrated into the modern 
search for bioactive compounds. Such approach might open new doors to improve and facilitate 
phytochemical drug discovery. In addition to the application of growth regulators or signal 
transducers, respectively, also the application of enzyme inhibitors could be used as an 
alternative approach to deliberately modify the content and composition of biologically active 
compounds in plants.  
Moreover, treatments combining enzyme inhibitors and growth regulators or signal transducers 
might be an effective tool to study the cytochrome P450 enzymes responsible for the stress-
induced conversion of MIAs. In further studies, this attractive topic should be followed 
enthusiastically. 
The application of growth regulators or signal transducers, respectively, could modulate the 
composition of secondary metabolites. In combination with the dereplication-guided isolation 
of the induced compounds, this approach could indeed promote the discovery of novel drugs, 
even in well-investigated medicinal plants.
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Zusammenfassung: 
Veränderung des Indolalkaloid-Spektrums von Vinca minor 
Änderungen im Gehalt von Naturstoffen und deren Zusammensetzung resultieren stets aus 
entsprechenden Veränderungen der Biosynthese, der Verlagerung und dem Abbau dieser 
Substanzen. Dabei werden diese Prozesse in unterschiedlicher Weise sowohl von 
Umweltfaktoren als auch von der Entwicklung und dem Wachstum der jeweiligen Pflanze 
beeinflusst. Hieraus folgt, dass der Einfluss all dieser Faktoren auf den Sekundärstoffwechsel 
sehr komplex und vielfältig ist. Dies wiederum eröffnet viele Möglichkeiten, in vielfältiger 
Weise absichtsvoll Änderungen des Sekundärstoffwechsels zu induzieren, um so die Suche 
nach neuen, pharmakologisch aktiven Naturstoffen zu verbessern.  
In Hinblick auf den Einfluss unterschiedlicher Umweltfaktoren sind besonders die stress-
induzierten Veränderungen vielversprechend; allerdings muss in diesem Zusammenhang stets 
auch der Einfluss von Wachstum und Entwicklung mit berücksichtigt werden. Entsprechend 
ergeben sich aus dem Einsatz verschiedener Wachstumsfaktoren und Signalsubstanzen viele 
unterschiedliche Möglichkeiten, den Sekundärstoffwechsel gezielt zu modifizieren. In diesem 
Kontext sind Methyljasmonat (MeJA), Wasserstoffperoxid (H2O2) und Salicylsäure (SA), die 
Bestandteile unterschiedlicher Signaltransduktionsketten sind, sehr vielversprechende 
Kandidaten. 
Das Ziel dieser Arbeit war es, den Einfluss von MeJA, H2O2 und SA auf das Spektrum der 
Monoterpen-Indolakaloide (MIAs) in Vinca minor zu erfassen. Dabei sollte vor allem analysiert 
werden, ob durch diese Behandlungen neue, bislang unbekannte Indolalkaloide gebildet 
werden. Diese Untersuchungen sollen klären, ob und in welchem Maße die Applikation von 
Wachstumsfaktoren und Signalsubstanzen eine aussichtsreiche Strategie sein kann, die 
Zusammensetzung pharmakologisch aktiver Naturstoffe zu verändern bzw. zu optimieren. 
Zunächst musste eine zuverlässige Methode etabliert werden, um die stressinduzierten 
Veränderungen in der Zusammensatzung der MIAs einwandfrei bestimmen zu können. Dazu 
wurden zunächst die Alkaloide aus gesunden und ungestressten V. minor Blättern extrahiert 
und mittels HPLC fraktioniert. Auf der Basis von HRMS und NMR konnten alle für V. minor 
beschriebenen Hauptalkaloide identifiziert werden; dabei handelt es sich um Vincamin, 
Strictamin, 10-Hydroxycathofolin und Vincadifformin.  
Die Behandlung der V. minor Pflanzen mit MeJA und H2O2 änderte das Spektrum der 
Indolalkaloide frappierend. Zwar blieben die Konzentrationen von 10-Hydroxycathofolin und 
Strictamin nahezu unverändert, doch die Gehalte von Vincamin und Vincadifformin 
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reduzierten sich drastisch. Des Weiteren resultierte aus der Applikation der Signalsubstanzen 
die Akkumulation drei anderer MIAs, die als Minovincinin, Minovincin, 9-Methoxyvincamin 
identifiziert werden konnten. Bei einem weiteren Alkaloid, dessen Stuktur noch nicht endgültig 
aufgeklärt werden konnte, handelt es sich wahrscheinlich um Kopsinin. Das Vorkommen von 
Minovincinin und Minovincin in V. minor war bekannt; allerdings wurde diesbezüglich 
lediglich das Vorhandensein von Spuren dieser Alkaloide berichtet. Beim 9-Methoxyvincamin 
handelt es sich um ein bislang noch nicht beschriebenes, und damit um ein neues Indolalkaloid.  
Aufgrund des sehr großen strukturellen Ähnlichkeiten von Vincamin and 9-methoxyvincamin 
und deren gegenläufigen Veränderungen ihrer Konzentrationen, wurde postuliert, dass 
Vincamin in 9-Methoxyvincamin umgewandelt wird. In gleicher Weise wird vermutet, dass 
Vincadifformin zunächst zu Minovincinin und dann zu Minovincin modifiziert wird. Diese 
Umwandlungen erfordern oxidative Enzyme. In Analogie zu den bereits bekannten Enzymen, 
die für die Biosynthese der MIAs in C. roseus verantwortlich zeichen, sollte es sich auch bei 
diesen Enzymen um Cytochrom P450-Enzymen handeln. Um diese Vermutung zu verifizieren, 
wurden in weiteren Versuchsreihen - parallel zur Behandlung mit MeJA – zusätzlich 
spezifische Inhibitoren eingesetzt, von denen bekannt ist, die Alkaloid Biosynthese in C. roseus 
zu hemmen. Wie erwartet, ergab die gleichzeitige Gabe der Signaltransduktoren (MeJA und 
H2O2) und der Enzyminhibitoren (Resveratrol, Naproxen) an V. minor, dass sowohl die 
Umwandlung von Vincamin zu 9-Methoxyvincamin als auch die von Vincadifformin über 
Minovincinin zu Minovincin unterdrückt wurde. Damit bestätigen diese Ergebnisse 
eindrücklich, die stressinduzierte, oxidative Umwandlung der Hauptalakloide aus V. minor, 
nämlich Vincamin und Vincadifformin, zu 9-Methoxyvincamin, bzw. zu Minovincinin und 
Minovincin.  
Diese stressinduzierten Umwandlungen und die Entdeckung von 9-Methoxyvincamin zeigen, 
dass selbst in intensive untersuchten Arzneipflanzen wie V. minor, noch immer eine vielver-
sprechende Quelle für die Entdeckung neuer pharmakologisch aktiven Naturstoffe sein kann. 
Dementsprechend sollten zukünftig stressinduzierte Änderungen des Natursoff-Spektrums, vor 
allem solche, die durch die Applikation von MeJA oder anderen Wachtumsregulatoren oder 
Signaltransduktoren induziert werden, bei der Suche nach neueen bioaktiven Substanzen 
berücksichtigt werden. Diese neuen Herangehensweise sollte viel neue Möglichkeiten eröffnen, 
die Suche nach neunen pharmakologisch aktiven Naturstoffen zu erleichten und deren Erfolg 
zu steigern. Zusätzlich zur Applikation von Wachtumsregulatoren oder Signaltransduktoren 
bietet auch der Einsatz von Enzyminhibitoren eine weitere Möglichkeit, um den Gehalt und die 
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Zusammensetzung von Naturstoffen in Arzneipflanzen gezielt beeinflussen und verändern zu 
können.  
Auch in Hinblick auf die Untersuchungen zu den Cytochrome P450-Enzymen, die für die 
stressinduzierte Umwandlung der MIAs verantwortlich sind, ist die Kombination von 
Enzyminhibitoren und Signaltransduktoren ein effektiver und vielversprechender Ansatz, der 
bei zukünftigen Forschungen zum Einsatz kommen sollte. 
In dieser Arbeit wurde gezeigt, dass die Applikation von Wachtumsregulatoren und 
Signaltransduktoren den Gehalt und die Zusammensetzung von Naturstoffen drastisch 
verändern kann. In Kombination mit dem Ansatz einer “dereplication-guided” Isolierung der 
induzierten Substanzen, sollte ein solches Vorgehen zukünftig zur Entdeckung weiterer neuer 
Wirkstoffe, selbst in gut untersuchten Medizinalpflanzen, beitragen. 
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  :الملخص العربى
 الصغرىمحتوى قلويدات الإندول فى نبات العناقية  تحوير
التوازن بين التخليق الحيوي، وإعادة توزيع وتكسير إن التغيير في محتوى وتكوين المنتجات الطبيعية يكون دائما ًنتاجا ًلعملية 
هذه المركبات. وتتأثر هذه العمليات الثلاثة بكٕل من العوامل البيئية ومراحل النمو المختلفه للنباتات. ونتيجة لذلك ، قد يكون 
الاعتبارات تفتح أبوابا جديدة التأثير الكلي لهذه العوامل على محتوى الأيض الثانوي معقًدا ومتنوًعا. و بالتالي ، فإن هذه 
 .وطرق متعددة لتغيير وتعديل مركبات الأيض الثانوية ، وتفتح المجال للبحث عن مصادر جديدة للأدوية
تأثير العوامل البيئية المختلفة على النباتات، يبدو أن  افتعال حالات الإجهاد المختلفة و الدراسة المتزامنة لمراحل  و بالنظر إلى
ن نهجا ًواعدا ًلتعديل مركبات الأيض الثانويه. ولهذا ، يجب أن يتم تعزيز و زيادة القدره الانتاجيه للنبات من هذه يشكلا النمو
المركبات  من خلال استخدام  منظمات النمو المختلفه أو ناقلات الإشارات المشاركة في عملية التحكم فى استجابة النباتات 
و حمض الساليسيليك  H(2O2)بيروكسيد الهيدروجين  و )AJeM(لميثيل جاسمونات للإجهاد. وفي هذا السياق ، يعتبر ا
 أكثر المركبات أهمية فى سلسلة نقل الاشارات والتى ينتج عنها تعديل مركبات الأيض الثانوية. )AS(
على تحوير محتوى وتكوين قلويدات الإندول فى نبات  H2O2 و ASو AJeMالهدف من هذه الأطروحة هو تقييم تأثير  
. وعلى وجه الخصوص ، دراسة قدرة هذه المعالجات على تكوين قلويدات إندول جديدة )ronim acniV(العناقية الصغرى 
ة أو ناقلات غير معروفة من هذا النبات. كما تهدف هذه الدراسه الى اثبات مدى امكانية تطبيق استخدام  منظمات النمو المختلف
 .الإشارات كإستراتيجية جديده لتحوير أو تحسين المحتوى الكيميائي للمنتجات الطبيعية
و في هذا السياق و بهدف تحديد القلويدات الجديدة المحتملة التي يسببها الإجهاد ، أولاً ، تم تحديد الطيف الكروماتوجرافي 
) وتجزئته وفصله sAIMعن طريق استخلاص المحتوى القلويدي () من نباتات صحية وناضجة. وتم ذلك sAIMللقلويدات (
). و تم التعرف على البنية التركيبية للقلويدات المفصولة باستخدام مطياف CLPHبواسطة  الاستشراب السائلي عالي الأداء (
الرئيسية مثل فينكامين )، و قد تم تحديد القلويدات RMN) ومطياف الرنين النووي  المغناطيسي (SMRHالكتلة عالى الدقه (
)، و enilofahtacyxordyh-01(هيدروكسي كاثوفولين -01)، enimatcirts)، إستركتامين (enimacniv(
 ).enimroffidacnivفينكاديفورمين (
قد أدى إلي تغيير نمط وتكوين قلويدات الإندول الموجودة في   H2O2و  AJeMو أوضحت الدراسة أن معالجة النباتات ب  
-01و هيدروكسي كاثوفولين  ( enimatcirts(نبات العناقية الصغرى. و على الرغم من أن تركيزات  استركتامين (
 nimroffidacniv( ) و فينكاديفورمين (enimacniv) لم تتغير تقريبا،ً فإن مستويات الفينكامين (enilofahtacyxordyh
 (sAIMإلى تراكم أربعة من القلويدات ( H(2O2)AJeM ,انخفضت بشكل كبير. وعلاوة على ذلك ، أدت معالجة  النباتات ب 
ميثوكسى -9، و  )enicnivonim()، مينوفينسين  )eninicnivonim مينوفينسينينالأخرى ، والتي تم تحديدها على أنها 
 )eninispok(. ويعتقد أن الرابع الذى لم يتم تحديد هيكله بشكل قاطع هو الكوبسينين. enimacnivyxohtem-9(فينكامين (
 ينسينينوفو مين  )enicnivonim(في حين أنه من المعروف بالفعل أن النبات قيد الدراسة يحتوى على مينوفينسين
مركبا ً )enimacnivyxohtem-9(ميثوكسي فينكامين  -9)، ولكن بكميات ضئيلة جدا ،بينما يمثل  )eninicnivonim
 طبيعيًا جديًدا.
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و  )enimacnivyxohtem-9(ميثوكسي فينكامين -9) و enimacnivو استناداً إلى تشابه التركيب الكميائى للفينكامين (
ميثوكسي فينكامين -9) يتحول إلى enimacnivتغييراتهما العكسية في التركيزات، يفترض أن الفينكامين (
 مينوفينسينين يتم تحويله أولاً إلى )enimroffidacniv(. وبالمثل ، يعتقد أن فينكاديفورمين  )enimacnivyxohtem(
، وتتطلب هذه التغييرات أنزيمات مؤكسدة. وبالنظر إلى  )enicnivonim(وأخيراً إلى مينوفينسين )eninicnivonim(
يوي لقلويدات الإندول الموجودة فى نبات البفتة او الونكا الإنزيمات المقابلة المسئوله عن عملية التخليق الح
، يبدو أنه من المرجح جدا أن تكون هذه التفاعلات محفزة بواسطة إنزيمات سيتوكروم بي  suesor suhtnarahtaC((
نزيمات ، تم أيضاً معاملته بمثبطات إ AJeM. ومن أجل التحقق من هذا الافتراض، وبالتوازي مع معالجة النبات ب 054
معينة  معروفة بتثبيطها أو تعديلها للتكوين الحيوي للقلويدات في نبات الونكا. وكما هو متوقع ، فإن معالجة النبات  
) enimacniv) ، على التوالي ، أدى الى منع تحويل الفينكامين ()nexopan) أو نابروكسين  )lortarevserبريسفيراترول
عن  )enimroffidacniv(  وكذلك منع تحويل فينكاديفورمين enimacnivyxohtem-9(ميثوكسي فينكامين (-9إلى 
، تؤكد هذه النتائج بوضوح أن . وبناًء عليه)enicnivonim(إلى مينوفينسين   )eninicnivonim(طريق مينوفينسينين 
 لعناقية الصغرى. الإجهاد يمكنه أن يحث التحويل التأكسدي لكل من قلويدات الإندول الرئيسية الموجودة فى نبات ا
-9(ميثوكسي فينكامين (-9و مما سبق نستطيع أن نخلص إلى أن التحولات الكميائيه الناتجه عن الإجهاد، وخاصة اكتشاف 
كمنتج طبيعي جديد، يظهر بوضوح أن النباتات المعروفه التى تم دراستها على نطاق واسع  مثل  enimacnivyxohtem
نبات العناقية الصغرى، قد يكون مصدًرا لاكتشاف عقاقير كيميائية جديدة. وبناًء على ذلك، فانه يجب في المستقبل أثناء  
ج عنه تحويرات في تكوين المنتجات الطبيعية، ويفضل أن البحث عن مركبات نشطة بيولوجيًا أن يتم دمج الإجهاد الذى ينت
وغيره من منظمات النمو. ومثل هذا النهج قد يفتح أبوابًا جديدة لتحسين و اكتشاف  AJeMيتم ذلك بمعاملة النباتات ب 
مثبطات الإنزيمات مركبات دوائية جديدة. و بالإضافة إلى تطبيق منظمات النمو أو ناقلات الإشارة، كما يمكن أيضا ًاستخدام 
كنهج بديل لتحوير المحتوى الكيميائى للمركبات النشطة بيولوجيا ًفي النباتات.علاوة على ذلك، يمثل استخدام المعالجات التي 
قلويدات الإندول ومنظمات النمو أو ناقلات الإشارات  المسؤولة عن تحوير 054تجمع بين مثبطات إنزيمات السيتوكروم بى 
 جهاد أداة ًفعالة ينبغي استخدامها في الأبحاث المستقبلية.أثناء عملية الا
وفقا لذلك ، تبين أن تطبيق منظمات النمو وناقلات الإشارات أثناء عملية الاجهاد يمكن أن يغير بشكل جذري محتوى الأيض 
 ات الناتجة عن الاجهاد الثانوي للنبات و الذي قد يسهم فى تكوين منتجات طبيعية جديدة. بالاضافة لذلك فإن فصل المركب
، حتى في ن يعزز اكتشاف عقاقير جديدةوبالتالى يمكن لهذا النهج أ "noitalosi dediug-noitacilpered"باستخدام نظام 
 النباتات الطبية التي التى تم دراستها على نطاق واسع.
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Chapter 1: Introduction  
Plants are sessile; they have no capacity to move from an adverse environment or to escape 
from an herbivore. Their only chance for survival is defense. This could be accomplished either 
mechanically, e.g. by creating barriers, thorns, and spines, or chemically. Chemical defense is 
based on the production of a tremendous array of different pungent, acrid or toxic substances. 
The biosynthesis of these compounds had been evolved during the entire plant phylogeny. In 
this context, the ecological interaction of plants with herbivores, pathogens, and unfavorable 
abiotic factors had been the driving force to select for both, general and specific defense 
compounds (Pichersky and Gang, 2000; Fini et al., 2017). The related protective effects, 
frequently simplifying denoted as defense function, entail selection advantages which finally 
lead to the establishing in the population. Many of these compounds reveal strong effects also 
on human metabolism, and accordingly, they are used for medicinal purposes. However, we 
always have to be aware: “Plants do not produce drugs” (Littleton, 2007). The production of 
the related natural compounds always has to be evaluated with respect to their ecological 
significance. Nevertheless, the related effects make them very useful as drugs. Due to the 
tremendous number of different compounds, up to now, the pharmacological effects of only a 
limited number of substances are investigated (Atanasov et al., 2015).  
1.1 Plant defense – an intriguing source for drug discovery 
As outlined, it is well known that plants generate a large number of new, natural products, 
which also might reveal high therapeutic value (Pan et al., 2013; Atanasov et al., 2015). 
However, the lack of reproducibility reported for more than 40% of related plant extracts is 
considered as one of the major drawbacks in using plants in pharmaceutical drug discovery 
(Cordell, 2000). Moreover, the biochemical profiles of plants harvested at different times and 
locations vary greatly (Poulev et al., 2003; Atanasov et al., 2015). With respect to defensive 
compounds, such variability is not surprising; in principle, there are two different mechanisms 
related to the production and accumulation of defense compounds. First, the so-called 
preexisting defense compounds also called phytoanticipins. These compounds constitutively 
are present in the plants, either already as active compounds like alkaloids, saponins or various 
phenolic compounds, or they are activated postmortem from pre-existing precursors like 
cyanogenic glucosides or glucosinolates (Matile, 1980;Tomas-Barberan and Gil, 2008; Iriti and 
Faoro, 2009). Secondly, the active compounds are produced only when the plant is stressed by 
biotic or abiotic factors. In this manner, for example, stilbenes are produced in response to high 
irradiation (Marti et al., 2014), or phytoalexins are synthesized de novo when the plant is 
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attacked by fungi or bacteria (Pusztahelyi et al., 2015; Jeandet, 2015). Notwithstanding, both 
mechanisms are not categorically separated, i.e., the contents of phytoanticipins could also be 
enhanced in response to stress. In this sense, the concentration of nicotine in leaves Nicotiana 
attenuata attacked by the larvae of Manduca sexta strongly is enhanced due to a stress-related 
induction of alkaloid biosynthesis (Winz and Baldwin, 2001; Steppuhn et al., 2004). 
Furthermore, the concentration of various natural products accumulated in numerous spice and 
medicinal plants is enhanced in response to drought stress (for review see (Kleinwächter and 
Selmar, 2014). In addition to these quantitative changes, stress may also alter the composition 
of the relevant compounds (Poulev et al., 2003; Wojakowska et al., 2013; Sampaio et al., 2016), 
like it was demonstrated for changes of phenolic profiles in the reaction of  lupin (Lupinus 
angustifolius) plants to infections with the pathogenic fungi  Colletotrichum 
lupini  (Wojakowska et al., 2013) . The composition of the volatile oil in poplar cuttings 
(Populus × euramericana ‘Nanlin 895’) was altered in response to methyl salicylate (Tang et 
al., 2015). In the same sense, the application of methyl jasmonate (MeJA) leads to a significant 
increase in the content of indole alkaloids in hairy root cultures of Catharanthus roseus, and to 
a shift in their composition (Rijhwani and Shanks, 1998; Rodriguez et al., 2003). Accordingly, 
the quantity, as well as the composition of healthy and non-stressed plants, could be quite 
different than those of the plants elicited by various biological and abiotic stress situations. Up 
to now, these coherences have not been taken into account adequately, when searching for novel 
pharmacological active natural products. Consequently, approaches for plant drug discovery 
may have been – at least in part - biased so far. We have to consider that a sound search for 
bioactivity requires that the wild plant species of interest should not only be analyzed 
exclusively on the basis of healthy adult individuals, but also the analyses of stressed 
individuals have to be implemented. 
A further aspect, which has to be considered, when comprehensively is searched for novel 
pharmacologically active compounds, is related to the plant development. The content, as well 
as the composition of natural compounds strongly depends on phenological stages, maturation 
and senescence processes (Skursky et al., 1969; Brown et al., 2003; Nezhadali et al., 2014). A 
very popular example for massive variations in the content of relevant compounds due to 
developmental differences is visualized by the well-known phenomenon of spice plants: the 
favour and thus the quality of the related material is much higher, when young leaves are used 
than in the case of mature ones, since the concentration of the aromatic monoterpene is far 
higher in young than in old leaves.  
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1.2 Objectives and approaches  
Based on the insights mentioned above, we can conclude: a thorough and comprehensive search 
for novel pharmacologically active compounds should include the application of various stress 
situations and the consideration of different developmental stages (Figure 1-1). 
 
Figure 1- 1: Schematic overview of the novel approach to study the effects of stress and growth 
regulators as promising tools for phytochemical drug discovery. 
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An alternative approach covering these requirements is to mimic the stress and the 
developmental processes by the use of growth regulators or inducers (Figure 1-1). In this sense, 
MeJA, hydrogen peroxide (H2O2), and salicylic acid (SA) have been used to induce 
characteristic stress responses, and also impacts secondary metabolism. An intriguing example 
of such approach is based on the analyses of the indole alkaloids of C. roseus treated with 
MeJA. When seedlings of C. roseus are treated with this signaling substance, the concentration 
of indole alkaloids is changed significantly and its composition is shifted (Aerts et al., 1994), 
for further details see the Scientific background. Another member of the Apocynaceae family, 
representing also an important medicinal plant that contains pharmacological important indole 
alkaloids, is lesser periwinkle (Vinca minor). Up to now, no information on putative stress-
related changes of the V. minor alkaloids is available. Accordingly, MeJA treatment on Vinca 
plants seems to be an appropriate and promising approach for identifying novel 
pharmacological products. 
In this sense, the major goal of this thesis is the elucidation of the impact of MeJA on the 
alkaloid metabolism in V. minor. The project is aimed to comprehend the effect of MeJA on 
the pattern of indole alkaloids of V. minor with a special emphasis on the appearance of novel, 
so far unknown indole alkaloids. In this manner, a new approach to identify pharmacologically 
active compounds in V. minor is introduced and thus, a novel strategy in plant phytochemical 
drug discovery is presented.   
To achieve these goals, different lines of experimental approaches have been followed: 
1- Phytochemical analyses of healthy, non-stressed V. minor plants, i.e., identification, 
isolation and structural elucidation of the major indole alkaloids. 
2- The phytochemical analyses (identification, isolation and structural elucidation) of the 
major alkaloids of V. minor plants, when treated with different plant growth regulators, 
such as MeJA, salicylic acid, and hydrogen peroxide. 
3- Establishing a reliable method for quantification of the relevant indole alkaloid(s) in V. 
minor. 
4- Studying the effect of inhibitors (e.g. naproxen and resveratrol) on the MeJA-induced 
conversion of indole alkaloids 
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1.3 Thesis outline 
The current thesis is divided into six chapters. Apart from the current introduction (chapter 1), 
the other four sections are:  
Chapter 2: The Scientific background presents a comprehensive review and the current 
knowledge about chemistry, biological activity, biosynthesis and regulation of indole alkaloids 
of V. minor plants. In addition, this literature survey focuses on the biosynthetic and regulation 
processes of indole alkaloids in well-studied C. roseus plant in order to create the basis for the 
designed experimental approaches with V. minor.  
Chapter 3: The materials and methods display the experimental procedures which were used 
for evaluating the impacts of application of growth regulators and signal transducers (e.g. 
MeJA, SA, and H2O2) on the spectrum and composition of indole alkaloids in V. minor leaves. 
Chapter 4: The Results present the outcome of this study, which vividly demonstrate that 
artificial elicitation indeed leads to massive qualitative as well as quantitative variations in the 
content of bioactive compounds. In consequence, the results verify that the utilization of growth 
regulators, especially of MeJA, could be a promising tool for altering and diversifying the 
composition of active substances in medicinal plants. 
Chapter 5: in the Discussion, the different aspects of the various novel insights are 
contemplated and evaluated in detail.  In addition, suggestions for further directions in 
phytochemical drug discovery are outlined.   
Chapter 6: in the Conclusion based on the results, novel insights, deductions, and promising 
strategies for both, the improved search for novel pharmacological agents and the elucidation 
of biosynthetic pathways will be presented. 
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Chapter 2: Scientific background 
The intention of this study was to investigate whether or not the application of growth regulators 
could be a novel strategy to modify the composition of active components in medicinal plants. 
In this study, mature Vinca minor (Apocynaceae) plants of defined physiological status were 
used as a model system to investigate the effect of elicitation with methyl jasmonate (MeJA) 
and other growth regulators. In this context, the applicability of using growth regulators or 
signal transducers as a promising tool for altering and diversifying the composition of active 
substances in V. minor was studied and evaluated. In the following chapter, the current scientific 
literature on the various aspects about chemistry, biological activity, biosynthesis and 
regulation of indole alkaloids of V. minor plant is reviewed. The major alkaloid in the leaves 
was reported to be vincamine, which has pronounced cerebrovasodilatory and neuroprotective 
activities (Vas and Gulyás, 2005; Hasa et al., 2013).  Despite the economic importance of V. 
minor alkaloids, little is known about their biosynthesis. However, its high genetic similarity to 
its close relative Catharanthus roseus, a model plant whose indole alkaloids biosynthesis 
pathways have been extensively studied (Thamm et al., 2016; Pan et al., 2016; Dugé de 
Bernonville et al., 2015; O'Connor and Maresh 2006), can be exploited to identify the 
corresponding processes in V. minor. Accordingly, this literature survey focuses on the 
biosynthetic processes in C. roseus in order to create the basis for the designed experimental 
approaches with V. minor. 
2.1 Classification of genus Vinca 
The genus Vinca was originally established by Carl von Linné in 1735 (Farnsworth 1961). 
Vinca species were originally native to Europe but extended to North-Africa and the Near-East. 
Outside this area, there is only one species, i.e., Vinca erecta, which occurs in the East of Central 
Asia. Genus Vinca was first classified by Pichon followed by Pobedimova (Aynilian et al., 
1974). Later on, Stearn (Stearn, 1973) intensified this classification and mentioned 16 species 
belonging to 6 sections as follows: 
Family: Apocynaceae 
   Subfamily: Plumieroideae 
     Genus: Vinca L. 
       Section: Herbacea 
          V. herbacea Waldst. et Kit. 
         V. pumila E. D. Clarke 
         V. libanotica Zucc. 
         V. sessilifolia DC. 
         V. bottae Jaub. & Spach. 
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         V. mixta Vel. 
         V. hausknechtii Bornm. et Sint. 
       Section: Erecta 
         V. erecta Regel. et Schmalh. 
       Section: Major 
         V. major L. 
          subspecies: major 
          subspecies: hirsuta (Boiss.) Stearn 
           (syn. V. pubescens Urv.) 
      Section: Difformis 
         V. difformis Pourr. 
           subspecies: difformis 
           subspecies: sardoa Stearn 
       Section: Minor 
         V. minor L. 
       Section: Balancia 
         V. balancia Penzes. 
 
According to Aynilian et al. (1974), the taxonomy of the genus Vinca was not fully coherent. 
Based on the great variety of indole alkaloids present in the various Vinca species, several 
previous chemotaxonomic attempts had been made. The first of these studies was conducted by 
(Paris and Moyse, 1957) followed by Janot and co-workers (1965) pointed out that V. minor 
contains mainly alkaloids of class B (Aspidospermine type), while other Vinca species 
contained alkaloids of class B and class A (Yohimbine type), the latter prevailing regularly. 
Alkaloids of class C (Iboga type) and dimeric bases of the mixed B-C classes, were absent in 
Vinca and seemed to be characteristic of the genus Catharanthus by studying the distribution 
of indole alkaloids in Vinca species (Janot et al., 1965; Figure 2-1).  
         
 
Figure 2- 1: Characteristic types of indole alkaloids present in the genus Vinca. 
A comprehensive study on the occurrence of the different structural type of indole alkaloid was 
published by Novacek & Stary (1973) see Table 2-1. 
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Table 2- 1: Classification and distribution of A and B classes of indole alkaloids in the genus 
Vinca. 
Section Species 
Number of 
characterized 
alkaloids 
Class 
A 
Class 
B 
Predominant 
class 
1. Minor 1. V. minor L. 39 7 32 B 
2. Major 2a. V. major L. 12 9 3 A 
2b. V. difformis Pourr. 9 6 3 A 
2c. V. pubescens Urv. 3 3 0 A 
3. Herbacea 3a. V. herbacea Waidst. et Kit. 19 15 4 A 
3b. V. libanotica Zucc. 12 9 3 A 
3c. V. haussknechtii Bornm. et Sint. - - - - 
4. Erecta 4. V. erecta Regel. et Schmalh. 44 24 20 A 
Based on the results of their chemotaxonomic studies and on a critical evaluation of published 
data on genus Vinca systematic, Trojanek et al. (1973) divided the genus Vinca into 4 sections, 
comprising 8 species (Table 2-1). This classification agrees well, not only with the distribution 
of the basic alkaloid classes A and B but also with that of corresponding structural subgroups 
within these classes. A careful examination of Table 2-1 shows that there is justification for 
devoting a separate section to V. minor since it is the only species able to synthesize about 80% 
of its alkaloids as the B type. 
2.2 Characterization of Vinca minor L. 
Vinca minor is commonly known as myrtle or lesser periwinkle. It is a member of family 
Apocynaceae and considered as an evergreen perennial herbaceous plant  (Robinson, 1870; 
Knight, 2007; Booy et al., 2015). V. minor is a small subshrub (chamaephyte), non-native 
archaeophyte, which has been planted for centuries as an ornamental, medicinal and ritual plant 
(Čepková et al., 2016). Although it represents a European species, V. minor has been cultivated 
in the Mediterranean region at least since Roman times. Yet, the exact natural range of its 
distribution is unknown (Meusel et al., 1978). Today, the species is widely naturalised also in 
other continents. In Northern America, it is even regarded as an extremely problematic invasive 
species (Darcy and Burkart, 2002).  
In general, V. minor represents a typical ground-cover plant with a high degree of stem rooting. 
Its maximal high is about 15 cm. In Central Europe, it only rarely produces fruits, and 
accordingly, V. minor predominantly is reproduced clonally by long stolons (Čepková et al., 
2016). Its evergreen leaves reveal a lanceolate to an elliptical shape and are arranged oppositely 
(Figure 2-2). They are pointed or blunt with a leathery texture and an entire margin. The young 
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leaves are yellowish green, whereas the mature ones are glossy dark green (Figure 2-2). The 
petioles are about 3-4 mm long. The flowers are solitary in the leaf axils. Due to an induction 
by short day conditions, flowers produced mainly from spring to early summer, however in 
mild falls there will also be few flowers produced. The flowers are about 9-11 mm long and 25-
30 mm in diameter revealing a five-lobed corolla. Generally, they are violet-purple, however, 
in some cultivated selections, they also might be pale purple or white. The fruit is a pair of 
follicles, containing numerous seeds (Robinson, 1870;  Miller, 2003).  
The closely related species Vinca major is quite similar, but larger in size of all parts, with 
broader leaves and a hairy margin (Booy et al., 2015). 
 
`  
Figure 2- 2: Vinca minor L. - (a) old leaf; (b) young leaf; (c) habitus. 
With respect to climatic adaptation, V. minor reveals some xeromorphic characters: the leaves 
of V. minor are thick and the outer cell wall of the upper epidermis is strongly cutinized with 
thread-like wax formations. The leaves reveal a thick, two-layered palisade chlorenchyma and 
fiber bundles in the veins. The non-articulated laticifers are unbranched and found only on the 
lower side of the vascular strands. They often contain spherical particles (Fjell, 1983). 
According to  Chen et al. (2017), V. minor is resistant to cold, and its optimal growth 
environment temperature is 10 ⁰C. In addition, the authors reported that V. minor might be better 
than C. roseus in the production of secondary metabolites based on the growth environment, 
leaf morphology characteristics, energy input and MIAs yields.  
2.3 Indole alkaloids from V. minor  
2.3.1 Structural variation of the Vinca alkaloids 
The alkaloids of Vinca minor had been studied thoroughly by several research groups in Europe. 
Up to now, more than 50 indole alkaloids have been extracted and isolated from lesser 
periwinkle (Taylor, 1965; Aynilian et al., 1974; Proksa and Grossmann, 1991). Although 
b 
a 
c 
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different studies frequently reveal quite different compositions of indole alkaloids of V. minor, 
in all cases, the major alkaloid in the leaves was reported to be vincamine (eburnamine-type, 
25-65%) (Proksa and Grossmann, 1991; D'Amelio Sr. et al., 2012; Hasa et al., 2013). Apart 
from vincamine, many different groups are outlined. The three main groups: eburnamine (e.g. 
vincamine), aspidospermine (e.g. vincadifformine) and akuammiline (e.g. strictamine) groups 
are displayed in Figure 2-3. The detailed presentation of all 62 different structures is given in 
(Table A-1) in the appendix.  Kaczmarek and Lutomski, (1965) reported that V. minor collected 
between the middle of April and June contained the most of alkaloids with hypotensive activity, 
and is, therefore, suitable for pharmaceutical purposes.  
N
N
O
OMe
H
OH
Eburnamine group 
( e.g. vincamine )
N
N
O
OMe H
Akuammiline group
( e.g strictamine)  
N
H
N
O OMe
H
Aspidospermine group 
( e.g. vincadifformine)  
Figure 2- 3: The major groups of indole alkaloids in Vinca minor. 
2.3.2 Biosynthesis of indole alkaloids – general aspects 
As the result of numerous very early feeding experiments, it turned out that the C-9 and C-10 
moiety of the monoterpene indole alkaloids (MIAs) were derived from the acetate-mevalonate 
pathway to yield the iridoid skeleton, which was incorporated into indole alkaloids whose 
skeleton derived from tryptamine. It was postulated that the aliphatic C-9 and C-10 units are 
incorporated in three different basic forms to produce the three basic classes of indole alkaloids 
mentioned in Figure 2-1 (Aynilian et al., 1974). Meanwhile, using C. roseus as model plant, 
the biosynthesis of MIA is comprehensively elucidated (Thamm et al., 2016; Pan et al., 2016; 
Dugé de Bernonville et al., 2015; O'Connor and Maresh 2006). In contrast, despite its high 
economic importance, the corresponding biosynthesis of the alkaloids from V. minor is poorly 
studied. Nonetheless, due to the high genetic similarity between these both plants, the ample 
knowledge on the alkaloid biosynthesis in C. roseus can be exploited to identify the 
corresponding processes in V. minor. Accordingly, this literature survey focuses on the 
biosynthetic processes in C. roseus in order to create the basis for the designed experimental 
approaches with V. minor.  
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As proposed several decades ago, indole alkaloids are derived from the convergence of two 
primary metabolic routes: the shikimate and the secoiridoid pathways generating the indole and 
the terpene moiety of the universal MIA precursor, strictosidine (van der Heijden et al., 2004; 
Verma et al., 2012b). From strictosidine, a tremendous variety of different MIAs is derived (see 
Figure 2-4).  
 
Figure 2- 4: Strictosidine as precursors for the great variety of indole alkaloids. The secologanin 
skeleton in bold highlights changes of the chemical structure arising by skeleton rearrangements during 
biosynthesis. STR1: strictosidine synthase; SG: strictosidine glucosidase (Wu et al., 2016). 
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In principle, the biosynthesis of  MIAs can be conveniently divided into four stages (Thamm et 
al., 2016; Pan et al., 2016): 
a. The production of tryptamine  
Tryptophan is produced by the shikimate–pathway, which subsequently is converted to yield 
tryptamine by the action of the tryptophan decarboxylase (TDC). 
b. The production of secologanin (MEP and secoiridoid pathway) 
• Isopentenyl pyrophosphate (IPP) and Dimethylallylpyrophospate (DMAPP) is pre-
dominantly1 produced by the MEP pathway (2-C-methyl-D-erythritol-4-phosphate).  
• The iridoid pathway that converts geraniol to secologanin.  
c. The condensation of tryptamine and secologanin 
The condensation of both educts is catalyzed by strictosidine synthase. The product, 
strictosidine, corresponds to the central precursor for most of the MIAs. Deglycosylation of 
strictosidine gives rise to a series of unstable intermediates for the biosynthesis of many 
different classes of MIAs. 
d. Final modifications: 
 The unstable intermediates generated by the strictosidine deglucosylation are modified and 
converted to the corresponding final products. 
2.3.2.1 The production of tryptamine  
The shikimate pathway, a major biosynthetic route for both primary and secondary metabolism, 
is responsible for the generation of the aromatic amino acids. In principle, erythrose-4-
phosphate and two molecules phosphoenolpyruvate combined to yield chorismate. Chorismate 
represents an important branching point leading either to phenylalanine and tyrosine or, via 
anthranilate, to tryptophan, respectively. According to Herrmann and Weaver, (1999), the key 
enzyme in tryptophan biosynthesis is the anthranilate synthase (AS). Yet, the enzymes 
converting anthranilate to tryptophan has not been studied in C. roseus so far. Further on, 
tryptophan is converted by tryptophan decarboxylase (TDC) to tryptamine which provides the 
indole moiety to MIAs (Figure 2-5; 2-6).  
In the aerial tissues, the epidermis of the leaf has the maximum expression of the TDC gene. In 
the underground tissues, TDC transcripts are localized in protoderm and cortical cells around 
                                                          
1 With respect to some former works, IPP and DMAPP used for the biosynthesis of secologanin could 
also be provided by the acetate-mevalonate pathways (Coscia et al. 1969) 
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the root apical meristem. The early steps of the tryptophan pathway are thought to occur in 
plastids. The TDC enzyme essentially operates in the cytosol. This implies that tryptophan has 
to move out from plastids to the cytosol for its decarboxylation by TDC to yield tryptamine, 
which is immediately transported to the cell vacuole for its subsequent condensation with 
secologanin (Figure 2-5; 2-6; (Zhu et al., 2015; Pan et al., 2016)). 
 
 
Figure 2- 5: Biosynthesis of Catharanthus monoterpenoid indole alkaloid. Enzymes are indicated 
using capital letters and metabolites using lowercase letters. Solid arrows indicate enzymatic 
conversions. AS: anthranilate synthase; DXR: 1-deoxy-D-xylulose-5-phosphate reductoisomerase; 
DXS: 1-deoxy-D-xylulose-5-phosphate synthase; G10H: geraniol 10-hydroxylase; GES: geraniol 
synthase; GPPS: geranyl diphosphate synthase; IDI: isopentenyl diphosphate isomerase; LAMT: 
loganic acid O-methyltransferase; SGD: strictosidine glucosidase; SLS, secologanin synthase; STR: 
strictosidine synthase; TDC: tryptophan decarboxylase (Zhu et al., 2015; Li et al., 2015). 
 
 
monoterpenoid indole alkaloids 
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2.3.2.2 The production of secologanin  
Production of activated isoprenes  
Isopentenyl diphosphate2 (IPP) and dimethylallydiphosphate2 (DMAPP), the precursor for all 
terpenoids, are produced by either the mevalonate biosynthetic pathway (Coscia et al., 1969) 
or the MEP (methylerythritol phosphate) pathway. The MEP pathway involves seven 
enzymatic steps, starting from the condensation of pyruvate with D-glyceraldehyde-3-
phosphate ending with the production of IPP (El-Sayed and Verpoorte, 2007). The final product 
IPP is converted to dimethylallyl diphosphate (DMAPP) by isopentenyl diphosphate isomerase 
(IDI). The generation of geranyl diphosphate (GPP) results from the condensation of IPP and 
DMAPP by GPP synthase (GPPS) (Figure 2-5). 13C labeling experiments followed by NMR 
proved that the mevalonate-independent pathway (MEP) is the major route for the biosynthesis 
of, secologanin in C. roseus (Contin et al., 1998).  
The primary locations for the expression of genes in the MEP pathway are the internal phloem 
associated parenchyma cells (IPAP)  present in the periphery of stem pith or intraxylary on the 
upper part of the vascular bundles in leaves (Simkin et al., 2013). 
Secoiridoid pathway 
In the first step of iridoid terpene biosynthesis, geraniol is hydroxylated by geraniol-10-
hydroxylase (G10H). 10-hydroxygeraniol converted and glucosylated to yield loganic acid, 
which by the action of loganic acid methyltransferase (LAMT) is methylated to loganin. 
Finally, secologanin synthase (SLS) catalyzes the conversion of loganin to secologanin (Figure 
2-5; 2-6). 
The MEP pathway and early steps of the secoiridoid pathways take place in internal phloem 
associated parenchyma (IPAP) cells while the last two steps of the secoiridoid pathway are 
localized in the epidermis. Loganic acid is the mobile intermediate transferred from IPAPs to 
the epidermis. It was indicated that its transport might be a key biosynthetic rate controlling 
point for the fluxes in secologanin production (Pan et al., 2016). After being imported, loganic 
acid is methylated in the cytosol of the epidermis cells and subsequently further oxidized in the 
ER to yield secologanin  (Pan et al., 2016). 
 
                                                          
2  The abbreviation IPP and DMAPP are based on the old names isopentenylpyrophosphate and 
dimethylallypyrophosphate instead of isopentenyldiphosphate dimethylallydiphosphate 
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2.3.2.3 The condensation of tryptamine and secologanin  
The condensation of tryptamine (indole moiety) and secologanin (terpenoid moiety), catalyzed 
by strictosidine synthase (STR), generates strictosidine, which represents the central 
intermediate in MIA biosynthesis (Figure 2-6). Deglycosylation of strictosidine gives rise to a 
series of unstable intermediates for the biosynthesis of many different classes of MIAs Figure 
2-4 (Thamm et al., 2016). 
 
 Figure 2- 6: Spatial model depicting the subcellular organization of the strictosidine biosynthetic 
pathway in an epidermal cell of C. roseus leaves. Loganic acid is translocated from the internal 
phloem associated parenchyma cells (IPAP) into the epidermal cells, where it is methylated a further 
converted to yield secologanin. ‘?’ indicates the putative transportation system of tryptamine, 
secologanin, and strictosidine across the tonoplast. The number of repetitions of each enzyme name 
indicates whether it has been identified as a homodimer (LAMT or TDC) or multimer (SGD) (Guirimand 
et al., 2011). 
2.3.2.4 Final modifications  
The unstable intermediates generated by the deglucosylation of strictosidine (Figure 2-4) are 
modified and converted to the corresponding final products. In this sense, a tremendously high 
amount of different structures is produced. Well investigated examples are the conversion of 
tabersonine to vindoline by the means of 7 modifying reactions or the coupling of vindoline 
and catharanthine to yield dimeric MIAs such as vinblastine (Costa et al., 2008). Apart from 
oxidation and rearrangements also the loss of one or more C-atoms frequently contributes to 
the huge structural variation. Decarboxylation especially occurs at the carboxylic group in the 
from 
IPAP 
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secologanin moiety (Dewick 2009). Yet, as these modifications generally are very specific for 
each species, no further details are outlined in this overview. 
2.3.3 The alkaloid biosynthesis in V. minor  
With respect to the alkaloid biosynthesis in V. minor, only limited information are available. 
Yet, due to the close genetic relationship to C. roseus, it is assumed that the same general 
biosynthetic pathway yielding strictosidine, resulting from the condensation of tryptamine and 
secologanin occurs also in V. minor (Figure 2-7). Verma et al. (2014b) proposed that 
strictosidine will be - catalyzed by a corresponding β-glucosidase (SGD) - deglucosylated and 
further converted to tabersonine. The latter one should represent the common intermediate for 
the major monoterpenoid indole alkaloids in V. minor. This assumption could be supported by 
incorporations of tabersonine  in vincamine biosynthesis (Kutney et al., 1971).  
 
Figure 2- 7: Terpenoid indole alkaloid pathway in V. minor according to Verma et al. (2014b). Red 
broken arrows represent multi-step or uncharacterized reactions. *TDC: tryptophan decarboxylase, 
SLS: secologanin synthase, STR: strictosidine synthase, SGD: strictosidine β-glucosidase. In C. roseus 
the right branch of the biosynthetic pathway leads to catharanthine via  4,21-dehydrogeissoschizine 
precursor (Guo et al., 2013).  
As the terpenoid skeleton in vincamine corresponds to type B (aspidospermine type, Figure 2-
1; 2-8) like vincadifformine and vincatine, it was suggesting that vincamine biosynthetically 
should be derived from vincadifformine or from vincatine (Wenkert and Wickberg, 1965; 
(Catharanthine 
in C. roseus) 
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Saxton, 1983a; Kellner et al., 2015). In this sense, it is worth mentioning that both alkaloids, 
vincatine (Doepke et al., 1969) and vincadifformine (Plat et al., 1962) co-occur with vincamine 
in V. minor (Herbert, 1983). 
 
Figure 2- 8: Putative conversion of vincadifformine to vincamine. According to Mascavage et al. 
(2010), there are two possibilities to obtain vincamine from vincadifformine. 
2.3.4 Regulation of indole alkaloids biosynthesis  
Most of the monoterpene indole alkaloids (MIAs) reveal an important pharmacological 
relevance. Examples for their pharmacological effects are the anti-tumoral activity of the 
alkaloids from C. roseus, or the peripheral vasodilator activity for those from V. minor 
(Kutchan, 1995; Hasa et al., 2013; Pan et al., 2016). Since certain bioactive alkaloids often are 
present only in low concentrations in the corresponding plants, of many attempts had been made 
to increase their yields and to identify the factors regulating their synthesis and accumulation. 
Numerous studies applying various biotic and abiotic cues to monoterpenoid containing plants, 
elucidated that many different signaling pathways, including activating phosphorylation 
cascades, ion channel activity, accumulation of jasmonic acid (JA), salicylic acid (SA), abscisic 
acid (ABA), ethylene, nitric oxide (NO) and reactive oxygen species (ROS) generation are 
involved in the regulation of the genes responsible for the alkaloid biosynthesis.  
Since most of these data are derived from research employing C. roseus, in the following 
chapter, the corresponding insights are outlined in detail first for C. roseus solely. Subsequently, 
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on these coherences are merged with the limited data available for V. minor, in order to generate 
the scientific basis for the actual research presented in this thesis. 
2.3.4.1 Regulation of alkaloids biosynthesis in C. roseus  
MIA biosynthesis is highly complex and related to plant defense. It is controlled by a number 
of different signals including developmental cues, light, biotic and abiotic stress. Moreover, the 
synthesis of indole alkaloids in C. roseus strongly is affected by growth hormones (for review 
see (Zhao et al., 2001a; El-Sayed and Verpoorte, 2007; Almagro et al., 2015; Zhu et al., 2015; 
Pan et al., 2016). Yet, as this is extensively studied and not of major relevance for this thesis, 
the following review focuses growth regulators, which are known to impact the indole alkaloid 
synthesis. In this context, JA reveals the main attention due to its importance as a key regulator 
in the corresponding signaling pathways (DeGeyter et al., 2012). 
Jasmonate 
Jasmonates (JAs) is frequently used as a collective term for 
jasmonic acid and their derivatives, like methyl jasmonate 
(MeJA) and other functionally active structural analogues. 
JAs are known to induce expression of genes involved in 
the biosynthesis of various natural products (e.g., De 
Geyter et al., 2012), including the biosynthesis MIA 
(Gundlach et al., 1992).  
JAs are fatty acid derivatives synthesized by the so-called 
the octadecanoid pathway (Wasternack, 2007). Cleavage of 
membrane lipids by lipases yields α-linolenic acid, which 
is converted to the stable intermediate 12-oxo-phytodienoic 
acid (OPDA) by actions of 13-lipoxygenase (LOX2), 13-
allene oxide synthase (AOS) and allene oxide cyclase 
(AOC). Reduction of this intermediate by OPDA reductase 
(OPR) and three subsequent β-oxidations yield jasmonate. 
Methylation of jasmonate yields the volatile hormone 
MeJA, and conjugation of jasmonate to isoleucine provides 
the most active form of JAs, jasmonoyl-isoleucine (JA-Ile; 
(Delker et al., 2006; Thines et al., 2007; Howe, 2018); 
Figure 2-9).  
Figure 2- 9: Scheme of jasmonates 
biosynthesis pathway (Delker et al., 
2006).  
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Jasmonates are plant hormones that play key roles in signal transduction in many different 
responses to biotic or abiotic stress, including attacks by pathogens and herbivores, or drought 
stress (Creelman et al., 1992; Gundlach et al., 1992; Creelman and Mullet, 1997; Turner et al., 
2002; Riemann et al., 2015). In most cases, jasmonate signaling leads to altered expression of 
genes, which encode various defense proteins or enzymes involved in the biosynthesis of 
natural products responsible for repelling herbivores or defending pathogens (Wei, 2010; 
Montiel et al., 2011; Okada et al., 2015). Moreover, jasmonic acid (JA) is also involved in the 
induction of leaf senescence and the corresponding catabolic processes (He et al., 2002; El-
Sayed and Verpoorte, 2005; Qi et al., 2015).  
One of the most prominent examples for the impact of methyl jasmonate (MeJA) on secondary 
metabolism concerns the indole alkaloids in Catharanthus roseus (Aerts et al., 1994; Rijhwani 
and Shanks, 1998; Rodriguez et al., 2003; El-Sayed and Verpoorte, 2005). Since jasmonates 
are involved in the induction and regulation of many different metabolic processes, clear and 
unequivocal cause-effect relationships cannot be observed in most cases. Indeed, when 
reviewing the related literature dealing with the impacts of MeJA on the synthesis and 
accumulation indole alkaloids in C. roseus, many - at first glance - contradictory findings are 
presented. For example, in hairy root cultures, the application of MeJA leads to a significant 
increase in the content of indole alkaloids and to a shift in their composition (Rijhwani and 
Shanks, 1998; Rodriguez et al., 2003). In the same manner, also in mature C. roseus plants, the 
indole alkaloid content was increased by MeJA application (Naeem et al., 2017). In contrast, 
Pan et al. (2010) showed that a MeJA treatment had no effect on the indole alkaloid 
accumulation in mature C. roseus leaves. Aerts et al. (1994) showed that MeJA effectively 
enhanced indole alkaloid biosynthesis in developing seedlings of C. roseus and that the 
enhancement of alkaloid biosynthesis decreased with age of the seedlings. In addition, the 
authors reported that the treatment of seedlings with MeJA induced changes in the content of 
tabersonine and caused the occurrence of additional peaks revealing a similar UV spectrum to 
tabersonine. However, due to preliminary results, the authors proposed that these alkaloids are 
neither hydroxy- nor methoxy- derivatives of tabersonine, which are known as the first two 
intermediates in the biosynthetic pathway from tabersonine to vindoline (Aerts et al., 1994). 
Further studies on the synthesis of MIAs employing C. roseus seedlings unveiled a high 
variability of the MeJA response (Wei, 2010). It was mentioned that the related impact of a 
MeJA treatment on the expression of genes responsible for alkaloid biosynthesis varied 
drastically - in magnitude as well as in timing. Accordingly, it is difficult to correlate any 
putative changes in indole alkaloid contents with alterations in the expression of specific genes 
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responsible for their biosynthesis (Wei, 2010). A compilation of the various MeJA effects on 
the MIA biosynthesis in C. roseus is outlined in Figure 2-10.  
 
Figure 2- 10: Gene regulation scheme of the reported transcription factors involved in the MIA 
pathways. Dashed lines represent interactions that may be direct or indirect. Solid lines indicate 
potentially direct interactions. Lines with arrows represent transactivation, and lines with bars represent 
transrepression. GA gibberellic acid, ET ethylene. Enzymes in black represent to be regulated by 
reported transcription factors, enzymes in grey represent that their regulation has not been reported and 
remained unclear (Pan et al., 2016). 
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Moreover, as further conjuncture is overcomplicating the described impacts of MeJA on the 
accumulation of MIA: when MeJA was applied to the detached leaves of C. roseus, the 
catabolism of alkaloids was strongly enhanced (El-Sayed and Verpoorte, 2005). All these – at 
least in part - inconsistent coherences clearly illustrate that in forthcoming investigations to 
elucidate any putative effect of MeJA on indole alkaloid biosynthesis, it is vital to consider 
thoroughly the physiological status of the plants. In this way, the effects of MeJA might be 
segregated from the effects of endogenous jasmonates produced due to natural stress situations 
or due to aging and senescence processes. 
Salicylic acid 
In addition to JA, salicylic acid (SA) is another important signaling molecule in plants. It has 
been well documented that SA is involved the defense responses related to the systemic 
acquired resistance (SAR) by activating defense-related genes (Thomma et al., 2001; 
Hasanuzzaman et al., 2017). Aerts et al. (1996) reported that the content of alkaloids is not 
affected when SA is applied to C. roseus seedling. In the same manner, Guo et al. (2013) did 
not find any effect on the MIAs when SA is applied to corresponding suspension cultures. In 
contrast, other authors reported the opposite effect: when SA is applied to seedlings or 
suspension cultures, respectively, the content of alkaloid increased (Godoy-Hernández and 
Loyola-Vargas, 1997; El-Sayed and Verpoorte, 2004). Similarly, the concentration of 
vinblastine, vindoline, and catharanthine significantly increased within a very short time period, 
when SA was applied to C. roseus plants at blooming stage (Pan et al., 2010).  
Hydrogen peroxide 
H2O2 (Hydrogen peroxide) is a strong oxidizing agent, which is produced in the course of many 
reactions occurring in plants. The main source of H2O2 is related to the detoxification of 
superoxide radicals produced in the chloroplasts under drought stress by superoxide dismutase 
(Cruz de Carvalho, 2008). In general, the hydrogen peroxide is removed by ascorbate 
peroxidase (Asada, 1992). Moreover, huge amounts of hydrogen peroxide are involved 
lignification by creating the precursors for the radical chain reaction, and in photorespiration, 
resulting from the peroxidation of glycolate, tremendous quantities of H2O2 are generated, 
which are removed by the action of catalase (Slesak et al., 2007; Saxena et al., 2016). 
In addition to these metabolic reactions, hydrogen peroxide also represents an important 
widespread signal molecule or signal transducer, respectively. It is involved in the induction of 
phytoalexin biosynthesis in the course of host-pathogen interactions, frequently denoted as 
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oxidative burst (Wojtaszek, 1997); or in numerous signalling events by interacting with other 
signal molecules, such as JA, ethylene, Ca++, NO etc. (for review see (Saxena et al., 2016)). 
Various reports have been published, outlining that hydrogen peroxide is enhancing gene 
expression of various plant secondary metabolites (Wang et al., 2011a). With respect to the 
MIAs only limited data are available. The concentration of indole alkaloids in leaves was 
positively elevated after exogenous application of H2O2 to C. roseus seedling. The time-course 
variations of alkaloid content showed significant correlation with redox state after H2O2 
treatment (Tang et al., 2009). Guo et al. (2013) mentioned that the application of H2O2 enhances 
the content of tabersonine in the cell suspension culture of C. roseus, while the biosynthesis of 
catharanthine and serpentine was significantly decreased. On the contrary, when the 
concentrations of hydrogen peroxide was increased further on, the content of tabersonine within 
the cells decreased, maybe as result of cell damage by high concentrations of H2O2. 
Alternatively, it could be assumed that tabersonine might be oxidized, since it is known that 
MIAs can act as an efficient substrate for peroxidase in C. roseus (Tang et al., 2009). The 
corresponding decrease in the concentration of H2O2 due to the peroxidation of MIAs is 
discussed by Tang et al. (2009) as contribution to antagonizes the oxidative environmental 
stress (Xu and Dong, 2005; Tang et al., 2009; Matsuura et al., 2014). 
2.3.4.2 Regulation of alkaloids biosynthesis in V. minor 
Based on the comprehensive knowledge of the regulation of alkaloid biosynthesis C. roseus 
outlined above, Verma and coworkers (2014b) used several approaches to elaborate 
information on the regulation of the biosynthesis of MIAs in V. minor. According to the 
biosynthetic pathway outlined in Figure 2-7, tabersonine represents an important branching 
point. The authors applied naproxen to hairy roots cultures of V. minor, which is known to 
modulate the serpentine biosynthesis in C. roseus by inhibiting the cyclooxygenase (Guo et al., 
2011). In contrast to the findings in C. roseus, where naproxen – as expected – lead to a decrease 
in the serpentine concentration (left branch outlined in Figure 2-7) accompanied by an increase 
in the catharanthine concentration (right branch). Yet, in hairy root cultures of V. minor, 
naproxen had no effect, neither on total alkaloid nor on vincamine content (Verma et al., 
2014b). Unfortunately, the authors used a system, in which no vincamine was present even in 
the control and thus no “right branch” was present. Nevertheless, some insights in the regulation 
of MIAs could be elaborated: hydrogen peroxide caused a significant enhancement of total 
alkaloid content. Obviously, H2O2 is involved also in V. minor in the regulation of MIAs.  
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2.3.5 Localization of indole alkaloids in V. minor and C. roseus: revision of the alleged 
surface localization  
Plants are well known to secrete an array of secondary metabolites onto their surfaces (e.g.; 
LoPresti, 2016). According to our basic understanding of chemical ecology, these substances 
represent the first chemical barrier against herbivory or attack by fungal or bacterial pathogens. 
Apart from waxes, these exudates may contain unusual fatty acids and triterpenes, e.g., the leaf 
of the bitter olive Olea europaea (Oleaceae) is heavily coated by oleanolic acid, which acts as 
a potent barrier (Kubo and Matsumoto, 1984). Unfortunately, only a little evidence for the 
secretion of alkaloids onto the plant surface is available. Just recently, it was reported that 
water-soluble pyrrolizidine alkaloids are present at the surface of Senecio jacobaea (Vrieling 
and Derridj, 2003). Although the levels found were small compared with those within the 
leaves, the authors deduce that the alkaloids had been exuded.  
Concerning the occurrence of MIAs on the leaf surface, various studies for C. roseus and V. 
minor had been published. Roepke et al. (2010) reported that catharanthine is present at the leaf 
surface of several Catharanthus species, whereas vindoline, anhydrovinblastine, and other 
MIAs would be accumulated only within leaf cells. Indeed, catharanthine was present in so-
called chloroform surface extracts, whereas chlorophyll and the other MIAs were absent - as 
well as chlorogenic acid, which the authors claimed to be a marker for symplastic leaf epidermis 
metabolites (Roepke et al., 2010). Unfortunately, these deductions are false, since chloroform 
– even when only a short time is applied – will destroy the plasmalemma of the epidermal cells 
and change the localization of substances (Bewick et al., 1993; Derridj et al., 1996). 
Consequently, catharanthine will also be present in the chloroform extract when it is localized 
within the epidermis (symplastically). Moreover, chlorogenic acid, the proposed symplastic 
marker, used by the authors, is insoluble in chloroform (Lu et al., 2004) and accordingly will 
not be present in the organic phase even when the cells are disrupted. Yet, the fact that 
catharanthine is present in the extracts whereas vindoline, anhydrovinblastine are not, points to 
a differential spatial localization of the different MIAs. It seems to be very likely that 
catharanthine is present in the epidermal layer, whereas the other MIAs predominantly are 
located within the mesophyll. In this context, much more research employing sound and reliable 
methods are required. The situation corresponding the localization of MIAs in C. roseus 
becomes even more complex, since by using both, imaging mass spectrometry (MS) and single-
cell MS, (Yamamoto et al., 2016) shown that – at least in the stem of C. roseus – all MIAs are 
accumulated in idioblast and laticifer, whereas the only catharanthine is also present in the 
epidermal layer. The authors did not detect any substances in the wax layer. 
Moreover, Demessie et al. (2017) postulated that MIAs, vincamine, akuammicine, lochnericine, 
minovincinine and vincadifformine are secreted on leaf surfaces of V. minor. Unfortunately, 
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also, in this case, the same doubtful method had been applied. Accordingly, there is no evidence 
for an apoplastic occurrence of MIAs in V. minor. It is worth mentioning that pattern of surface 
and whole leaves extract of indole alkaloid mentioned by (Demessie et al., 2017) did not match 
at all to earlier published data of chemistry of leaves of V. minor (Proksa and Grossmann, 1991; 
D'Amelio Sr. et al., 2012; Hasa et al., 2013) especially vincamine is present only in minor 
amounts. Overall, the data presented in this publication have to be queried. 
According to the alleged occurrence of MIAs on the surface of V. minor leaves, it was argued 
that corresponding carrier systems must be present, which should be responsible to exude the 
alkaloids into the apoplastic cuticle. Based on transporter assays employing yeast cell, in which 
the putative transporters (CrTPT2) had been heterologously expressed, efflux velocities for 
vincamine and vincadifformine had been analyzed (Demessie et al., 2017). The authors 
postulated that the secretion mechanism of the MIAs is mediated by an ABC transporter. 
However, as in many cases, alkaloids are re-located within the plants (Yazaki et al., 2008; 
Pakdeechanuan et al., 2012). In this context, it has to be considered that these transporters have 
to efficiently bind and translocate the alkaloid cations, whereas the free base diffuses freely 
through biomembranes. In fact, using isolated vacuoles from C. roseus leaves,  Carqueijeiro et 
al. (2013) demonstrated that catharanthine and vindoline were accumulated in the vacuoles of 
mesophyll cells. The authors postulated that this accumulation is driven by a specific proton 
antiport system, which dependents on the transtonoplast pH gradient generated by V-H+-
ATPase from leaves. In addition, Yamamoto et al. (2016) reported that the complex distribution 
pattern of the MIA intermediates in C. roseus suggested that the enzymes responsible for 
synthesis are located in one cell type, but that the enzyme products are then moved to other 
cells. Furthermore, the former authors tried to explain these contradictions in the observed 
results by assuming that different cultivars with different developmental stages, and growth 
conditions, may likely affect the compartmentalization expression of the MIAs pathway. In 
consequence, the occurrence of a transporter for MIAs does not prove that the alkaloids are 
exuded. Based on the coherences outlined, it seems to be very likely that these transporters are 
required for translocation of these substances out of the vacuoles. 
2.4 Non-alkaloidal compounds of V. minor 
In comparison to the extensive literature on MIAs, only very little work has been done 
concerning the isolation and identification of non-alkaloidal natural products from V. minor. 
Up to now, predominantly various phenolic compounds are reported to occur; apart from 
several typical flavanoids (various kaempferol and quercetin glycosides) also chlorogenic acid 
and some dihydroxybenzoic acid derivative had been reported (Raynaud et al., 1970; Nishibe 
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et al., 1996). Moreover, ursolic acid and various steroids (β-sitosterol, triacontane; (Le Men and 
Hammouda, 1956) also lignans such as lirioresinol B, and anthocyanin (Tatsuzawa, 2015) had 
been detected to occur in the little periwinkle (Garnier et al., 1975). 
2.5 Biological activity of V. minor 
2.5.1 In folk medicine 
In folk medicine, little periwinkle is used internally for circulatory disorders, cerebral 
circulatory impairment and support for the metabolism of the brain. It is also used internally for 
loss of memory, hypertension, cystitis, gastritis, and enteritis, diarrhea, raised blood sugar levels 
and to help weaning. Periwinkle is used externally for sore throats, nose bleeds, bruising, 
abscesses, eczema and to stop bleeding. In Homeopathy extracts of V. minor are used to treat 
weeping eczema and bleeding mucous membranes (Fleming, 2004). 
2.5.2 Vincamine and derivatives as cerebrovascular and neuroprotective agents 
Vincamine, frequently denoted as ‘‘mother compound’’ of cerebrally active eburnamine 
derivatives, was first isolated from the leaves of Vinca minor. The first pharmacological studies 
were done by several research groups in the 1960s (Raymond-hamet, 1954; Quevauviller et al., 
1955). These studies demonstrated the beneficial effect of vincamine on circulation by 
decreasing arterial blood pressure, cardiac output, and heart rate. Yet, the extensive 
investigation revealed that vincamine strongly improved cerebral functions, rather than to lower 
the blood pressure. In consequence, vincamine was introduced for the treatment of cerebral 
insufficiencies in Europe (Vas and Gulyás, 2005). Subsequently, research focused on the 
mechanism of action of this alkaloid. Furthermore, based on structural modification and the 
identification of further MIAs, more potent derivatives had been searched. Out of several 
thousand derivatives investigated, only three reached the pharmaceutical market. These 
compounds reveal the significant beneficial effect on brain circulation and neuronal 
homeostasis. The common structural features of these three molecules are given by the cis-
fused ring system of vincamine, and the esterification of the carbonyl function at C-16 (Figure 
2-11). 
Until now, various molecular targets of vincamine and its synthetic derivative (vinpocetine) are 
known, the phosphodiesterase-1 (PDE-1), the voltage-dependent Na+ and Ca2+ channels, and 
glutamate receptors. In particular, the inhibition of PDE-1 seems to be responsible for the 
positive vascular effects, for the improvement in cerebral circulation, and for the beneficial 
effect on platelets (Tárnok et al., 2008; Nemes, 2010; Medina, 2011). 
Chapter 2: Scientific background 
 
26 
  
 
Figure 2- 11: Structures of clinically used vincamine derivatives according to Nemes, (2010). 
Abdel-Salam et al. (2016) reported that the low therapeutic doses of vincamine and vinpocetine 
present in several nootropic drugs reveal antioxidant and neuroprotective effects. Higher doses 
are thought to have pro-oxidant and pro-inflammatory properties. This is underlined by the 
finding that vincamine protects PC12 cells against hydrogen peroxide-induced oxidative stress. 
The underlying molecular mechanism was elucidated by (L Wu et al., 2016) who demonstrated 
an up-regulation of superoxide dismutase and an activation of the phosphatidylinositol-3 
kinase/protein kinase B pathway. Other studies also provide the evidence that vinpocetine may 
exert protective effects via modulating oxidative stress and apoptosis in Mn-induced 
neurodegeneration in NE-4C cells (Bora et al., 2016). In addition, further studies showed that 
vinpocetine possessed anti-inflammatory activity by inhibiting of NF-κB activation and 
subsequent up-regulation of pro-inflammatory cytokines (Ghosh et al., 1998; Jeon et al., 2010; 
Medina, 2010), while others demonstrated a novel role of vinpocetine to decrease lipid 
accumulation and atherosclerosis formation in mice (Cai et al., 2013). 
Antioxidant activity of alkaloids could have implications for the better understanding of plant 
protection mechanisms against stresses and to find out additional pharmacological uses for 
MIAs. For instance, vincamine of V. minor, used as a neuroprotective agent, caused a decrease 
in the iron content of rat brain, possibly decreasing oxidative stress caused by the accumulation 
of this metal during neurodegenerative processes (Fayed, 2010; Han et al., 2017). Additionally, 
the semi-synthetic MIA vinpocetine (produced from vincamine) inhibited the free radical 
formation and lipid peroxidation in brain striatum-isolated nerve endings (Herrera-Mundo and 
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Sitges, 2013). These studies could state the proposed protective role of vincamine in the plant 
against ROS produced under different stress situations. 
2.5.3 The cytotoxic and antimicrobial activities of V. minor 
Numerous studies have been carried out to investigate the cytotoxic and antimicrobial activities 
of the V. minor plant extracts. The corresponding results are displayed in Table 2-2. 
Table 2- 2: Cytotoxic and antimicrobial activities of V. minor. 
Compound/ extract Activity References 
Vincarubine  Cytotoxic effect against leukemia cells (Proksa et al., 1986; 
Sturdíková et al., 1986; 
Proksa et al., 1988) 
Vincadifformine The cytotoxic activity against leukemia 
cells is higher than that of vinblastine 
(Sturdíková et al., 1986; 
Khanavi et al., 2010) 
Vincamine Antifungal and antibacterial activity (Ozçelik et al., 2011) 
Fractions of alkaloid 
extract  
Cytotoxic effects on breast ductal and 
colon carcinoma, and colorectal 
adenocarcinoma cells 
(Khanavi et al., 2010) 
Aquatic, acetone 
and ethyl acetate 
extracts 
Toxic effects against Rhodotorula and 
Candida. 
(Yildirim et al., 2013; 
Grujić et al., 2015) 
2.6 Completion 
The brief review of the literature presented above expounds that - in contrast to the rich 
literature on the biosynthesis of indole alkaloids and its regulation in C. roseus –corresponding 
information for V. minor is limited. Although numerous studies outlined quite different 
compositions of indole alkaloids of V. minor, in all cases, the major alkaloid in the leaves was 
reported to be vincamine (Proksa and Grossmann, 1991; D'Amelio Sr. et al., 2012; Hasa et al., 
2013). As known for other alkaloids, the content of vincamine varies largely depending on 
growth and climatic conditions, the season, and putative stress situations (Boyadzhiev et al., 
2002). Accordingly, in this study, which should generate new approaches for phytochemical 
drug discovery, only mature V. minor plants of defined physiological status will be used to 
investigate the effect of MeJA treatment and of application of other growth regulators on the 
composition of alkaloids. Apart from such modulation of the composition of pharmaceutically 
active compounds by applying growth regulators, in principle, also gene technological 
approaches, i.e., by modifying certain gene responsible for the secondary metabolism or its 
regulation respectively, could be accomplished. Yet, such strategy is not in the centre of focus 
of this thesis. 
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Chapter 3: Materials and methods 
3.1 Plant material and chemicals  
3.1.1 Plant material 
Vinca minor L. mature plants at the blooming stage were purchased from a commercial market 
garden (Brennecke GmbH, Braunschweig, Germany). 
3.1.2 Chemicals  
Name Purity  Company  
• Acetic acid HPLC Fisher Scientific, Loughborough, UK 
• Acetonitrile HPLC VWR, Leuven, Belgien, Germany 
• Ammonium acetate HPLC Fluka, Steinheim, Germany 
• Ammonium hydroxide 25% Roth, Karlsruhe, Germany 
• Catharanthine  ≥ 95% Sigma-Aldrich, Steinheim, Germany 
• CHCl3-d 99.96 % Deutero, Kastellaun, Germany 
• Chloroform Analytical grade Fisher Scientific, Loughborough, UK 
• DMSO-d6 99.96 % Deutero, Kastellaun, Germany 
• Formic acid 99% LC/MS VWR, Leuven, Belgien, Germany 
• Hydrochloric acid 37% Roth, Karlsruhe, Germany 
• Hydrogen peroxide 30% Roth, Karlsruhe, Germany 
• Methanol  HPLC VWR, Leuven, Belgien, Germany 
• Methyl jasmonate 95% Sigma-Aldrich, Steinheim, Germany 
• Naproxen  ≥ 98% Sigma-Aldrich, Steinheim, Germany 
• Resveratrol  ≥98 % Roth, Karlsruhe, Germany 
• Salicylic acid ≥99 % Sigma-Aldrich, Steinheim, Germany 
• Strychnine  98% Sigma-Aldrich, Steinheim, Germany 
• Triethylamine HPLC Fisher Scientific, Loughborough, UK 
• Trifluoroacetic acid 99.9% Roth, Karlsruhe, Germany 
• Triton X- 100 laboratory grade Sigma-Aldrich, Steinheim, Germany 
• Vincadifformine  95% Carbosynth, UK  
• Vincamine  ≥97.0% Sigma-Aldrich, Steinheim, Germany 
• Vindoline ≥98.0% Sigma-Aldrich, Steinheim, Germany 
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3.2 Equipment and parameters  
➢ High-Performance Liquid Chromatography (HPLC)  
• Pump: YL9110 Quaternary Pump 
• Degasser: YL9101 Vacuum Degasser 
• Injector: Autosampler Midas Spark Holland, Model 830 
• Column oven: YL9130 Column Compartment 
• Detector: YL9160 PDA Detector 
• Software: YL-Clarity, Chromatograph Data System, Vers. 4.0.4.987 
➢ Liquid chromatography-mass spectrometry (LC-MS)  
• HR-ESI-MS and LC-ESI-MS/MS experiments were recorded using a Bruker maxis HD 
UHR-TOF mass spectrometer with Apollo II ion funnel ESI Electrospray source. A 
UHPLC-system (Ultimate3000RS from Dionex/Thermo) was used for separation.  
• The program used for analysis of LCMS data: Bruker Compass Data Analysis 4.2 
(Bruker Daltonic GmbH, Bremen, Germany). Included Function (Find Molecular 
Features) was used for the quantification. The mass spectrum calculation was performed 
with Line Spectra. 
• Mass spectrometric condition: The mass spectrometer was operated in positive 
electrospray ionization mode and spectra were recorded by scanning the mass range 
from 50 to 1500 m/z in both MS and MS/MS modes. Nitrogen was used as drying, 
nebulizing and collision gas. The drying gas flow rate was 9.0 L/min. The dry gas 
temperature was set to 200 °C and nebulizer pressure at 4.0bar. For the MS/MS analysis, 
the collision energy was ramped between 17 and 55 eV, depending on the fragmented 
m/z and the charge state of the isolated mother ion.  
➢ Nuclear Resonance Spectroscopy (NMR)  
NMR spectra were recorded using a Bruker Avance III 700 spectrometer with a 5 mm TCI 
cryoprobe (1H 700 MHz, 13C 175 MHz) and an Avance III 500 (1H 500 MHz, 13C 125 MHz) 
spectrometer (performed by Dr. Frank Surup, Microbial Drugs Department, Helmholtz Centre 
for Infection Research, Braunschweig). 
➢ Polarimeter 
Optical rotations were determined using a Perkin-Elmer 241 Polarimeter, USA  
➢ UV-Vis spectrophotometer 
UV spectra were recorded using a Shimadzu UV-Vis spectrophotometer UV-2450, Japan 
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➢ Freeze drying  
• Device: Lyovac GT2, Finn-Aqua, Germany 
• Pumpe: Trivac, Leybold 
➢ Ball mill (Retsch MM200), Germany 
➢ Turbo Vap LV evaporator (Zymark), USA 
➢ Rotary Evaporators (Heidolph type VV2000), Germany  
➢ Ultrasonic bath (Bandelin Sonorex), Germany 
➢ Hettich Rotixa/RP Centrifuge, Germany 
➢ Eppendorf centrifuge (5415 D), Germany 
➢ Vortex-Genie 2, Scientific industries, USA 
3.3 Extraction and isolation of indole alkaloids from Vinca minor control and MeJA-
treated leaves 
3.3.1. Plant growing conditions 
Vinca minor mature plants at the blooming stage were purchased from a commercial market 
garden (Brennecke GmbH, Braunschweig, Germany). The individual plants were transferred 
into pots (15 cm in diameter) containing a soil-sand mixture (3:1), prepared from commercially 
available substrate (Floragard, Oldenburg, Germany) and sand. During acclimation phase, the 
soil moisture of all pots was adjusted to 25–30%, and the temperature range during the 
experiment was 15–20 °C. Plants were grown in the garden of the Institute of Plant Biology of 
TU-Braunschweig. Plants were kept under rain shelter to prevent water input from the rain 
Figure 3-1. 
 
Figure 3- 1: Vinca minor plants at the beginning of the experiment. 
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3.3.2 Application of methyl jasmonate 
For application of MeJA, plants were taken out of the growth area and transferred into an open 
area in about 20 m distance from the control plants and sprayed with MeJA solution (0.5 mM, 
containing 0.2% Triton X; (Kleinwächter et al., 2015)) on both sides of the leaves, until liquid 
dripped from the leaves (15 mL/plant), MeJA was applied two times during the experiment (on 
days 1 and 4). Treated plants were harvested after 9 days. 
3.3.3 Sampling 
Arial parts of experimental plants were cut from their roots. The leaves were separated from 
the stems. The plant material was shock frozen in liquid nitrogen and stored at −20 °C until 
further extraction and analyses. For preparative work, above ground parts of 6 plants were cut 
from their roots and shock-frozen and freeze-dried in liquid nitrogen.  
3.3.4 Analytical methods 
For determination of alkaloids, 300 mg of freeze-dried leaves was ground to a fine powder 
using a ball mill (RetschMM200). Then a sample was extracted with methanol (3 × 2 mL) in 
an ultrasonic bath at 50 °C for 30 min. After centrifugation (10 min at 2,500 x g), the combined 
methanolic (MeOH) extracts were evaporated using Zymark Turbo Vap evaporator, USA, at 
50 ⁰C. The dried MeOH extract was further extracted with 2 mL and subsequently with 1 mL 
of 3% HCl (twice) in an ultrasonic bath at 50 ⁰C for 30 min. After centrifugation (10 min at 
4000 rpm), the combined aqueous extracts were cooled at 4 °C and treated with 25% ammonium 
hydroxide (NH4OH) to reach pH 8-9. Alkaloids were extracted three times with CHCl3 (3 × 2 
mL). Combined CHCl3, extracts were dried (constant weight) and then dissolved in MeOH (1 
mL). Before performing LCMS analysis, samples were filtrated (0.45 µm, Spartan). 
The LC-MS separation was performed on a Kinetex C18-column (1.7 µm, 100 Å, 150 × 2.1 
mm) from Phenomenex, using a gradient system. Solvent A was water with 0.1% formic acid, 
and solvent B was acetonitrile with 0.1% formic acid. The gradients used were 0 min, 1% B; 5 
min, 15% B; 42 min, 30% B; and 50 min, 100% B. The flow rate was 300 µL/min. The overall 
runtime was 60 min at a column temperature of 40 °C.  
3.3.5 Extraction and isolation of pure compounds from MeJA-treated plants  
Ten grams of freeze-dried aerial parts were extracted as previously mentioned to obtain 
approximately 150 mg of crude alkaloids. The alkaloids were dissolved in methanol and 
separated by HPLC. Separation was performed on a VP 250/10 Nucleosil 100-5µ RP-18 semi-
preparative column using a gradient system. A: acetonitrile; B: ammonium acetate (15 mM), 
Chapter 3: Materials and methods 
 
32 
  
containing 0.2% triethylamine, adjusted with acetic acid to pH 4. The gradients used were 0 
min, 15% A, 85% B; 7 min, 20% A, 80% B; 42 min, 40% A, 60% B; 47 min, 80% A, 20% B; 
50 min, 15% A, 85% B; and 60 min, 15% A, 85% B. The flow rate was 3 mL/min. The injection 
volume was 100 µL by manual injection. Alkaloids were monitored using a photodiode array 
(PDA) detector at 254, 280, and 330 nm. Fractions were manually collected and combined 
according to the observed peaks. Eight fractions were collected (Figure 3-2; 3-3): fraction 1 
afforded compound 9 with a retention time tR= 10.5 min; fraction 2, compound 6 at tR= 16.8 
min; fraction 3, compound 1 at tR= 21.8 min; fraction 4, compound 2 at tR= 25.9 min; fraction 
5, compound 7 at tR= 29.4 min; fraction 6, compound 5 at tR= 30.2 min; fraction 7, compound 
3 at tR= 35.1 min; and fraction 8, compound 4 at tR= 39.3 min. 
 
Figure 3- 2: Semi-preparative HPLC separation chromatogram of the major indole alkaloids 
determined in V. minor treated with MeJA. 
Due to the presence of NH4OAc and Et3N, the exact weight of the substances could not be 
determined at this stage of isolation. Thus, to eliminate the NH4OAc and Et3N and for further 
purification, the freeze-dried samples were dissolved in MeOH and again purified by HPLC. 
Solvent A: acetonitrile, 0.1% formic acid or TFA; B: H2O with 0.1% formic acid or TFA. The 
gradients used were 0 min, 15% A; 5 min, 20% A; 42 min, 40% A; 45 min, 80% A. The flow 
rate was 3.5 mL/min. After freeze-drying, the alkaloids were weighed (approximate yield 
compound 9= 1 mg, 6 = 3 mg, 1 = 3 mg, 2 =3 mg, 7 = 1.5 mg, 5 = 3 mg, 3 = 2 mg, 4 = 2 mg) 
and analysed (Figure 3-3). 
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Figure 3- 3: The main steps of extraction and isolation of MIAs from V. minor leaves. 
3.4 Application of different growth regulators on V. minor leaves 
3.4.1 Plant material 
Vinca minor mature plants at blooming stage were purchased from a commercial market garden 
(Brennecke GmbH, Braunschweig, Germany). Girre (1971), and Boyadzhiev et al. (2002) 
reported that the two highest concentration of vincamine in the herb which coincides with the 
periods of flowering and fruits ripening in April and in September, respectively. In addition, V. 
minor is more resistant to cold, and its optimal growth environment temperature is 10 ◦C (Chen 
et al., 2017). Thus, the experiment was established in April 2017. The individual plants were 
transferred into pots (15 cm in diameter) containing a soil prepared from the commercially 
available substrate (Floragard, Oldenburg, Germany). During acclimation phase, the soil 
moisture of all pots was adjusted to 25–30%. The medium temperature during the experimental 
period was 8 ⁰C with a minimum of 4.4 ⁰C and a maximum of 11.5 ⁰C. Then, the flowers were 
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removed from all plants 2 weeks before the starting of the experiment. Plants were grown in 
the garden of the Institute of plant biology of TU-Braunschweig (Figure 3-4). Plants were kept 
under rain shelter to prevent water input from the rain.  
 
Figure 3- 4: Vinca minor plants during the experiment. 
About two weeks later, the following treatments were set up in comparison to a control 
(Figure 3-5).  
3.4.2 Application of methyl jasmonate (MeJA), salicylic acid (SA) and hydrogen peroxide 
(H2O2) 
Application of MeJA was performed by using (0.5 mM) solution. For adequate solubilization, 
solutions contained 0.2% Triton X was used according to Kleinwächter et al. (2015). 
Application of SA and H2O2 were performed by using a 0.5 mM and 20 mM solutions 
respectively, which also contained Triton X (0.2%). For all approaches, plants were sprayed 
with 15 mL of the solutions (Figure 3-5). In the case of MeJA treated plants were taken out of 
the growth area and transferred in an open area about 30 m distance from the control plants and 
sprayed with MeJA solution on both sides of leaves until liquid dripped from the leaves. 
Six plants were collected before the application of the treatment. After one day of the 
application of treatments, the first harvest was performed. The remaining plants were sprayed 
again after 3 days and plants were harvested at fourth, eighth and fourteen days from the 
beginning of the experiment. For each treatment (control, Triton X100, 0.5 mM MeJA or SA, 
and 20 Mm H2O2), six replicates were sampled at each harvest. Accordingly, in total, 96 pots 
have been grown.  
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Figure 3- 5: V. minor leaves treated with different growth regulators. Spray applications were 
applied two times during the experiment. Sampling dates: 18.04.2017, 21.04.2017, 25.04.2017 and 
1.05.2017. 
3.4.3 Sampling 
Arial parts of experimental plants were cut from their roots. Leaves were separated from stems 
and divided into young and old leaves (Figure 3-6). The plant material was shock-frozen in 
liquid nitrogen and stored at −20◦C until further extraction and analyses, respectively. 
Moreover, to calculate the average gain of biomass per leaf during the maturation: the weight 
of six groups of young and old leaves (each group contains eight leaves) was measured before 
and after freeze drying. 
 
Figure 3- 6: Leaves were separated and divided into a) young leaves and b) old leaves. 
MeJA 
0.5 mM methyl jasmonate  
control 
plants watered to keep soil 
moisture between 25-30% 
SA  
0.5 mM salicylic acid 
H2O2 
20 mM hydrogen peroxide 
15 ml 
leaves were sprayed two 
times at t=0 and t=4 
Vinca minor 
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3.4.4 Extraction and quantification of indole alkaloids in Vinca minor 
- Extraction of indole alkaloids 
For the determination of alkaloids, 100 mg of freeze-dried leaves were ground to fine powder 
using a ball mill (RetschMM200). Subsequently, the sample was extracted once with 1 mL of 
MeOH containing 300 mg/L strychnine as internal standard (IS) and then with 1.5 mL pure 
MeOH (twice) in an ultrasonic bath at 50°C for 30 min each and last time was kept overnight 
for complete extraction. After centrifugation (10 min at 13000 rpm) the combined MeOH 
extract was evaporated using Zymark Turbo Vap evaporator, USA, at 50 °C. The dried MeOH 
extract was further extracted with 1.5 mL and subsequently with 1 mL of 3 % HCl (twice) in 
an ultrasonic bath at 50°C for 30 min. After centrifugation (10 min at 13000 rpm), the combined 
aqueous extract was cooled at 4°C and treated with 25% ammonium hydroxide to reach pH 8-
9. Alkaloids were extracted three times with CHCl3 (4 mL each). Combined CHCl3 extracts 
were dried (constant weight) and then dissolved in 1 mL of MeOH for HPLC analysis (Figure 
3-7).  
- Quantification of indole alkaloids using HPLC: 
The separation was performed on an X select C18-column, 2.5 µm, 100A, 4.6 x 100 mm from 
Waters, using a gradient system. Solvent A: acetonitrile; B: ammonium acetate (15 mM), 
containing 0.2% triethylamine, adjusted with formic acid to pH 3.5.  0 min: 15% A, 85% B; 5 
min: 20% A, 80% B; 20 min: 30% A, 70% B; 23 min 60%A, 40% B; 24min: 80% A, 20% for 
5 min. The flow-rate was 700 µL/min. The overall runtime was 35 min at a column temperature 
of 40°C. Alkaloids were quantified at 280 nm using a photodiode array (PDA) detector. 
Quantification was based on the calibration curve using vincamine and vincadifformine 
standards (1 mg/mL), which were diluted down to 0.05 mg/mL by MeOH containing 300 mg/L 
strychnine as internal standard (IS). Thus, for IS, ratios of peak areas are used in quantification 
instead of peak area: a plot of the area ratios versus concentration ratios.  The response factor 
(R) can be calculated from a calibration plot of AX/AIS versus CX/CIS, where the response factor 
is the slope. Then, the unknown concentration can be calculated from the measured area ratio 
from the experiment.  
 
 
                                     (A: peak area; C: concentration; R: response factor) 
The standards of methoxyvincamine, minovincine and minovincinine were not available, hence 
quantification of these compounds was based upon the UV response factor of vincamine and 
Cx= 
Ax/Ais 
R 
× Cis 
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vincadifformine their putative precursors.  Therefore, methoxyvincamine was calculated as 
vincamine; whereas minovincine and minovincinine were calculated as vincadifformine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3- 7: The extraction procedure of indole alkaloids from V. minor leaves. 
 
1. MeOH extract 
2. acidic aqueous extract 
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- Data analysis and statistics: 
Because of unbalanced design, data from alkaloid concentration, of each period of time (1, 4, 
8, 14 days) were analyzed by General Linear Model (GLM) and the significance of the 
treatment means was determined using the Least Significant Difference (LSD) test at P≤0.05. 
All analyses were performed using the SPSS statistical package release 24 (SPSS Inc., Chicago, 
IL, USA). 
- Quantification of indole alkaloids using LCMS (performed by Dr. Ulrike Beutling Chemical 
Biology, Helmholtz Centre for Infection Research, Braunschweig) 
The Total Ion Chromatogram (TIC) of the LC-MS runs could be used for quantification, 
assuming that the analyzed substances have similar ionization behavior. For the calculation of 
the peak areas, the Find-Molecular-Feature function of the Data Analysis Program (Bruker 
Daltonics) was used. Accordingly, further analyses of the MeJA-treated as well as of the control 
plants were conducted by using LC-MS analyses. For this, the old leaves were extracted as 
mentioned above. Strychnine was added as internal standard to the solvent used in the 
extraction. After analysis of the samples by LC-MS, the peak areas are calculated. 
Subsequently, peak areas are normalized to the internal standard strychnine. The separation was 
performed on a Kinetex C18-column (1.7 µm, 100 Å, 150 × 2.1 mm) from Phenomenex, using 
a gradient system as mentioned above.  
➢ Mass spectrum calculation was performed with Line Spectra 
➢ Compounds - Molecular Features function: This function is performed using the 
Compounds - Molecular Features command. It finds compounds on an LC-MS 
chromatogram trace. It searches the selected chromatogram within the selected retention 
time range and generates compounds with Mass Lists for each compound. Compounds - 
Molecular Features is based on the principles that the traces of all ions belonging to one 
compound have a high time-correlation and that the chromatographic peaks of these ions 
are strongly overlapping. Furthermore, the algorithm interprets mass distances (e.g. as 
distances of isotopes or distances according to different charges) between ions. Finally, a 
compound is a collection of ions satisfying the two criteria for high correlation in time and 
the mass distances can be interpreted. The core algorithm is applied to line spectra. If no 
line spectra are available or an option to use profile spectra is set, then the line spectra are 
computed in a pre-processing step using the current method parameter settings for Mass 
List finding. 
 
 
Chapter 3:  Materials and methods 
39 
 
➢ The settings used for peak finding in Data Analysis Program: 
• S/N Threshold: 5 
• Correlations coefficient threshold: 0.7 
• Minimum compound length: 10 spectra 
• Smoothing width: 2 
3.5 Effect of inhibitors on the MeJA and H2O2 induced conversion of indole 
alkaloids 
- Resveratrol application on the irrigated water 
100 mL resveratrol solution (200 mg/L) was added to the irrigation water, resulting in a dose 
of 20 mg resveratrol per pot. Triton X-100 (0.2%) was used for solubilization of resveratrol and 
applied to the soil as a negative control. The concentration of resveratrol used in this study 
reflected the concentration found in Fallopia japonica leachates and was based on the previous 
results of Fan et al. (2010), and Tucker Serniak, (2016). Solutions of resveratrol and Triton X 
were applied to the soil every five days and plants were harvested four times before next 
addition of the second treatment during the experiment. Six replicates were sampled at each 
harvest (48 pots).  
- Elicitor and inhibitors application as a spray 
Application of MeJA, H2O2, naproxen, and resveratrol were performed by using a 0.5 mM, 20 
mM, 75 mg/L, and 100 mg/L solutions, respectively which contained Triton X (0.2%). 
Naproxen (75 mg/L) was applied directly after MeJA and H2O2 treatment. In the same manner, 
resveratrol (100 mg/L) and MeJA was applied concomitantly (Figure 3-8). For all approaches, 
plants were sprayed with 15 mL of the solutions. In the case of MeJA, treated plants were taken 
out of the growth area and transferred in an open area about 30 m distance from the control 
plants and sprayed with MeJA solution on both sides of leaves until liquid dripped from the 
leaves. 
Three plants were collected before the application of the treatment. After three days of the first 
application of treatments, the first harvest was performed. The remaining plants were sprayed 
again and harvested at nine days from the beginning of the experiment. For each treatment 
(control, MeJA, H2O2, MeJA + naproxen, H2O2 + naproxen, and MeJA + resveratrol), three 
replicates were sampled at each harvest. Accordingly, in total 36 pots had been grown.  
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Figure 3- 8: Experimental design of the pot experiment with V. minor. *treatment was applied as 
spray 15 mL/plant, ** treatment was applied as irrigation in the soil 100 mL/pot. 
3.6 Extraction of indole alkaloids from fruits and flowers of V. minor 
Fruits and flowers were collected from mature V. minor plants in April 2017 (Figure 3-9). The 
extraction and analysis of indole alkaloid pattern were performed as mentioned above. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3- 9: Fruits and flowers separated from mature V. minor plant. 
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Chapter 4: Results 
Nowadays, there is a tremendous demand for further alternative indole alkaloid-based 
pharmaceuticals derived from Vinca minor (Hasa et al., 2013). It has been reported that V. 
minor contains a large amount of a wide spectrum of indole alkaloids. So far, more than 50 
indole alkaloids have been extracted and isolated from lesser periwinkle (Table A-1). Although 
a quite different composition of indole alkaloids of V. minor is outlined in the literature, in all 
cases the major alkaloid in the leaves is reported to be vincamine (Proksa and Grossmann, 1991; 
D'Amelio Sr. et al., 2012). Due to its pronounced cerebrovasodilatory and neuroprotective 
activity, many remedies containing vincamine are promoted to treat memory disorders or as 
stimulants for the CNS (Hasa et al., 2013). In this sense, the major goal of this investigation is 
to elucidate, how the quality and composition of alkaloid extracts from V. minor could be 
altered. As known for alkaloids, the content of vincamine and other monoterpenoid indole 
alkaloids (MIAs) varies largely depending on growth, climatic conditions, the season, and 
putative stress situations (Boyadzhiev et al., 2002). Accordingly, as outlined in the chapter 
“Scientific background”, the application of growth regulators, being part of the various signal 
transduction chains, seems to be a promising approach to alter the alkaloid composition in 
plants.  
In this study, mature V. minor (Apocynaceae) plants of defined physiological status were used 
as a model system to investigate the effect of elicitation with methyl jasmonate (MeJA) and 
other growth regulators on the composition and pattern of alkaloids with special emphasis on 
the appearance of novel, so far unknown indole alkaloids.   
4.1 Optimization of extraction and HPLC analyses of MIAs from V. minor  
As outlined above, quite different pattern of MIAs in V. minor has been reported so far. 
Accordingly, the first task was the sound investigation of the alkaloids present in the 
experimental plants used for this study. Based on the various protocols described so far, a sound 
and reliable methods for extraction, identification and quantification of the MIAs present in the 
leaves of V. minor had to be implemented. 
4.1.1 Internal standard  
Vincamine in plants was reported to be efficiently extracted with organic solvents or acidic 
aqueous solution or in combinations (Verma et al., 2014b; J Liu et al., 2015). One of the first 
steps was the selecting of an appropriate internal standard, which should be employed to 
minimize methodological errors and to consider the putative differences in the extraction 
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efficiency. In principle, the standard has to have three important properties. First, it must reveal 
a quite similar solubility in various solvents and thus a nearly identical extraction efficiency, 
secondly, there should be no interference in the HPLC analysis which the corresponding 
compounds present in the plants to be extracted; and finally, the internal standard has to be 
detectable by the same detection method as the molecules of interest, i.e., the indole alkaloids 
isolated from V. minor, which are registered by a photodiode array detector (PDA) (Hisiger and 
Jolicoeur, 2007). Strychnine turned out to be the best choice as the internal standard for this 
study.  
4.1.2 Extraction method 
In principle, the best extraction for alkaloids corresponds to an acidic aqueous extraction 
followed by alkalinization and transfer of the alkaloids into an organic solvent. Applying this 
classical procedure, an alkaloid solution is obtained, which is devoid of most compounds, which 
might interfere with the further analyses, e.g., chlorophylls, fatty acids etc. (Evans, Evans 
2009). Yet, when applying this procedure, it turned out that the indole alkaloids from V. minor 
where not completely dissolved in the aqueous solution. In several papers, chloroform was used 
for the first extraction step of indole alkaloids (J Liu et al., 2015). Unfortunately, also this 
method failed, too. Obviously, the polarity of the different alkaloids from V. minor is quite 
diverse, which hampers a complete extraction applying both of these methods.  
Alternatively, the first extraction step was done using methanol. It turned out that the alkaloids 
are totally dissolved in the methanol. However, most of the undesired compounds were also 
present in the extracts. Thus, an alternative procedure had to be developed, which allows the 
complete extraction all various alkaloids from V. minor, while most of the undesired 
compounds remain in the solid phase. In this sense the following approach was developed: the 
finely ground plant powder was extracted with methanol (which contains strychnine as an 
internal standard). After centrifugation, the pellet was extracted twice with pure methanol. 
Subsequently, after evaporation, the residue of the methanolic solution was extracted three 
times with aqueous 3% HCl using an ultrasonic bath at 50°C for 30 min.  Alternatively, also 
TFA (pH 1) could be used. To avoid decomposition of alkaloids, especially saponification of 
ester groups the combined acidic extracts were cooled at 4°C before alkalinisation by 25% 
ammonium hydroxide. Subsequently, indole alkaloids were extracted three times with 
chloroform. Combined chloroform extracts were dried (constant weight) and then dissolved in 
methanol for HPLC analysis. This procedure ensures that all alkaloids were extracted efficiently 
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and prevents the occurrence of most undesired compounds in the extracts. Accordingly, it was 
used for all analyses presented in the thesis.  
4.1.3 HPLC analyses 
Because of the medicinal importance of indole alkaloids, several HPLC methods have been 
established for their separation and quantification (Gerasimenko et al., 2001; Hisiger and 
Jolicoeur, 2007; J Liu et al., 2015). An effective separation can be achieved using a saline buffer 
with potassium phosphate or ammonium acetate as an aqueous phase, and methanol or 
acetonitrile as an organic phase. As ammonium acetate buffer is more volatile than phosphate 
buffer, it can be easily removed. Thus, in all cases when MS (mass spectroscopy) should be 
applied ammonium acetate is preferred (Hisiger and Jolicoeur, 2007). Other studies are 
suggesting the use of ion-pairing additives such as TEA or TFA, which are commonly used for 
masking non-derivatized silanol groups and enhance peaks shape and reducing peak tailing. In 
addition, mobile phase pH is an important parameter and acidic pH (pH 3–4) enables better 
peak shape for basic alkaloids. At low pH, most of silanol groups are undissociated and ion-
exchange interactions are then limited, even if the alkaloids are protonated (McCalley, 2002; 
Heijden et al., 2004). Weak variations in the mobile phase preparation can change the degree 
of protonation of the alkaloids, and thus influence the elution pattern and the reproducibility in 
the retention times. Based on these data comprehensive alterations, changes and optimizations 
including the usage of different reversed-phase columns had been performed. 
Best separation was achieved by using X select C18-column and applying a gradient system 
containing TEA and ammonium acetate buffer at pH 3.5 as an aqueous phase and acetonitrile 
as an organic phase (for details see material and method section). At the start of the work, just 
the Nucleosil 100-5µ RP-18 column was available. Accordingly, the first row of experiments 
was employed by using this column. Later, when X select was C18-column was on hand, this 
column, which reveals a better resolution and a much shorter run time, was applied. The best 
detection of the various MIAs was achieved by using a PDA detector at three different channels 
(280, 254 and 330 nm). 
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4.2 Composition of MIAs of mature and healthy V. minor plants 
4.2.1 HPLC analyses  
Using the optimized methods described above, the alkaloids from old and young leaves from 
mature V. minor plants were analyzed by using HPLC technique (Figure 4-1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4- 1: HPLC-chromatogram of the alkaloids from young and old leaves of V. minor at 
different wavelengths using PDA detector. 
It was clearly observed that vincamine represents the major alkaloid of old V. minor leaves 
(Figure 4-1). This could be easily deduced by comparing the retention time and UV spectrum 
of standard vincamine (Appendix: Figure A-1), with those obtained from the chromatogram of 
alkaloids in both young and old V. minor leaves (Figure 4-1). On the other side, the major 
alkaloid from young leaves was concluded to be vincadifformine. However, a reliable 
identification of this alkaloid required much more information and this cannot be achieved 
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before the isolation and spectroscopic identification by NMR techniques (see below for details). 
In the same manner, the identification of the other peaks displayed in Figure 4-1 also required 
much more information. Firstly, in an attempt to isolate these alkaloids, the extracts from the 
leaves (old and young) of V. minor were analyzed by ultra-performance liquid chromatography-
mass spectrometry (UHPLC-MS). The related chromatogram, which revealed four main 
alkaloids’ peaks (1, 2, 3, 4), is displayed in Figure 4-2. The corresponding data are given in 
Table 4-1.  
 
Figure 4- 2: LC-MS separation of the major indole alkaloids determined in V. minor control 
plants leaves.  
Table 4- 1: UHPLC-PDA-MS data for MIAs of V. minor leaves in positive ion mode. 
Compounds 
tR 
(min) 
UV 
(λmax) (nm) MW 
ESI+ (m/z) 
(rel. int. %) 
Molecular formulae 
[M+H]+ 
1 10.49 208, 245, 
312 
354 355 (100) C21H27N2O3 
2- Vincamine 12.14 220, 270 354 355 (100), 337 
(60) 
C21H27N2O3 
3 13.62 220, 270 322 323(100) C20H23N2O2 
4 19.77 221, 330 338 339 (100), 307 
(83) 
C21H27N2O2 
 
Although the molecular masses were determined – apart from vincamine - no reliable 
assignment of the different peaks was possible on the basis of the properties mentioned in Table 
4-1. In consequence, the relevant compounds had to be isolated in order to elucidate their 
structures by applying 1H, 13C NMR, COSY, TOCSY, ROESY, HSQC, and HMBC 
experiments and high-resolution mass spectrometry (HR-MS).  
 
1 3 
 4 
 2       
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4.2.2 Identification and characterization of the alkaloids from mature V. minor leaves 
(control plants)  
For identification of the major peaks in V. minor leaves, the alkaloidal extract was subjected to 
Nucleosil 100-5µ RP-18 semi-preparative column using a gradient system (for details see 
material and method). The isolated structures of vincamine together with three highly purified 
compounds were characterized by 1H, 13C NMR, COSY, TOCSY, ROESY, HSQC, and HMBC 
experiments and further confirmed by high-resolution mass spectrometry (HR-ESI-MS).  
Compound 1: 
Compound 1 was obtained as an amorphous powder. The molecular formula of 1 was 
determined as C21H26N2O3 on the basis of its HR-ESI-MS at m/z 355.2025 [M+H]
+, (Calculated 
m/z for M+H, 355.2022). The MS2 spectra of compound 1 showed a peak at m/z 252, resulting 
from loss of both the ester group and a C2H5N fragment (Appendix, Figure A-2). In addition, a 
characteristic ion of a hydroxy indole moiety at m/z 160.0756 (143 Da + OH) might be generated 
by the loss of a terpene moiety by Retro Diels Alder (RDA) cleavage of the C-ring  (Figure 4-
4; (Kumar et al., 2016a)). The UV spectrum of 1 (MeOH) exhibited maxima at max 208 and 
312 nm (Figure A-2).  
The corresponding NMR spectra are displayed in the appendix (Figure A-3: A-9). The relevant 
NMR-data extracted from these figures are presented in Table 4-2.  
The 1H NMR spectrum of 1 (Table 4-2 & Figure A-3) showed three ABX-system 
protons at H 6.33 (1H, d J= 1.8 Hz, H-9), 6.42 (1H, dd J= 7.8, 1.8 Hz, H-11) and 6.47 (1H, d 
J= 7.8 Hz, H-12) assigned for a 10-substituted dihydroindole (Balsevich et al., 1982). Two 
downfield methyl singlets at H 3.72 and 2.53 were assigned to the ester’s methyl and the N-
methyl groups, respectively (Balsevich et al., 1982). An olefinic proton at H 5.34 (1H, q, J= 
7.10 Hz, H-19) and a methyl signal at H 1.52 (3H, dd, J = 7.0, 1.72 Hz, H-18) established the 
presence of an ethylidene group (Balsevich et al., 1982). 
Accordingly, the 13C NMR spectrum of 1 (Table 4-2 & Figure A-4) displayed 
characteristic signals for an oxygenated aromatic tertiary carbon at c 150.7 (C-10), a 
nitrogenated aromatic tertiary carbon at c 145.8 (C-13), a quaternary aromatic carbon at c 
141.5 (C-8), an aliphatic quaternary carbon at c 42.4 (C-7), a pair of olefinic carbons at C 
139.5 (C-20) and 118.2 (C-19), an ester carbonyl carbon at C 172.5 (C-17), three methyls at 
C 35.3, 51.4, and 12.7 (C-N1, C-22 and C-18) and four methylenes at C 49.7, 30.8, 32.5, and 
54.1 (C-5, C-6, C-14, and C-21) indicating a dihydroakuammiline skeleton (Balsevich et al., 
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1982). However, the COSY and HMBC data (Table 4-2) also disclosed partial structures that 
are reminiscent of a dihydroakuammiline except that the NCHCH2CH partial structure, 
corresponding to C(3)-C(14)-C(15), has been extended to include CHCO fragment, 
corresponding to C(16)-C(17). The location of a methyl ester at C-16 was established from the 
HMBC correlation of the methine proton H-16 to the ester carbonyl C-17. The ethylidene group 
substituent, C(18)–C(19),  attachment to C-20 was deduced by the HMBC correlations of H-
18, H-21 with C-20 Figure 4-3. 
The above spectral data of 1 was in agreement with the published data of 10-
hydroxycathofoline (Figure 4-3)  isolated from Vinca major and its glycoside isolated from the 
root of Catharanthus roseus (Balsevich et al., 1982; Wang et al., 2012) respectively. It is worth 
noting that this is the first report for the isolation of 10-hydroxycathofoline from V. minor. 
 
Figure 4- 3: Selected 2D NMR correlations for 10-Hydroxycathofoline (1). 
Figure 4- 4: Proposed mass fragmentation of 10-hydroxycathofoline (1) according to 
MS-MS data (Appendix: Figure A-2). 
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Table 4- 2: 1H and 13C NMR spectral data (700 MHz for 1H, 175 MHz for 13C) of 10-
hydroxycathofoline (1) formic acid salt in DMSO-d6. 
Pos. 
C 
Shift 
XHn 
H 
Shift 
H Multiplicity 
(J Hz) 
COSY TOCSY ROESY 
C 
HMBC 
1Me 35.3  CH3  2.53  m    6   2, 13 
2 78.7 CH  2.42  m      14, 16  14, 1 Me, 
16 
3 46.9  CH  3.95 m  14  14, 14, 16, 
15  
5  7, 15 
5 49.7  CH2  2.53  m  6, 5  6, 6, 5  21, 6, 5, 3, 
12  
6, 7, 21 
3.63  m  6, 5, 6  6, 5, 6  6, 5   
6 30.8  
 
CH2  
 
1.16  dd (15.2, 5.1)  6, 5  5, 6, 5  5  2, 5, 7 
2.97  m  6, 1Me, 
5, 5  
6, 5, 5  5   
7 42.4  C   ---          
8 141.5 C   ---          
9 108.8 CH  6.33  d (1.8)    12    7, 11, 13 
10 150.7 C   ---          
11 112.5 CH  6.42 dd (7.8, 1.8) 12      9, 10, 13 
12 110.4  CH  6.47 d (7.8)  11  9  5  7, 8, 10 
13 145.8 C   ---          
14 32.5  CH2  1.67 br dd (12.7, 
2.8)  
14, 15  14, 16, 15, 3  14, 2, 16  2, 3, 15, 
16 
2.22 dt (11.3, 2.1, 
2.1)  
14, 15, 3  14, 16, 15, 3  14, 15, 21   
15 33.9  CH  3.45 m  14, 14, 
16  
18, 14, 14, 
16, 3, 19  
18, 14, 16  7 
16 51.7  CH  2.95 m  15  14, 14, 15, 3  14, 2, 15  6, 8, 14, 
17,20 
17 172.5 C   ---          
18 12.9 CH3  1.42 dd (6.9, 1.7)  21, 19  21, 15, 21, 
19  
15, 22, 19  19, 20 
19 118.2 CH  5.34  q (7.1)  18  18, 21, 15, 
21  
18, 21  18, 21, 15 
20 139.5 C   ---          
21 
 
54.1 CH2  2.90  br d (16.6)  21  18, 21, 19  5, 21, 19  5, 3, 20, 
19, 15 
3.80  br d (17.4)  18, 21  18, 21, 19  14, 21, 22   
22 51.4 CH3  3.72  s      18, 21  17 
Note: Overlapped signals are reported without designating multiplicity. 
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Compound 2 (Vincamine): 
Compound 2 was obtained as a solid white powder. The molecular formula of 2 was determined 
as C21H26N2O3 on the basis of its HR-ESI-MS peak at m/z 355.2024 [M +H]
+, (Calculated m/z 
for M+H, 355.2022) (Figure A-10). The MS2 fragmentation of 2 (Figure A-10) showed the loss 
of a water molecule to give a peak at m/z 337 [M – H2O+H]+. In addition, a characteristic ion 
of indole moiety at m/z 144.0811 was generated by the loss of the terpene moiety through C-
ring cleavage via Retro Diels Alder (RDA) followed by bond breaking between N1 and C14 
(Figure 4-6; Akhgari et al., 2015; Kumar et al., 2016a). The UV spectrum (MeOH) exhibited 
maxima at wavelengths 220 and 269 nm (Figure A-10). 
The corresponding NMR spectra are displayed in the appendix (Figure A-11: A-16). The 
relevant NMR-data extracted from these figures are presented in Table 4-3.  
13C NMR spectrum of 2 (Table 4-3& Figure A-12) showed the presence of a hemiaminal 
quaternary carbon (C 81.4, C-14), four quaternary aromatic carbons including a two 
nitrogenated tertiary carbons C 124.7 (C-2), 135.1 (C-13) and two quaternary carbons C 104.8 
(C-7), 127.3 (C-8), an ester carbonyl carbon (C 172.3, C-22) and seven methylene carbons, of 
which two were nitrogenated.  
1H NMR and HSQC data of 2 (Table 4-3 & Figure A-11) showed significant signals 
characteristic for four aromatic protons of the indole system at H 7.53 (1H, d, J= 8.0 Hz, H-9), 
7.23 (1H, m, H-10), 7.26 (1H, m, H-11) and 7.15 (1H, m, H-12). 1H NMR spectrum also showed 
a methoxy signal at H 3.87 (H-23), assigned to the ester group at C-14 based on its HMBC 
correlation with C-22. Also, the presence of a hydroxyl group at C-14 was confirmed from the 
HMBC correlation of the methylene protons at H-15 to C-14. The presence of a nitrogenated 
methine carbon at C 59.7 (C-3) was deduced from the HMBC correlation between the proton 
signal at H 4.65 (H-3) and C-2. The ethyl side chain substituent, C(20)–C(21) represented by 
the signals at H 2.38, 1.60 (H2-20) and 0.97 (H3-21), was assigned to C-16 as deduced from 
the long-range coupling between H-20 to H-3 in the H–H ROESY spectrum and from 
correlation of H-20 and 21 to C-16 in HMBC spectrum.   
Comparison of the above results with the reported data (Farahanikia et al., 2011) clearly 
verified that this compound is vincamine (Figure 4-5). 
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Figure 4- 5: Selected 2D NMR correlations for vincamine (2). 
 
Figure 4- 6: Proposed fragmentation of vincamine (2) according to MS2 data (Appendix: Figure 
A-11). 
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Table 4- 3: 1H and 13C NMR spectral data (700 MHz for 1H, 175 MHz for 13C) of vincamine 
(2) TFA salt in CDCl3. 
Pos. C Shift XHn 
H 
Shift 
H Multiplicity 
(J Hz) 
COSY ROESY C HMBC 
2 124.7  C           
3 59.7  CH  4.65  br s    5, 15, 20  2, 7 
5 50.9  CH2  3.76  m  6  6, 18 7 
6 16.1  CH2  3.11  m  5  9, 5, 3  7, 2 
7 104.8  C   ---        
8 127.3  C   ---        
9 119.0  CH  7.53  d (8.0)  10  10, 6  11, 7, 13 
10 121.5  CH  7.23  m  9  9  8, 12 
11 123.7  CH  7.26  m  12    9, 13 
12 110.9  CH  7.15  m  11    10, 8 
13 135.1  C   ---        
14 81.4  C   ---        
15 43.3  
 
CH2  2.28  d (14.7)      3, 13, 16, 14 
2.33  m  21, 20  21, 3  22, 3, 16, 17 
16 35.8  C   ---        
17 23.0  CH2 1.85  m  17  17, 18  16, 18, 20 
1.68  br s  15  15  3, 19, 20 
18 18.3 CH2 2.12  m  18  18, 17   
1.64  m  18  18  
19 44.5  CH2 2.94  m  3  6, 3   
3.35  br d (11.6)  3  3  17, 3 
20 27.9  CH2 1.60  m  21, 20, 15  20, 3 15, 21, 16, 17 
 27.9  CH2 2.38  m  21, 20  20  
21 7.3  CH3  0.97  m  20, 15, 20  15  16, 20 
22 173.3  C   ---        
23 54.8  CH3  3.87  m      22 
Compound 3: 
Compound 3 was obtained as a white powder. The HR-ESI-MS of 3 afforded the molecular ion 
peak at m/z 323.1757 [M+H]+, suggesting the molecular formula C20H22N2O2 (Calculated m/z 
for M+H, 323.1760; Figure A-17). The MS2 fragmentation of 3 (Figure A-17) showed the loss 
of methanol to give a peak at m/z 291[M – CH3OH + H]+, indicating the presence of methyl 
ester group. The UV absorption at 220 and 270 nm showed the presence of an indolenine 
chromophore, which was confirmed by the characteristic chemical shift of C-2 at δC 179.6 in 
the 13C-NMR spectrum (Atta-ur-Rahman and Habib-ur-Rehman, 1986). 
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The corresponding NMR spectra are displayed in the appendix (Figure A-18: A-25). The 
relevant NMR-data extracted from these figures are presented in Table 4-4.  
The 1H NMR spectrum of 3 (Table 4-4, Figure A-18) showed four aromatic protons at 
H 7.49 (br d J= 6.7 Hz), 7.29 (m), 7.44 (t J= 7.1 Hz) and 7.74 (br d J= 6.5 Hz) assigned to H-
9, 10, 11, and 12, respectively, of the indole moiety, indicating the OH group at C-10 in 1 was 
absent in 3. The methyl proton singlet at H 3.77 (H-22) was assigned to the ester group at C-
16. An olefinic proton at H 5.85 (br q, J= 7.1 Hz) and a methyl signal at H 1.67 (dd, J = 7.2, 
2.3 Hz) indicated the presence of an ethylidene group. In addition, the signals observed at H 
5.28 (br s), 3.71(br s), and 3.67 (br d, J=16.4) corresponding to H (3), H (15), and H (21β), 
respectively, are characteristic of an akuammiline type alkaloid (Kan et al., 1995). 
13C NMR spectrum of 3 (Table 4-4, Figure A-19) confirmed the presence of four 
downfield quaternary carbons including a nitrogenated tertiary carbons at C 154.5 (C-13) and 
imine carbon C 179.6 (C-2) of an indolenine nucleus. In addition, a quaternary olefinic carbon 
at C 127.1 (C-20), and an ester carbonyl carbon at C 170.5 (C-17) were also present. 
  The COSY and HMBC spectral data also disclosed partial structures that are 
reminiscent of an akuammiline skeleton, except that the NCHCH2CH partial structure, 
corresponding to C(3)−C(14)−C(15), has been extended to include a CHCO fragment, 
corresponding to C(16)−C(17) (Lim et al., 2007). The location of a methyl ester at C-16 was 
confirmed from the HMBC correlation of H-16 to C-17. The ethylidene group substituent, 
C(18)–C(19),  attachment to C-20 was deduced from HMBC correlations of H-18 and H-19 
with C-20. In addition, the assignment was confirmed by COSY and TOCSY experiments 
(Figure A-22, 23), which established the vicinal relationship between C-16H/C-15H and the 
allylic relationship between C-15H/C-18 protons. 
 
Figure 4- 7: Selected 2D NMR correlations for strictamine (3). 
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Based on the above spectral data and by comparison with literature data (Atta-ur-
Rahman and Habib-ur-Rehman, 1986), compound 3 was confirmed as strictamine (Figure 4-
7), which has been isolated before from V. minor (Mokrý et al., 1967). 
Table 4- 4: 1H and 13C NMR spectral data (700 MHz for 1H, 175 MHz for 13C) of strictamine 
(3) TFA Salt in CDCl3. 
Pos. 
C 
Shift 
XHn 
H 
Shift 
H Multiplicity 
(J Hz) 
COSY ROESY C HMBC 
2 179.6  C   ---        
3 55.4  CH  5.28  br s  14    2, 15 
5 51.3  CH2  3.29  dd (13.8, 5.6)  5, 6  6, 5, 21, 6  21, 3, 6 
2.92  m  6, 5, 6  6, 5, 21  6 
6 25.6  CH2  3.82  br m  6, 5, 5  6, 5  5, 2, 16 
2.23  dd (15.9, 5.2)  5, 6  5, 5, 6, 9  5, 16, 8 
7  C* ---     
8 144.4  C   ---        
9 123.6  CH  7.49  br d (6.7)  10  22, 6  11, 13 
10 127.4  CH  7.29  m  11, 9  11  8, 12 
11 129.3  CH  7.44  t (7.1)  10, 12  10  9, 13 
12 122.3  CH  7.74  br d (6.5)  11    8, 10 
13 154.5  C   ---        
14 33.6  CH2  2.90  m  14, 3  14, 15, 21  21, 16, 17, 2, 3 
2.04  dd (14.8, 3.0)  14, 15  14, 15, 16  15, 2, 20, 16 
15 31.0 CH 3.71 br s 14, 16 18, 14, 16, 14 14 
16 54.1  CH  2.19  m  15  14, 15  2, 6, 20, 14, 15, 
17 
17 170.5  C   ---        
18 13.3  CH3  1.67  dd (7.2, 2.3)  21, 19  15, 22, 19  15, 19, 21, 20 
19 127.2  CH  5.85  br q (7.1)  18  18, 21, 21  15, 20, 18, 21 
20 127.1  C   ---        
21 52.6  CH2  4.48  br d (16.1)  18, 21  14, 21, 19, 5  19, 5 
3.67  br d (16.4)  21  5, 21, 19  19, 14, 3, 15, 5 
22 52.2  CH3  3.77  s    9, 18  17 
*unidentified 
Compound 4: 
Compound 4 was obtained as a yellowish white powder. The molecular formula of 4 was 
determined as C21H26N2O2 on the basis of its HR-MS peak at m/z 339.2072 [M +H]
+, 
(Calculated m/z for M+H, 339.2073). The MS2 fragmentations of 4 were predominated by the 
loss of methanol molecule to give m/z 307.1811 [M – CH4O + H]+ indicating the presence of 
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methyl ester group. The UV spectrum (MeOH) of 4 exhibited maxima at wavelengths 221, 293 
and 330 nm (Figure A-26), which characteristic of aspidosperma-type alkaloids (Akhgari et al., 
2015). 
The corresponding NMR spectra are displayed in the appendix (Figure A-27: A-33). The 
relevant NMR-data extracted from these figures are presented in Table 4-5.  
1H NMR and HSQC data of 4 (Table 4-5 & Figure A-27, A-32) showed significant 
signals for four A2B2-system protons at H 7.84 (br d, J =7.5 Hz, H-9), 7.01 (t, J= 7.4, H-10), 
7.21 (t, J= 7.6, H-11) and 6.85 (d, J= 7.5 H-12), of the indole moiety, and a NH signal at δH 
9.01. It also showed a methoxy proton signal at H 3.87 (H-23) assigned to an ester group.  
13C NMR spectrum of 4 (Table 4-5 & Figure A-28) showed the presence of seven 
methylene carbons including two nitrogenated methylene (C 47.7, C-3 and 52.9, C-5) and a 
nitrogenated methine (C 68.9, C-21). This was confirmed from the HMBC correlations 
between H-21 and C-5, 17 and 19. 13C NMR spectrum further indicated the presence of a 
methoxycarbonyl (C-22), four quaternary carbons (C-7, C-8, C-16, C-20), and two nitrogenated 
(C-2, C-13) tertiary carbons. The location of a methyl ester was confirmed from 13C NMR 
spectrum and from the HMBC correlation of the methyl proton signal, H-23 to C-16. The ethyl 
side chain substituent C(18)–C(19), represented by the signals at H 0.94, 1.15 (H2-19) and 0.64 
(H3-18) was deduced by the correlation between H-18 and 19 to C-20 (C 35.1)  in HMBC 
spectrum.  
Comparison of the above results and the literature data (Wang et al., 2017) confirmed 
that compound 4 is vincadifformine (Figure 4-8), which has been isolated before from V. minor 
(Mokrý et al., 1967).  
 
Figure 4- 8: Selected HMBC correlations for vincadifformie (4). 
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Table 4- 5: 1H and 13C NMR spectral data (700 MHz for 1H, 175 MHz for 13C) of 
vincadifformine (4) TFA Salt in CDCl3.  
Pos. C Shift XHn H Shift 
H Multiplicity 
(J Hz) 
COSY ROESY C HMBC 
2 163.6  C   ---        
3 47.7  CH2  3.57  br d (11.8)  14, 14, 3  3  5 
3.47  br d (12.5)  14, 3  3  21, 15 
5 52.9  CH2 3.75  br s  6, 5  6, 5   
6 42.8  CH2 2.53  m  5, 5  5  8, 7 
7 56.0  C   ---        
8 133.5  C   ---        
9 123.1  CH  7.84  br d (7.5)  10  21, 10  11, 7, 13 
10 122.6  CH  7.01  t (7.4)  11, 9  11, 9  12, 8 
11 129.1  CH  7.21  t (7.6)  12, 10  12, 10  13, 9 
12 109.5  CH  6.85  d (7.5)  11  11, 1  10, 8 
13 142.2  C   ---        
14 14.7  
 
CH2 1.99  br d (13.1)  15, 14, 15, 
3, 3  
17   
1.90  br d (14.2)  15, 14, 15, 
3  
   
15 31.0  CH2 2.06  br d (14.0)  15, 14, 14  18, 15  3, 21, 20, 17 
1.61  m  14, 14, 15  19, 15  20, 17, 14 
16 90.0  C           
17 28.6  CH2 2.44  d (16.6)  17  5, 14  22, 2, 19, 
20, 16, 21 
2.56  m  17  18  19, 2, 20, 
16, 22 
18 6.4  CH3  0.64  t (7.4)  19, 19  15, 17  19, 20 
19 32.2  CH2 0.94  br dd (14.2, 7.1)  18, 19  19, 15, 21  20, 15, 21, 
18, 17 
1.15  dd (14.2,7.5)  18, 19  19, 21  18, 21, 20 
20 35.1  C   ---        
21 68.9  CH  3.97  m    19, 19, 9  6, 8, 7, 5, 19, 
17, 20 
22 168.2  C   ---        
23 51.5  CH3   3.81      17 22, 16 
1   NH  9.01 s    12  7, 8, 2, 13 
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4.3 The effect of MeJA on the pattern of indole alkaloids of V. minor 
4.3.1 Application of MeJA alters the alkaloid pattern in V. minor leaves (stressed plants) 
In order to generate a massive stress situation, V. minor plants were treated two times with 
methyl jasmonate (MeJA) as described in the material and method section. After nine days, 
leaves had been harvested and the MIAs had been extracted and analyzed using the optimized 
method mentioned above  
Surprisingly, the alkaloid pattern of V. minor leaves treated with MeJA was entirely different 
(Figure 4-9). Whereas the concentrations of strictamine (3) and 10-hydroxycathofoline (1) were 
not altered significantly, vincamine (2) and vincadifformine (4) contents were strongly reduced 
in the response to the MeJA treatment. Moreover, the concentration of several other indole 
alkaloids was increased massively.  
Summing-up – 4.2 Composition of MIAs of mature and healthy V. minor leaves 
The mature and healthy leaves of the Vinca minor plants used in this study contain the 
four main alkaloids, i.e., vincamine, vincadifformine, 10-hydroxycathofoline, and 
strictamine, belonging to the three major groups of indole alkaloid: 
1. Eburnamine group (vincamine) 
2. Aspidospermine alkaloids (vincadifformine) 
3. Akuammiline group (10-hydroxycathofoline, strictamine) 
Whereas the occurrence of vincamine, strictamine and vincadifformine in V. minor 
was already reported earlier (D'Amelio Sr. et al., 2012), 10-hydroxycathofoline, which 
is known to occur in Vinca major (Balsevich et al., 1982) was isolated for the first 
time from V. minor. It is important to mention that the 1H and 13C chemical shifts 
deviated significantly from literature data, probably due to the protonation of the basic 
nitrogen atoms by TFA or protonation of formic acid during HPLC fractionation. This 
illustrates that metabolite de-replication using carbon chemical shifts is hampered in 
cases where the compounds act as weak acids or bases. 
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Figure 4- 9: LC-MS separation of the major indole alkaloids determined in Vinca minor. In the 
upper part (A) the composition of indole alkaloids extracted from control plants is shown, which already 
had been displayed in Figure 4-2, whereas in the lower part (B) the composition of indole alkaloids of V. 
minor plants nine days after treatment with MeJA are displayed. 
In the same manner, as described for the four main alkaloids in the control plants (see chapter 
4.2), the newly appearing compounds should be purified using semi-preparative HPLC and 
analyzed by HR-MS, 1H, 13C NMR, COSY, TOCSY, HSQC, and HMBC experiments. 
Unfortunately, it turned out that peak 8 consists of more than one alkaloid, which could not be 
separated using the preparative column. In consequence, 5, 6, 7 and 9 were purified and 
characterized. The analytical data of the various alkaloids of V. minor up-regulated by the MeJA 
treatment are compiled in Table 4-6. 
Table 4- 6: UHPLC-PDA-MS data for MIAs of V. minor leaves treated with MeJA in positive 
ion mode. 
Compound tR (min) UV (λmax) (nm) MW 
ESI+ (m/z) 
(rel. int. %) 
Molecular formulae 
[M+H]+ 
5 15.17 224, 268 384 385 (100), 367 C22H29N2O4 
6 7.87 220, 330 354 355 (100),  323 (59) C21H27N2O3 
7 9.99 221, 331 352 353 (100), 321 C21H25N2O3 
8 * 9.35 240, 292 338 339 (100) C21H27N2O2 
9 5.9 219, 285 368 307, 210 C21H25N2O4 
* In contrast to the preparative column, the separation using the ultra-performance HLPC allows 
separating compound 8 from the MIAs which interfered in the preparative separation. Accordingly, the 
mass of this alkaloid could be determined but no NMR analyses could be conducted. 
 7 
1: 10-hydroxycathofoline 
2: vincamine 
3: strictamine 
4: vincadifformine 
A 
B 
5 
2 
8 
3 
4 
 9 
1 
 6  
3 
4 
1 
2 
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4.3.2 Characterization and identification of the main alkaloids up-regulated in V. minor 
leaves after application of MeJA 
The highly purified compounds (see Material and Methods, chapter 3, page 32) extracted from 
the MeJA-treated plants were characterized and structure elucidated using HR-MS and several 
NMR techniques (1H, 13C NMR, COSY, TOCSY, ROESY, HSQC, and HMBC experiments). 
Compound 5: 
Compound 5 was obtained as a colorless oil, []20D +117 (c 0.05, MeOH); UV (MeOH) max 
(log ) 224 NM (3.63) and 268 nm (3.06). The molecular formula of 5 was determined as 
C22H28N2O4 on the basis of its HR-ESI-MS peak at m/z 385.2130 [M +H]
+ (Calculated m/z for 
M+H, 385.2127). The MS2 fragmentations of 5 were predominated by the loss of a water 
molecule to give a fragment at m/z 367.2022 [M – H2O+H]+ (Calculated m/z for M – H2O+H, 
367.2022) Figure (A-34). 
The corresponding NMR spectra are displayed in the appendix (A-35: 41). The relevant NMR-
data extracted from these Figures are presented in Table4-7.  
1H NMR and HSQC data (Table 4-7) showed the presence of three methyl groups (including 
two O-methyl singlets), seven methylene, a nitrogenated methine, and three aromatic methine 
protons.  
The 13C NMR spectrum additionally confirmed the presence of eight further carbons including 
a methoxycarbonyl, a hemiaminal carbon, three quaternary carbons, an oxygenated tertiary 
carbon and two nitrogenated tertiary carbons.  
1H and 13C NMR data of 5 (Table 4-7) were closely related to those of vincamine (2), with the 
key difference in the replacement of the methine carbon (C-9) in 2 with an oxygenated tertiary 
carbon (C 154.7) in 5. Furthermore, an additional O-methyl signal (H 3.89, C 55.3) group 
was observed, which showed HMBC correlation to C-9. In addition, the splitting pattern of the 
aromatic protons H-10, H-11, and H-12 indicated that they are contiguous and ortho coupled 
as J10,11 = J11,12 = 8.2 Hz.  
 
Figure 4- 10: Selected HMBC correlations for 9-methoxyvincamine (5). 
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Therefore, the structure of 5 was defined as 9-methoxyvincamine (Figure 4-10). A closely 
related compound, 11-methoxyvincamine, was reported earlier from V. minor (Štrouf and 
Trojánek, 1964; Szabó et al., 1996), but 9-methoxyvincamine was isolated for the first time as 
a natural product.  
Table 4- 7: 1H and 13C NMR spectral data (700 MHz for 1H, 175 MHz for 13C) of 9-methoxy-
vincamine (5) TFA Salt in CDCl3. 
Pos. 
C 
Shift 
XHn 
H 
Shift 
H 
Multiplicity 
(J Hz) 
COSY NOESY C HMBC 
2 122.6 C  ---       
3 60.0 CH 4.47 br s   5, 15, 20  2, 7, 16, 17, 19, 20 
5 51.6  CH2 3.61,  
3.72 
dt (12.6, 6.2) 
m 
5b, 6a, 6b 
5a, 6a, 6b 
3  19 
7, 3 
6 18.0  CH2 3.37 
3.26 
m 
m 
6b 
5a, 5b, 6a  
6 
6 
2, 7, 8 
2, 7 
7 105.1  C  ---       
8 117.6  C  ---       
9 154.7 C  ---       
10 101.5 CH 6.58 d (8.2) 11    8, 9, 12 
11 124.8 CH 7.14 dd (8.2, 8.2) 10, 12    9, 13 
12 103.8  CH 6.71 d (8.2) 11    8, 10 
13 136.5  C  ---       
14 81.4 C  ---       
15 43.4 CH2 2.27 m   3, 21  3, 14, 16, 17 
16 35.8 C  ---       
17 22.9 CH2 1.85 
1.66 
td (14.2, 3.6) 
m 
17  
17 
17, 
17, 21 
16, 20 
3, 16, 19 
18 18.2 CH2 1.62 
2.18  
m 
m   
18 
18  
18 
18  
 
19 44.5 CH2 2.94 
3.30  
m 
br d (10.8) 
19b  
19a 
19b  
19a 
 
3, 17 
20 28.7 CH2 1.61 
2.57  
m  
dq (14.7, 7.4) 
20, 21 
20, 21 
3, 20  
20, 21 
3, 15, 16, 17, 21 
3, 15, 16, 21 
21 7.4  CH3 0.98 t (7.4) 20, 20 15, 17, 20 20, 16 
22 173.3 C  ---       
23 54.8 CH3 3.87 s     22 
9-
OMe 
55.3 CH3 3.90 s     9 
 
 
Chapter 4: Results 
 
60 
  
Compound 6: 
Compound 6 was obtained as a white powder. The molecular formula of 6 was determined as 
C21H26N2O3 on the basis of its HR-ESI-MS peak at m/z 355.2023 [M +H]
+ (Calculated m/z for 
M+H, 355.2022). The MS2 fragmentations of 6 were predominated by the loss of a methanol 
molecule to give a peak at m/z 323.1760 [M – CH4O+H]+ (Calculated m/z for M – CH4O+H, 
323.1760), or a water molecule [M – H2O+H]+ to give a peak at m/z 337.1918 (Calculated m/z 
for M – H2O+H, 337.1916). These fragmentations are indicating the presence of a methyl ester 
and a hydroxyl groups, respectively (Figure A-42). The UV spectrum (MeOH) exhibited 
maxima at wavelengths 220, 290 and 330 nm (Figure A-42), which characteristic of 
aspidosperma-type alkaloids (Akhgari et al., 2015). 
The NMR data of 6 (Table 4-8 and Figure A-43: 49) was closely related to those of 
vincadifformine (4), with the key difference in the presence of a 3H doublet at H 0.73 (d, J = 
6.5, H3-18) coupled with a downfield quartet of one proton at H 3.18(q, J = 6.5 Hz, H-19) 
suggested the presence of a hydroxyethyl group attached to C-20. In addition, the attachment 
of a hydroxyl group to C-19 was deduced by the downfield shift of C-19 (C 64.9). This was 
confirmed from the HMBC correlations between H-19 and C-18, 17, 20, and 21. Thus, 
compound 6 was identified as minovincinine (Figure 4-11), which has been isolated before 
from V. minor (Plat et al., 1962). 
 
Figure 4- 11: Selected HMBC correlations for minovincinine (6). 
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Table 4- 8: 1H and 13C NMR spectral data (700 MHz for 1H, 175 MHz for 13C) of minovincinine 
(6) formic acid in DMSO-d6. 
Pos. 
C 
Shift 
XHn 
H 
Shift 
H 
Multiplicity 
(J Hz) 
COSY ROESY C HMBC 
2 166.5  C   ---        
3 50.2  CH2  3.05  m  3  14, 3, 5  14, 15, 21 
2.33  br d (3.0)  14, 3  14, 21, 3  21, 15 
5 50.9  CH2  2.44  m  6, 6, 5  6, 5, 9  7, 21, 6, 3 
2.84  m  6, 5  6, 5, 3  7, 6, 21 
6 46.0  CH2  1.48  m  6, 5  6, 5  8, 7 
1.85  br d (6.5)  6, 5, 5  5, 6  5, 8, 2, 7 
7 55.0  C   ---        
8 136.7  C   ---        
9 120.4  CH  7.20  d (7.1)  10  5, 21  7, 11, 13 
10 119.9  CH  6.79  t (7.4)  11, 9    12, 8 
11 127.2  CH  7.07  t (7.8)  10, 12    13, 9 
12 109.9  CH  7.01  d (7.5)  11  1  10, 8 
13 143.8  C   ---        
14 21.4  CH2  1.53  m  14  14, 3, 21   
1.72  m  14, 3  14, 17, 3  3, 15, 20 
15 25.6  CH2  1.50  m    17  20, 21, 3, 14, 17 
1.41  br d (4.3)    18, 21  3, 20, 17, 14, 19 
16 91.3  C   ---        
17 25.7  CH2  2.56  m    15, 14, 19  20, 22, 16, 21, 
19, 2 
18 17.9  CH3  0.73  d (6.5)  19  15, 21, 19  19, 20 
19 64.9  CH  3.18  m  18  18, 21, 17  18, 17, 20, 21 
20 42.1  C   ---        
21 67.4  CH  2.55  m    18, 15, 3, 9, 
14, 19  
8, 3, 15, 7 
22 167.7  C   ---        
23 50.4  CH3  3.64  m      16, 22 
1   NH  9.45  s    12  7, 8, 2, 13 
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Compound 7: 
Compound 7 was obtained as a white amorphous powder. The molecular formula of 7 was 
determined as C21H24N2O3 on the basis of its HR-ESI-MS peak at m/z 353.1869 [M +H]
+ 
(Calculated m/z for M+H, 353.1865). The MS2 fragmentations of 7 were predominated by the 
loss of methanol molecule to give a peak at m/z 321.1604 [M – CH4O+H]+ (Calculated m/z for 
M – CH4O+H, 321.1598) indicating the presence of a methyl ester group (Figure A-50). The 
UV spectrum (MeOH) exhibited maxima at wavelengths 221, 293 and 331 nm (Figure A-50), 
which characteristic of aspidosperma-type alkaloids (Akhgari et al., 2015). 
The NMR data of 7 (Table 4-9 and Figure A-51: 56) were closely related to those of 
vincadifformine (2), with the key difference in the replacement of the ethyl side chain with a 
methyl ketone as deduced by the C 206.3 (C-19) and H 2.14 (s, 3H, COCH3). This was 
confirmed from the HMBC correlations between H-18, 17 and C-19. Compound 7 was assigned 
as minovincine (Laforteza et al., 2013; Figure 4-12), which has been isolated before from V. 
minor (Plat et al., 1962). 
 
 
Figure 4- 12: Selected HMBC correlations for minovincine (7). 
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Table 4- 9: 1H and 13C NMR spectral data (700 MHz for 1H, 175 MHz for 13C) of minovincine 
(7) TFA salt in CDCl3. 
Pos. C Shift XHn H Shift 
H Multiplicity 
(J Hz) 
COSY ROESY C HMBC 
2 173.1  C   ---        
3 46.8  CH2  3.52  br s  14     
5 52.8  CH2  3.87  m  6, 4NH+  6, 6, 17  21, 7 
6 35.5  CH2  2.97  m  6, 5  6, 9, 5  5, 2, 8 
2.83  br dd (14.3, 5.5)  6  6, 5   
7 60.2  C   ---        
8 143.8  C   ---        
9 123.7  CH  8.45  d (7.5)  10  6, 21, 11, 10  13, 11, 7 
10 129.2  CH  7.45  t (7.5)  9  9  8 
11 128.9  CH  7.40  m  12  9  13 
12 122.2  CH  7.60  d (7.5)  11    10, 8 
13 151.6  C   ---        
14 14.3  CH2  2.03  m  3     
15 29.8  CH2  1.66  m  15  15, 21  17 
2.19  br d (13.6)  15  15, 17  3, 21 
16 62.9  C   ---        
17 43.8  CH2  3.46  br d (16.4)  17  18, 15, 17  19, 22, 2, 21, 
20, 16 
3.04  br d (16.6)  17  17, 5, 18  22, 16, 19, 15, 
20 
18 24.2  CH3  2.14  s   23, 17 20, 19, 15 
19 206.3  C   ---        
20 48.1  C   ---        
21 65.5  CH  4.47  m  4NH+  9, 15  7, 17, 5, 8 
22 169.0  C   ---        
23 54.4  CH3  3.97 s   18 22 
4NH+   13.49 br s    
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Compound 9: 
Compound 9 was obtained as colorless crystals. The molecular formula of 9 was determined as 
C21H24N2O4 on the basis of its HR-ESI-MS at m/z 369.1815 [M+H]
+ (Calculated m/z for M+H, 
369.1814) (Figure A-57). The MS2 fragmentation of 9 (Figure A-57) showed the loss of 
methanol to give a peak at m/z 337[M – CH3OH+H]+, indicating the presence of methyl ester 
group. The UV spectrum (MeOH) exhibited maxima at wavelengths 219 and 285 nm indicating 
the presence of an indolenine chromophore, which was confirmed by the characteristic 
chemical shift of C-2 at δC 186.9 in the 13C-NMR spectrum(Atta-ur-Rahman and Habib-ur-
Rehman, 1986; Figure A-57). 
The NMR spectral data of 9 (Table 4-10 and Figure A-58:64) suggested an akuammiline 
skeleton, a closely related structure to that of 3 (strictamine). 
1H NMR spectrum of (9) showed three ABX-system protons at H 6.96 (d J= 2.6 Hz, H-9), 6.65 
(dd J= 8.3, 2.6, H-11), 7.27 (d J= 8.3, H-12) indicating the presence of a 10-substituted 
indolenine moiety. 13C NMR spectrum (Table 4-10 and Figure A-59), confirmed the presence 
of two nitrogenated tertiary carbons (C 147.9 & 186.9) and an oxygenated tertiary carbon (C 
155.4) confirming a 10-hydroxy substituted indolenine nucleus. In addition, substitution of the 
free hydrogen at H-16 in strictamine (3) with a CH2OH group in 9 was also revealed. This was 
confirmed by the downfield shift of the carbon signals of C-7 and C-16 and from HMBC 
correlations of H-17 with these two carbons. 
In conclusion, the above spectral data of 9 was in agreement with the published data of 
ercinamine  (Figure 4-13), which has been isolated from Vinca erecta (Yagudaev et al., 1983) 
and the tissue culture of Catharanthus roseus (Guéritte et al., 1983). It is worth noting that this 
is the first report for the isolation of ercinamine from V. minor. 
 
Figure 4- 13: Selected HMBC correlations for ercinamine (9). 
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Table 4- 10: Table 13. 1H and 13C NMR spectral data (700 MHz for 1H, 175 MHz for 13C) of 
ercinamine (9) formic acid salt in DMSO-d6.  
Pos. 
C 
Shift 
XHn 
H 
Shift 
H-
Multiplicity 
(J Hz) 
COSY TOCSY N/ROESY C HMBC 
2 186.9  C   ---          
3 53.8  CH  4.28  d (4.5)  14, 14  14, 14, 15  14, 14  2, 7, 15, 21 
5 51.3 CH2  2.32  br d (4.5)  5, 6  6, 5, 17, 6  6, 5  3, 6, 7 
2.51  dt (3.6, 1.8)  5, 17  6, 5, 17, 6  6, 5  6 
6 38.3  CH2  3.42  m  6, 5  6, 5, 5  6, 17  6, 2, 7, 8, 16 
1.78  m  6  5, 5, 17, 6  5, 5, 6, 9   
7 58.2  C   ---          
8 146.4  C   ---          
9 112.5  CH  6.96  d (2.6)      6  7, 11, 12 
10 155.4  C   ---          
11 114.0  CH  6.65  dd (8.3, 2.6)      12  9, 13,  
12 120.5  CH  7.27  d (8.3)      11  8, 10, 13 
13 147.9  C   ---          
14 30.2  CH2  2.31 m  14, 3  14, 15, 3  14, 15, 21, 3  2, 15, 16, 20, 
21 
1.73  m  14, 15, 
3  
14, 15, 3  14, 17, 17, 
15, 3  
 
15 33.4  CH  3.62 br s  14  18, 14, 14, 
21, 21, 3  
18, 14, 14, 
17  
3, 7, 16, 20 
16 59.7 C   ---          
17 62.0  CH2  2.77  d (11.8)  5, 17  5, 17  14, 17  3, 7, 15, 16, 
22 
2.52 m  17  6, 5, 17  14, 17, 21, 6, 
15  
 
18 13.13  CH3  1.58  dd (7.2, 2.3)    21, 15, 21  15, 23, 19  19, 20 
19 117.8  CH  5.37 br d (7.1)    21  18, 21  15, 18, 21 
20 140.9  C   ---          
21 53.3  CH2  3.08  br d (17.2)  21  18, 15, 21, 
19  
17, 21, 19  5, 19, 20 
3.94 br d (17.2)  21  18, 21, 15  14, 21   
22 173.0  C   ---          
23 51.4  CH3  3.69 s      18  22 
CH2OH     8.35 br s         
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Compound 8: 
In contrast to the other alkaloids mentioned above, the alkaloid denoted as compound 8 could 
not be isolated so far since the resolution of the semi-preparative column did not allow the 
isolation of this compound. Accordingly, only limited information on this alkaloid is available.  
 The molecular formula of 8 was determined as C21H26N2O2 on the basis of its HR-ESI-
MS peak at m/z 339.2045 [M +H]+ (Calculated m/z for M+H, 339.2073) (Figure 4-17). The UV 
(MeOH) spectrum exhibited a maximum at wavelength 240, 292 nm (Figure 4-14; Vachnadze 
et al., 2010).  
 In comparison to the MS2 fragmentations of minovincinine (6) and vincadifformine (4) 
which were predominated by the cleavage of the ester bond to give [M − CH4O +H]+ at m/z 
323.1760 and 307.1811, respectively, compound 8 showed a peak at m/z 339.2045 [M + H]+ as 
the base peak (Figure 4-17). The initial fragmentation pattern of compound 8 (Figure 4-15) 
involves fission of ring C, with expulsion of the ethylene group and the formation of an ion at 
m/z 311.18 [M – 28+H]+, as in the aspidospermidine fragmentation (Saxton, 1983a) and 
followed by the loss of C2H4O2 to give a peak at m/z 251.15. The MS
2 peak at m/z 251.15 of 
the previously mentioned compounds (4, 6, and 8) produced a series of fragment ions in MS2 
spectra. The driving force for this fragmentation is presumably the aromatization of the indole 
ring and the relief of ring strain in the fused hexacyclic system via Retro Diels Alder (RDA) 
cleavage of the C-ring (Saxton, 1983a). Further cleavage at the benzylic positions gives the 
piperidine-derived fragment at m/z 110.10, 96.08 and two aromatic ions at m/z 170.10 and 
130.07 (Figure 4-16).  
 Therefore, the MS-MS spectrum of compound 8 was similar in fragmentation patterns 
to kopsinine determined by FAB-tandem mass spectrometry (Laprévote et al., 1990). 
           
 
 
Minovincinine (7) 
 
Kopsinine (8) Vincadifformine (4) 
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Figure 4- 14: UV spectrum of compound 8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4- 15: Suggested scheme for fragmentation pattern of compound 8. 
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Figure 4- 16: Suggested scheme for fragmentation pattern of minovincinine (6). 
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Figure 4- 17: MS-MS spectra for; (a) minovincinine; (b) compound (8); (c) vincadifformine 
(zoomed spectra). 
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4.3.3 Quantitative differences in the MIA contents of control and stressed V. minor leaves  
To comprehensively describe the MeJA effect, a sound determination of the corresponding 
changes of the indole alkaloids concentrations are required. For this, a solid quantification of 
the MIAs presents in MeJA treated plants in comparison to the control plants is required. 
Unfortunately, due to the putative differences in UV absorbance, the peak area from the PDA 
detection cannot be used a reliable basis for any quantification. In contrast, the response 
intensities in the Total Ion Chromatogram (TIC) of the LCMS runs could be used for 
quantification, assuming that the analyzed substances have a similar ionization behavior. For 
the calculation of the peak areas, the Find-Molecular-Feature function of the Data Analysis 
Program (Bruker Daltonics) was used. Accordingly, further analyses of the MeJA treated as 
well as of the control plants were conducted by using LC-MS analyses. For this, the old leaves 
were extracted as mention in the Material and Method section. Strychnine was added as an 
internal standard to the solvent used in the extraction. After analysis of the samples by LC-MS, 
the peak areas are calculated. Subsequently, peak areas are normalized to the internal standard 
strychnine (Table 4-11).    
Based on the comparison of the peak areas in both samples when normalized to the internal 
standard, the relative changes (fold change) could be calculated. For this, the differences in the 
areas of a certain MIA between the MeJA treated and the control plants were divided by that of 
the control. Consequently, the relative change for the strychnine standard is zero. A value less 
than zero means that the concentration of this compound is lower in the treated plants than that 
in the controls; meaning that it decreased in response to the MeJA treatment. Values higher 
than zero state that the amount of this certain compound is higher in the treated sample than in 
the control, signifying that the concentration of the compounds increased in response to the 
MeJA treatment. In all cases, in which no peak area couldn’t be calculated (i.e., due to the 
absence of any peak or because its value was below the detection limit), no value was 
calculated. The corresponding data are compiled in Table 4-11. In order to prevent a mixing of 
the indication with the numbering of the nine compounds mentioned above, the compounds 
were termed A1 to A68.  
It clearly could be recognized that the concentrations of most of the compounds are changed in 
response to the MeJA treatment. Surprisingly, many substances show the same fold change 
value. We can conclude that these substances are converted in a similar manner, mentioning 
that the mode of conversion either is the same or is related to the same pathway. 
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Table 4- 11: Changes in the alkaloid composition of old leaves from MeJA treated V. minor 
plants in comparison to the control. 
Compound 
RT 
[min] 
Mass m/z 
[M+H]+ 
Area 
Fold 
change  Control MeJA 
A-1- ercinamine 6.12 369.1814 290213 713002 1.4568 
A-2 6.37 399.1899  11757  
A-3 7.05 339.1702 25261   
A-4 - strychnine -  
         internal standard 
7.55 335.1754 2265468 2265468 0.0000 
A-5- minovincinine 7.78 355.2017 690832 3967222 4.7427 
A-6 7.87 387.1915 17734   
A-7 7.98 351.1705 237845 159802 -0.3281 
A-8 7.95 353.186 135482   
A-9 8.2 369.1809 111127 282113 1.5387 
A-10 8.21 371.1597 9146   
A-11 8.27 461.2272 8679   
A-12 8.43 351.1706  66024  
A-13 8.68 371.1963  28844  
A-14 8.73 367.1648  29523  
A-15  kopsinine? (8) 9.11 339.2072 269042 1596549 4.9342 
A-16 9.15 369.1808  124189  
A-17 9.21 341.1864 94954   
A-18 9.5 383.1971 361767 747430 1.0661 
A-19 9.57 355.2012 12328   
A-20 9.61 369.181 90157 634032 6.0326 
A-21- minovincine 9.73 353.1865 746834 3840636 4.1426 
A-22 9.65 321.1601  45373  
A-23 9.82 197.1172 30277 34279 0.1322 
A-24 9.82 413.2071 18002 41205 1.2889 
A-25 9.79 321.1601  171255  
A-26 9.86 355.2017 93520   
A-27 10.06 299.2115  31033  
A-28 10.2 355.2017 3264562 4931241 0.5105 
A-29 10.18 353.1856 60543   
A-30 10.26 399.1916 104693   
A-31 10.43 383.1964  101943  
A-32 10.67 429.2025 98505   
A-33 10.76 371.1969 99686 163620 0.6414 
A-34 10.96 353.1858 55324 85790 0.5507 
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Compound 
RT 
[min] 
Mass m/z 
[M+H]+ 
Area 
Fold 
change  Control MeJA 
A-35 11.24 369.1797  34402  
A-36 11.32 281.2019 1263299 994446 -0.2128 
A-37 11.32 299.2124 221377 161857 -0.2689 
A-38 11.29 351.1696  119096  
A-39 11.4 383.1969 148865 436987 1.9355 
A-40- vincamine 11.66 355.202 11889948 2166515 -0.8178 
A-41 11.66 337.1911 125178   
A-42 11.66 745.3726 45245   
A-43 11.66 747.3713 10454   
A-44 11.75 399.191  302515  
A-45 11.99 369.2172  98857  
A-46 12.64 385.2129 614505   
A-47 12.7 351.1705 56374 185933 2.2982 
A-48  12.93 339.1702 222699 138744 -0.3770 
A-49 - strictamine 13.14 323.1758 2158369 1943188 -0.0997 
A-50 - methoxyvincamine 14.07 385.2123 97681 769062 6.8732 
A-51 14.51 341.1862 447273 393610 -0.1200 
A-52 - 9-methoxyvincamine 14.58 385.2125 1065412 6041931 4.6710 
A-53 14.51 805.3912  5897  
A-54 15.32 323.1754 269266 200044 -0.2571 
A-55 15.77 401.2071 155801   
A-56 15.86 369.1813 747136   
A-57 16.16 323.1762 776500 850393 0.0952 
A-58 16.29 338.1811  338742  
A-59 16.93 323.1755  120218  
A-60 16.97 397.1762 238746   
A-61 17.65 339.2072 168451   
A-62 18.3 355.2022 319555   
A-63 - vincadifformine 19.1 339.2074 1687203 793954 -0.5294 
A-64 20.41 354.1944  249623  
A-65 22.38 369.2168 304875 208057 -0.3176 
A-66 22.43 353.2222 959790 1266222 0.3193 
A-67 22.92 355.2375 260067 265583 0.0212 
A-68 23.43 369.2166 550914 205161 -0.6276 
 
Chapter 4:  Results 
73 
 
 
The numbering of alkaloids mentioned in Table 4-6 is added to the chromatograms presented in as 
Figure 4-9.  
Unfortunately, for most of the observed changes – until now – no prediction on the exact 
molecular structure and the biosynthetic pathway involved could be made. However, based on 
the structural similarities of vincamine and 9-methoxyvincamine and their inverse changes in 
concentrations (which already had been presented in Figure 4-9), it is postulated that vincamine 
serves a precursor for 9-methoxyvincamine (Figure 4-18). In the same manner, it could be 
deduced that vincadifformine is converted first to minovincinine and subsequently to 
minovincine (Figure 4-18). Because of the similarities to other modifications of secondary 
metabolites (Rodriguez et al., 2003; Giddings et al., 2011), it is likely that the corresponding 
reactions are catalyzed by cytochrome P450 enzymes. An unequivocal confirmation for the 
occurrence of such conversions should be provided by classical pulse-chase experiments using 
13C or 14C labeled alkaloids, which could be generated by feeding the corresponding labeled 
precursors (tryptophan) to V. minor plants before MeJA treatment.  
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Figure 4- 18: Postulated conversion of indole alkaloids in V. minor in response to MeJA 
treatment. 
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4.4 Application of different growth regulators on V. minor  
The various indole alkaloids present in V. minor extracts reveal quite different biological active-
ties (Khanavi et al., 2010; Hasa et al., 2013). Accordingly, the alkaloid patterns and 
concentrations determine the related biological potency, and thus, also the corresponding 
pharmacological effectivity. As outlined above, the treatment with MeJA strongly alters the 
alkaloid composition in V. minor. In order to elucidate the extend of these changes and also to 
investigate whether other growth regulators (e.g., salicylic acid, hydrogen peroxide) have 
similar effects, further experimental approaches have been conducted. Apart from growth 
regulators, also resveratrol was applied to the V. minor plants. This stilbene is known to inhibit 
oxidative enzymes (Fan and Mattheis, 2001; Kutil et al., 2014) and thus, might interfere with 
the indole alkaloid biosynthesis, too. These studies – in combination with the data revealed 
from the experiments, in which MeJA was applied – should indicate, if and to which extent the 
alkaloid pattern of V. minor could be modulated by exogenous factors. 
In the course of these experiments, the growth regulators had been applied twice; the second 
application was performed two days after the first treatment. Resveratrol was applied four times 
via the irrigation water. Leaves – separated to young and old ones – had been collected four 
times after the treatment (for details see material and method section). In order to estimate 
putative losses during the entire extraction and quantification process, strychnine was added as 
an internal standard to the solvent used in the first extraction step. In the same manner, the 
authentic alkaloid solutions (vincamine and vincadifformine) used for quantification were 
prepared using the identical solvent containing the internal standard. Accordingly, the ratio of 
peak areas between the analyte and internal standard could be used to quantify the 
Summing-up – 4.3 The effect of MeJA on the pattern of indole alkaloids of V. minor 
MeJA treatment causes a significant shift in the alkaloid pattern. Based on the reverse 
changes, it is deduced that vincadifformine is transformed first to minovincinine and finally 
to minovincine. In the same manner vincamine is converted to 9-methoxyvincamine (Figure 
4-18). The identification of the enzymes involved in the conversion steps, appears to be an 
attractive topic for further studies.  
The discovery of 9-methoxyvincamine as a novel natural product further outlines that even 
well-known, extensively studied plants such as V. minor, might be an auspicious source for 
the generation of novel phytochemical drugs, when grown under defined stress conditions.  
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concentrations of these alkaloids in the various samples. However, a major problem with 
respect to the quantification of the other alkaloids (which were not available as standard 
substances) corresponds to the fact that these alkaloids may reveal quite different absorbance 
spectra. For instance, vincamine displays a higher absorbance at 280 than vincadifformine, 
whereas the latter one reveals a far higher absorbance at 330 nm than vincamine. Consequently, 
it is quite problematic (and nearly impossible) to soundly calculate the concentration of a certain 
alkaloid, whose absorbance is not known. Indeed, according to the literature, minovincine and 
minovincine possess quite similar UV spectra as vincadifformine; consequently, they could be 
quantified based on the response factor of vincadifformine. In the same manner, epivincamine 
and methoxyvincamine - due to their similar absorbance properties as vincamine - could be 
quantified based on the vincamine calibration curve. For all other alkaloids, putative differences 
in their concentration could only be determined as relative values.  
4.4.1 Effect of growth regulators on growth and development of V. minor 
The application of growth regulators and resveratrol, respectively, did not change the 
performance of the V. minor plants (Figure 4-19). 
 
 
 
 
 
 
 
 
 
 
Figure 4- 19: V. minor plants treated with different growth regulator: Abbreviations: MeJA (methyl 
jasmonate); H2O2 (hydrogen peroxide); SA (salicylic acid). 
 
control resveratrol MeJA H2O2 SA 
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In contrast to the habitus, the appearance of individual leaves of treated and control plants 
differs significantly. Whereas the leaves of control plants show the typical healthy and vital 
appearance, those of the treated plants reveal typical stress symptoms (Figure 4-20). 
 
 
 
 
 
 
 
 
Figure 4- 20: Leaves of V. minor plants treated with a different growth regulator 
 
The most significant difference of the treated plants in comparison to the control concerns the 
young leaves: independently to the compound applied, many young leaves exhibit several 
necrosis. On the contrary, in old leaves, these stress symptoms are much rare and their extent 
is quite smaller. In Figure 4-21 these typical differences are displayed exemplarily. 
 
 
 
 
 
 
Figure 4- 21: Characteristic differences of leaves from control and stressed plants. 
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4.4.2 Effect of growth and development on the content and composition of indole alkaloids 
in V. minor 
As already mentioned, in old leaves of V. minor, vincamine represents the major alkaloid. Yet, 
in young leaves, vincadifformine turned out to represent the alkaloid exhibiting the highest 
concentration (Figure 4-1, page 44). Consequently, before the effect of the various growth 
regulators were analysed in detail, the influence of leaf age on the alkaloid content was 
quantified. 
In the controls, the concentration of vincadifformine is markedly lower in old leaves than in 
young ones (Figure 4-22), putatively due to the massive gain of biomass per leaves3. From this, 
it could be argued that no further biosynthesis of vincadifformine occurs in old leaves. 
However, due to the dynamic equilibrium of biosynthesis, degradation, and conversion of the 
indole alkaloids, the situation is much more complex and will be stressed in detail in the next 
chapter (discussion section: 5.1). In contrast, the concentration of vincamine is markedly higher 
in old leaves (Figure 4-22). Accordingly, the total content of vincamine per leaf increases in the 
course of leaf maturation, suggesting that this alkaloid is synthesized also in old leaves.   
 
Figure 4- 22: Concentration of vincamine and vincadifformine of young and old leaves. Values 
correspond to the average of all control plants analysed in this part of the investigation. 
                                                          
3  When the content of a certain alkaloid is identical in young and in old leaves, - due to the massive gain 
the leaf weight (fourfold) - the alkaloid concentration in old leaves will be markedly lower (about one 
forth).  
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These data clearly show that a sound assignment of the developmental stage of the leaves used 
for the scheduled experiments is required. Accordingly, for all approaches quantifying the 
alkaloid concentration in differentially treated plants, always a differentiation between old and 
young leaves had been made. 
The various growth regulators had been applied two times to V. minor plants during the 
blooming phases. The leaves were collected at four different time intervals (1, 4, 8, and 14 days 
after the treatment). As already mentioned for MeJA, also the application of salicylic acid and 
H2O2 impact the pattern and the concentration of the alkaloids. 
4.4.3 Effect of growth regulators on the composition of indole alkaloids in V. minor 
Qualitative changes in response to salicylic acid  
The application of salicylic acid (SA) induced only minor changes in the concentration of 
MIAs4 (see below 4.4.4) but did not cause any qualitative changes, i.e., SA did not elicit the 
generation of new alkaloids.  
Qualitative changes in response to H2O2  
In contrast to the treatment with SA, which indeed altered the only concentration of alkaloids, 
but did not induce major changes in their composition of MIAs the treatment with H2O2 
significantly impacts on both, alkaloids concentration and their spectrum. As outlined in the 
scientific background (section 2.3.4.1) H2O2 is involved in the induction of phytoalexin 
biosynthesis in the course of host-pathogen interactions, frequently denoted as oxidative burst 
(Wojtaszek, 1997), and in numerous signalling events by interacting with other signal 
molecules, such as JA, SA, ethylene, Ca++, NO etc. (for review see (Saxena et al., 2016). 
Previous studies showed that exogenous application of H2O2 induced indole alkaloid bio-
synthesis in C. roseus (Tang et al., 2009). In addition, in hairy roots cultures of V. minor, 
H2O2 increased the total alkaloid content (Verma et al., 2014b). However, the authors did not 
analyze the entire alkaloid pattern. Accordingly, the application of H2O2 to V. minor plants 
seemed to be very promising and it was integrated into this study, too. 
                                                          
4 In case of SA no significant change in the spectrum of the alkaloids was observed; except for single 
plant after 14 days, which showed a drastic decrease in 9-methoxyvincamine, whereas minovincinine 
and minovincine were present in high concentration. Since the reasons for this particular and unique 
finding are unknown, it remained unconsidered in the related deductions (Appendix: Figure A-66). 
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In addition to the changes mentioned to be induced by a MeJA treatment, further modifications 
of the alkaloid composition were detected when H2O2 was applied. These differences mainly 
concern 9-methoxyvincamine and a so far, unknown alkaloid, denoted 10 in Figure 4-23. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4- 23: HPLC chromatogram of the old leaves treated with H2O2. The stressed plant contains 
two peaks (green arrows) have the same UV spectrum of methoxyvincamine with a comparison to 
control. Compounds are represented by numbers: 10-hydroxycathafoline (1); strictamine (3); 
vincadifformine (4); minovincinine (6). minovincine (7). *As mentioned above, due to the problems in 
separating vincamine and epivincamine, always the sum of these both alkaloids are denoted as 
vincamine. 
Compound 10: 
In the same manner, as a massive increase of the 9-methoxyvincamine concentration could be 
detected in MeJA treated plants, the concentration of the unknown substance was considerably 
enhanced in H2O2 treated plants. Astonishingly, the UV-spectrum of this unknown substance 
was very similar to that of 9-methoxyvincamine. In order to get further information on this 
compound, the samples were re-analyzed using LC-MS. It turned out that the substance 
responsible for the unknown peak reveals a molecular weight of 384, which is identical to that 
of 9-methoxyvincamine. In order to find out, if there might be a metabolic relation between this 
unknown substance and 9-methoxyvincamine, a further thorough analysis of the chromatogram 
of the control plants was performed. 
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When checking the extracted ion chromatogram (EIC) of all peaks revealing a mass identical 
to methoxyvincamine (M+H+ = 385 m/z), it turned out that several compounds are present in 
control as well as in the stressed plants that reveal this molecular mass (Figure 4-24).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4- 24: The extracted ion chromatograms (EIC of 385 m/z). In both samples, control leaves 
and H2O2 treated leaves, the mass of 385.21 (corresponding to methoxyvincamine) is present as double 
peaks. Has to be mentioned that the expansion of both samples strongly differs. 
Interestingly, two main double peaks could be detected in the control as well as in the stressed 
leaves; but their retention time differs by about 3 min (Figure 4-24). Nonetheless, the MS-MS 
fragmentation patterns of these four compounds are very similar, except the intensity of the 
fragment (367 m/ z, corresponding to [M -18+H]+; Figure 4-25, Table 15).  
As 11-methoxyvincamine was already reported to occur in V. minor (Štrouf, Trojánek 1964; 
Szabó et al., 1996), it can be concluded that the compounds eluting between 12 and 13 min 
correspond to this compound, whereas the substances eluting between 14 and 15 is 9-
methoxyvincamine. Like it was reported for stereoisomers having an eburnane basic skeleton 
(e.g. vincamine, eburnamine), the observed double peaks for 11- and 9-methoxyvincamine, 
respectively, might be due to epimers at C-14 (Kováčik and Kompiš, 1969; Czira et al., 1984), 
i.e., in methoxyvincamine and methoxy-14-epivincamine. 
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Figure 4- 25: MS-MS spectra of the double peaks in control and H2O2 treated plants. The 
fragmentation pattern of the two isomers is different, especially in the intensity of 367m/z; yet 
the abundance of other fragments is nearly the same. * The methoxy group at 11-position in 
the indole ring was reported by Štrouf and Trojánek, (1964) and Szabó et al. (1996). 
As outlined above, in stressed plants, methoxyvincamine is derived from the vincamine 
(Figure 4-18). In this manner, the epimers of both methoxyvincamine isomers mentioned 
above should be derived from corresponding 14-epimers of vincamine; i.e., vincamine and 
14-epivincamine. Accordingly, an EICs for the mass of vincamine (M+H+ = m/z 355) was 
generated for control V. minor extracts (Figure 4-26). The extracted ion channel (m/z 355) 
showed three major peaks. Yet only two revealed the same fragmentation pattern of vinca-
mine, representing 14-epivincamine and vincamine (Figure 4-27); the other peak eluting at 
about 10 min, about 10 min, corresponding to 10-hydroxycathofoline. 
11-methoxy-14-epivincamine * 
RT = 12.1 
 
11-methoxyvincamine * 
RT = 12.9 
9-methoxy-14-epivincamine 
RT = 14.6 
 
9-methoxyvincamine 
RT = 15.2 
control 
Chapter 4:  Results 
83 
 
 
Figure 4- 26: LC-MS chromatograms – TIC and EIC 355.2 [M+H]+. The total ion 
chromatogram (TIC) outlines all alkaloids present in the control sample, whereas the extracted 
ion chromatogram (EIC) only displays those revealing a mass of 355.2 (M+H+). As 14-
epivincamine cannot be fully separated from vincamine, it is detectable just as a shoulder of 
the vincamine peak. 
With respect to the fragmentation pattern of both vincamine related peaks, we have to consider 
that in the MS-MS-spectrum – apart from the [M+H]+-fragment (=355 m/z) - the most abundant 
mass corresponds to the dehydrated molecule. It is noteworthy to mention that the different 
stereochemistry at C-14 influences this loss of water, resulting in different intensities of the 
[M -18+H]+-fragment (=337 m/z; Figure 4-27; (Czira et al., 1984; Kováčik and Kompiš, 1969)). 
Due to the higher stability of the equatorial hydroxyl group, the abundance of the 337 m/z-
fragment is quite lower in 14-epivincamine than in vincamine, which exhibits an axial (more 
unstable) hydroxyl group ((Czira et al., 1984; Saxton, 1983b); Figure 4-27, Table 4-12).  
Table 4- 12: Relative abundance (%) of the main fragments of vincamine, methoxyvincamine, 
and their 14-epimers. 
RT 
min 
Compound [M+H]+ 
%Relative abundances 
[M+1]+ [M-18+1] m/z 174 m/z 144 
11.4 14-epivincamine 355.2025 100 16.1 0 5.3 
11.7 vincamine (2) 355.2027 100 76.6 0 9.9 
12.1 11-methoxy-14-
epivincamine? 
385.2128 100 10.4 4.8 0 
12.9 11-methoxyvincamine? 385.2129 37 100 7.9 0.2 
14.6 9-methoxy-14-
epivincamine (10) 
385.21304 100 9.7 3.4 1 
15.2 9-methoxyvincamine (5) 385.2132 100 95.2 11.2 2.8 
10-hydroxy 
cathafoline 
TIC  
EIC-355.2 [M+H]+ 
 vincamine 
14-epivincamine 
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Figure 4- 27: MS-MS spectra of the two peaks with RT 12 min in control sample. The fragmentation 
patterns are very similar, except the difference in the intensity of the first fragment (337 m/z) (like in case 
of the methoxyvincamine). 
In the same manner, it can be explained that the methoxy-14-epivincamines are more stable 
with respect to a dehydration than the methoxyvincamine; a fact that properly explains the 
differences in the intensity of their fragmentation pattern (Figure 4-25). In both cases, the [M -
18+H]+-fragment (=367 m/z) has a higher abundance in the fragmentation pattern of the 
methoxyvincamines than in the case of the methoxy-14-epivincamines (Figure 4-28; Table 4-
12).  
Figure 4- 28: Main fragments of vincamine (2) and methoxyvincamine (5). 
 
[M-H2O+H]+ 
337.191776 
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In conclusion, is can be deduced that in leaves of V. minor, methoxyvincamine is derived from 
vincamine, and methoxy-14-epivincamine from 14-epivincamine, respectively. However, we 
have to conclude that the position of methoxylation depends on the physiological state of the 
plant. Whereas 11-methoxyvincamine and its 14-epimer are present in the healthy and 
unstressed control plants, 9-methoxyvincamine and its 14-epimer are produced in stressed 
leaves. 
Compound 11 and 12: 
Up to now, the presence of a putative intermediate, 9-hydroxyvincamine could not be 
established; however, some evidence is already available. When checking the extracted ion 
chromatogram (EIC) of all peaks revealing a mass of hydroxyvincamine (M+H+ = 371 m/z), it 
turned out that several compounds are present in control as well as in the stressed plants showed 
this molecular mass (Figure 4-29). 
 
Figure 4- 29: The extracted ion chromatograms (EIC of 371 m/z) of old control and H2O2 treated 
leaves. The major unknown alkaloids are denoted 11, 12, 13 and 14. 
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Figure 4- 30: MS-spectra of the peaks with mass (M+H+ = 371m/z), in both control, and H2O2 -
treated plant. * Further analyses revealed that these both compounds reveal a molecular mass of 369 
– the positive signal in the EIC (371) is due to the 13C-isotope. 
Based on the data mentioned above, it could be concluded that the compounds 11 and 12 
(second double peak in the chromatograms of H2O2 treated plants and the compound 13 (the 
second substance of the first double peak) reveal the mass of 371 m/z (M+H+), i.e., that of a 
putative hydroxyvincamine. In contrast, compound 14 (M+H+ = 369 m/z) does not represent the 
postulated intermediate, maybe it corresponds to a further oxidation product (Figure 4-30).  
However, based on the previously published data of MIAs isolated before from V. minor (Table 
A-1), apart from a 20-hydroxyvincamine or 19-hydroxyvincamine (depending on the 
H2O2 H2O2-treated 
control 
compound 12 
compound 11 
* 
compound 12 
compound 11 
compound 13 
compound 14 * 
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numbering of secologanin skeleton) also vincatine, which also reveals a molecular weight of 
370 is described to occur in V. minor leaves (Doepke and Meisel, 1966; Doepke et al., 1969). 
In order to elucidate the structure of the three compounds (11; 12; 13), the exact masses of these 
three compounds were compared with the calculated masses of hydroxyvincamine and 
vincatine, respectively (Figure 4-31). This comparison clearly outlines that the sum formula of 
all three compounds is C21H26N2O4: the calculated deviation of the mass shifts is less than 2ppm 
for hydroxyvincamine (C21H26N2O4) but nearly 100ppm for vincatine (C22H30N2O3). This 
means that all three substances correspond to a sum formula of C21H26N2O4 and accordingly, 
most likely to hydroxyvincamine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4- 31: The comparison of molecular weights of estimated values for the two suggested 
formulas of (hydroxyvincamine and vincatine) and the measured values. 
The MS-MS fragmentation patterns of the three compounds, especially those revealing the 
retention times of 10.8 min (compound 11) and 11.3 min (compound 12) have many 
similarities, but they are also different to some extent, which might be due to different positions 
of the hydroxyl group (Figure 4-32; 4-33).  
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The compounds were tentatively further characterized and identified on the basis of the known 
fragmentation pathway for vincamine to elucidate 9-hydroxyvincamine (11) and 20-
hydroxyvincamine (12), respectively. Both showed the characteristic fragment ions at m/z 
354.19 due to the losses of OH. The fragment ion at m/z 337.1554 and 309.159 is thought to be 
due to the loss of a further OH followed by that of C2H4, respectively, from compound 12 Table 
4-13. In addition, compound 12 provided fragment ions at m/z 144.0808, whereas compound 
(11) at m/z 160.0755 (the 143Da fragment + OH) indicating that the hydroxyl group is attached 
to indole moiety (Table 4-13; Figure 4-32; 4-33). The 143Da  fragment should be generated by 
the loss of the terpene moiety through C-ring cleavage via Retro Diels Alder (RDA) followed 
by bond breaking between N1 and C14 (Kumar et al., 2016b).  
 
Figure 4- 32: Main fragments of compound 11 and 12 in comparison to those of vincamine (2). 
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Table 4- 13: Relative abundance (%) of the main fragments of 9-hydroxyvincamine and 20-
hydroxyvincamine. 
RT 
min 
Compound [M+H]+ 
%Relative abundances 
[M+1]+ 
[M-
18+1]+ 
[M-
17+1]+ 
[M-17-
17+1]+ 
[M-17-
17-28+1]+ 
m/z 
144 
m/z 
160 
10.8 9-hydroxy-
vincamine (11) 
371.1949 57.8 4.8 100 0 0 0.6 17.3 
11.3 20-hydroxy-
vincamine (12) 
371.1955  100 44.2 46.1 14.9 50.1 22.5 0.1 
It is worth mentioning that compound 11 showed 50% increase in the concentration in the H2O2-
stressed plant, whereas no change was detected for compound 12 (Figure 4-29). Whereas the 
occurrence of 19-hydroyvincamine (12) in V. minor was already reported earlier (Taylor and 
Farn-Sworth, 1974), 9-hydroxyvincamine (11) was identified for the first time in V. minor. 
 
 
Figure 4- 33: MS-MS spectra of the peaks corresponding to 20-hydroxvincamine and 9-
hydroxyvincamine in control and H2O2 treated plants. The fragmentation patterns have many 
similarities, but they are also different to some extent, which might be due to different positions of the 
hydroxyl group. 
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Compound 14: 
On the basis of its HR-ESI-MS at m/z 369.181628, the molecular formula of 14 was determined 
as C21H25N2O4 (calculated m/z for [M +H]
+: 369.180884). The mass 368 m/z of compound 14 
might be due to the oxidation of the OH-group of 20-hydroxvincamine, yielding in a corres-
ponding carbonyl derivative (Figure 4-34; the OH-group at C-20 represents the only vicinal 
hydrogen atom, which could be oxidized to a related carbonyl). The corresponding compound, 
i.e., 20-oxo-vincamine was already described to occur in V. minor and denoted as vincaminine 
(Trojánek et al., 1961).  
 
Figure 4- 34: MS-MS spectra of the compounds at 8.1 with mass (M+H+ = 369 m/z) in H2O2 treated 
plants.  
However, when checking the extracted ion chromatogram (EIC) of all peaks revealing a mass 
of vincaminine (M+H+ = 369 m/z), it turned out that two further isomers are also present in 
the stressed plants (Figure 4-35).  
 
Figure 4- 35: The extracted ion chromatograms (EIC of 396 m/z) of control and H2O2 treated old 
leaves. The major unknown alkaloids are denoted 14 isomers. 
The MS2 fragmentations of 20-oxo-vincamine (14) are results in a m/z 337, putatively due to 
the loss of methanol. Subsequently, the removal of a C3H5N unit is thought to produce a m/z 
282 (Figure 4-34; Figure 37). In contrast, the MS2 of the two isomers (RT 9.13 and 9.53 min) 
control 
H2O2 treated plants 
EIC 369 m/z 
9.13 min 
9.35 min 
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showed a characteristic fragmentation ion at m/z 351 which is postulated to result from the loss 
of water molecule [M – H2O+H]+ (Figure 4-36; Figure 37). Subsequently, the same 
fragmentation as for vincamine might occur, i.e., the generation of the characteristic indole 
moiety at m/z 143.0729 or m/z 144.080947, respectively (Figure 4-36). Also, in this case, the 
fragment should be generated by the loss of the terpene moiety through C-ring cleavage via 
Retro Diels Alder (RDA) followed by bond breaking between N1 and C14 (Figure 4-37; Akhgari 
et al., 2015; Kumar et al., 2016a). Based on these considerations, it can be stated that 
compounds at 14 and its isomers indeed are vincaminine. 
 
Figure 4- 36: MS-MS spectra of the compounds at 9.13 and 9.35 with mass (M+H+ = 369 m/z) in 
H2O2 treated plants. The fragmentation patterns are very similar. 
Figure 4- 37: Proposed mass spectral fragmentation of vincaminine (14) and its putative isomers 
according to MS-MS data. 
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Compound 13: 
On the basis of its HR-ESI-MS at m/z 371.196879, the molecular formula of 13 (RT 8.7 min) 
was determined as C21H26N2O4 (calculated m/z for [M +H]
+: 371.196534). The MS2  spectrum 
displayed the characteristic fragment ions m/z 354 ([M + H - OH]+) and m/z 339 ([M + H – 
CH3OH]
+), which might be due to the loss of a hydroxyl group and methanol, respectively. In 
addition, the MS2 fragmentations revealed a base peak fragment at m/z 140.107183 (C8H14NO), 
(Calculated m/z for M+H: 140.106990), which indicates that compound 13 might have a 
hydroxyl or an N-oxide piperidine moiety. As the fragmentation patterns of this compound have 
many similarities to minovincinine (Figure 4-38; (Das et al., 1966)), it is postulated that it 
corresponds to hydroxyminovincinine. 
 
Figure 4- 38: MS-MS spectra of the compound at RT 8.7 min with mass (M+H+ = 371 m/z) in H2O2 
treated plants. The fragmentation patterns have many similarities to minovincinine (figure 4-17). 
Further unique compounds detected only on the H2O2 treated sample: 
As illustrated above, the capability of MS analyses can be massively increased by extracting 
certain ions from total ion chromatograms (TIC; (Zhou et al., 2008). In the current study, a 
mass filter was applied to detect further peaks, which are only present or strongly enhanced in 
their concentration, respectively, in the stressed samples. In this context, the extracted ions from 
TIC had been the basis to detect isomers, minors, and co-eluting alkaloids. Consequently, many 
further minor peaks could be detected in H2O2 treated samples, which tentatively are identified 
and displayed in the Table 4-14, and Figure 4-39. Some of these compounds had been identified 
for the first time to occur in V. minor.  
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Figure 4- 39: The extracted ion chromatograms (EIC of 351, 297, and 399 m/z) of control and H2O2 
treated old leaves. 
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Table 4- 14: Identification of further minor compounds from H2O2 treated sample by UHPLC-
ESI-MS/MS. 
≠ 
RT 
min 
Molecular 
formula 
Obs. mass 
m/z[M+H]+ 
Calc. mass 
m/z[M+H]+ 
MS2 
fragment 
ions m/z 
Identification References 
15 8.36 C21H22N2O3 351.1709 351.1703 351 (90), 
319 (100), 
291, 277, 
249 
14, 15- dehydro-
minovincine 
 
(Langlois 
and 
Andriamial
isoa, 1979) 
16 8.36 C19H24N2O 297.1966 297.1961 297 (100), 
279, 253 
aspidofractinin-
16-ol 
(Zhou et 
al., 2006) 
17 8.45 C22H26N2O5 399.1922 399.1914 399 (100), 
367, 355, 
244, 232 
14,15-didehydro-
10-hydroxy-11-
methoxy 
(epi)vincamine 
isomers 
(Zhang et 
al., 2007) 
18 8.85 C22H26N2O5 399.1917 399.1914 399 (100), 
367, 244, 
218, 122 
19 11.2 C22H26N2O5 399.1914 399.1914 399 (100), 
381, 216, 
122 
20 11.0 C22H26N2O5 399.1914 399.1914 399 (100), 
381, 339, 
174 
vincinine isomers (Trojánek 
et al., 
1961) 
21 11.9 C22H26N2O5 399.1918 399.1914 399 (100), 
382, 340, 
173 
22 18.2 C41 H46 N4 O5 
 
675.3542 675.3542 675 (100), 
114, 108 
dimeric alkaloid 
(unknown) 
----------- 
Compound 15: 
On the basis of its HR-ESI-MS (m/z 351.170905 [M +H]+), compound 15 (RT 8.36 min) reveals 
a molecular formula of C21H22N2O3  (calculated m/z for [M +H]
+: 351.170319). The MS2 data 
of this compound are very similar to those of minovincine (C21H25N2O3 [M+H] 
+), except the 
loss of two hydrogen atoms. As its MS2 fragmentations were predominated by the loss of 
methanol yielding in a m/z 319.14455 [M – CH3OH+H]+, compound 15 thought to contain a 
methyl ester group (Figure 4-40; 4-41). Accordingly, this alkaloid was tentatively identified to 
be 14, 15- dehydrominovincine (Langlois and Andriamialisoa, 1979), which corresponds a new 
record for V. minor.  
Figure 4- 40: The main fragments of compound 15. 
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Figure 4- 41: MS-MS spectra of the compound at RT 8.3 min with mass (M+H+ = 351 m/z) in H2O2 
treated plants. The fragmentation patterns have many similarities to minovincine (Figure A- 50). 
Compound 16: 
On the basis of its HR-ESI-MS (m/z 297.196581 [M +H]+), compound 16 (RT 8.36 min) reveal 
a molecular formula of C19H24N2O (calculated m/z for [M +H]
+: 297.196140). The MS2 
fragmentations of 16 (Figure 4-42; 4-43) pointed to the characteristic of loss of water, followed 
by C2H2 unit yielding in m/z 279 and m/z 253, respectively. The MS
2 spectrum shows high 
similarities to the previously characterized alkaloid kopsinine (Figure 4-17). These data suggest 
that this alkaloid corresponds to aspidofractinin-16-ol (Zhou et al., 2006), which putatively was 
identified for the first time in V. minor. 
 
Figure 4- 42: The main fragments of compound 16. 
 
Figure 4- 43: MS-MS spectra of the compound at RT 8.3 min with mass (M+H+ = 297 m/z) in H2O2 
treated plants. The fragmentation patterns have many similarities to kopsinine (8) Figure 4-17. 
compound 15 
compound 16 
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Compound 20 and 21: 
On the basis of their HR-ESI-MS (m/z 399.191394, and 399.191809 for [M +H]+), the molecular 
formula of 20 and 21 (RT 11.03 and 11.9 min) were determined for both as C21H26N2O5 
(Calculated m/z for [M +H]+: 399.191448). The two compounds reveal a similar MS2 spectrum, 
revealing a characteristic ion of m/z 381[M – H2O+H]+, which may result from the loss of water 
molecule followed by the removal of a COCH2 moiety (42 Da) as outlined for vincaminine 
(Figure 4-36; 4-44). Subsequently, due to loss of the terpene moiety via C-ring cleavage by 
RDA followed by bond breaking between C3 and C14 (Akhgari et al., 2015; Kumar et al., 
2016a), a characteristic ion of indole moiety at m/z 174.0915 or m/z 173.0832 (143+ OCH3 
(31Da) is generated. Based on these considerations, it could be stated that both compounds are 
isomers of a methoxylated vincaminine, in which the methoxy group is attached to indole 
moiety (Figure 4-45). It is very likely that one of these compounds (20 or 21) corresponds to 
11-methoxyvincaminine, denoted as vincinine, which already had been described to occur in V. 
minor (Trojánek et al., 1961). Accordingly, the other compound (20 or 21) should correspond 
to an isomer of vincinine. 
Figure 4- 44: MS-MS spectra of the compounds at RT 11.03, and 11.9 min with mass (M+H+ = 399 
m/z) in H2O2 treated plants. The fragmentation patterns have many similarities to vincaminine isomers 
(14) (figure 4-36). 
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Figure 4- 45: The main fragments of compound 20 and 21. 
Compound 17, 18, and 19: 
For the compounds 17, 18 and 19, a molecular formula of C21H27N2O5 was estimated on the 
basis of their HR-ESI-MS (m/z 399.1922, 399.191729 and 399.191365 for [M + H]+; the 
calculated m/z for [M +H]+ is 399.191448). The two compounds 17 and 18 (RT 8.45 and 8.85 
min) reveal a quite similar MS2 spectrum that shows a characteristic ion at m/z 367, which is 
thought to result from the loss of methanol [M – CH3OH + H]+ (Figure 4-46; 4-47). In contrast, 
compound 19 (RT 11.2 min) showed a characteristic ion at m/z 381[M – H2O + H]+, which 
might be due to the loss of a water molecule (Figure 4-46; 4-47). All three compounds exhibit 
a characteristic ion of an indole moiety at m/z 218 or m/z 216, which should be due to removal 
of the terpene moiety via C-ring cleavage by RDA followed by bond breaking between C3 and 
C14 (Akhgari et al., 2015; Kumar et al., 2016a; Kumar et al., 2016b). Based on these 
considerations, it can be argued that these compounds are similar to vincinine (20), however, 
an additional hydroxyl group is attached to the indole moiety. These compounds could be 
identified as 17,18-didehydro-10-hydroxy-11-methoxy vincamine isomers, which isolated 
before from Ervatamia species (Zhang et al., 2007).  
Figure 4- 46: The main fragments of compound 17,18 and 19. 
 
Chapter 4: Results 
 
98 
  
 
Figure 4- 47: MS-MS spectra of the compounds at RT 8.45, 8.85 and 11.2 min with mass (M+H+ = 
399 m/z) in H2O2 treated plants.  
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Compound 22: 
In addition to the compounds described so far, there is also some evidence for the presence of 
dimeric indole alkaloids in stressed V. minor plants. On the basis of its HR-ESI-MS (m/z: 
675.3542 for [M + H]+), the molecular formula of C41H46N4O5 (calculated m/z for [M + H]
+: 
675.3542) was determined for compound 22 (RT 18.3 min), which only was present in the 
stressed plant. Furthermore, this molecular formula was confirmed by the comparison of the 
measured and the theoretical isotopic pattern of C41H46N4O5 (m/z 675 +1 and +2; Figure 4-48). 
Unfortunately, the fragmentation of m/z 675 is not very intense for solid structure deductions; 
however, it generated the typical peak of m/z 144 for typical vincamine-type indole alkaloids 
(Figure 4-49). In addition, when checking the extracted ion chromatogram (EIC) of all peaks 
revealing a mass from 500 to 900 m/z, it turned out that several unique dimeric alkaloids are 
present only at the stressed plants (Appendix: Figure A- 65). 
Figure 4- 48: The comparison of the measured isotope pattern of m/z 675 at 18.3min (black) with 
the theoretical isotopic pattern of C41H46N4O5 (red).   
 
Figure 4- 49: MS-MS spectra of the compounds at RT 18.3 min with mass (M+H+ = 675 m/z) in 
H2O2 treated plants. 
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Summing-up -  4.4.3 Effect of growth regulators on the composition of alkaloids in V. 
minor 
Whereas the application of SA did not induce major changes in the composition of MIAs, 
the treatment with MeJA and H2O2 significantly impacts on the spectrum. 
Similar to MeJA, also the application of H2O2 to V. minor markedly changed the pattern 
of the indole alkaloids, and reversed changes in their concentrations have been observed: 
a decrease in the vincadifformine and vincamine concentrations and a concomitant 
increase in the minovincine, minovincinine and 9-methoxyvincamine concentration. 
Whereas in the MeJA treated plants basically 9-methoxyvincamine was produced, in the 
H2O2–treated leaves, also epi-9-methoxyvincamine - putatively derived from epi-
vincamine – was present in significant amounts. These findings nicely support the 
existence of the alterations proposed in Figure 4-18.  
A further – but even minor – effect of the H2O2 treatment concerns 11-methoxyvincamine 
and its epimers, i.e., epi-11-methoxyvincamine. Whereas both alkaloids are present in 
small amounts in the untreated plants, they are lacking in H2O2–treated leaves, or are 
present only in traces.  
The extraction of several ions from the TIC revealed clean chromatograms and sharp 
peaks of compounds of interest, which were used to detect the presence of the putative 
intermediate in 9-methoxyvincamine, i.e., 9-hydroxyvincamine, and other, minor 
components, which are tentatively identified for the first time in V. minor. 
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4.4.4 Effect of growth regulators on the alkaloid concentration  
As outlined above, the treatment with MeJA strongly alters the alkaloid composition in V. 
minor. In order to elucidate the time frame and the extend of these changes, the experiment was 
repeated during the blooming time and leaves were collected at four different time intervals. 
Moreover, also the other growth regulators (H2O2, SA) had been applied two times to V. minor 
plants during the blooming phases. Leaves were collected at four different time intervals (1, 4, 
8, and 14 days after the treatment) and separated into young and old leaves. The concentration 
of the different main alkaloids was in control and treated plants are presented in Figure 4-50: 
4-52.  
The first response after the application of the different growth regulator was the massive 
increase of vincadifformine in young as well as in old leaves. Especially 4 days after the first 
application of SA and H2O2, (i.e., 24 hours after the second application of the signal molecules) 
the vincadifformine concentration was strongly increased (Figure 4-51). This enhancement was 
followed by a drastic decrease, which occurred earlier in the case of SA. This decrease is 
accompanied by a significant increase in the concentration of vincamine in young leaves. This 
observation might support that vincadifformine is a putative precursor to vincamine 
biosynthesis (Wenkert and Wickberg, 1965; Dewick 2009; Kellner et al., 2015; Saxton, 1983a). 
Yet, the decrease of vincamine and vincadifformine, which already was outlined above (4.3) 
reveals a different time pattern in the plants treated with MeJA or with H2O2. The most 
pronounced decrease in vincamine concentration concurred in particular in old leaves with an 
increase of 9-methoxyvincamine. In contrast, the reduction in vincadifformine concentration 
and reverse appearance of minovincinine and minovincine was especially observed in young 
leaves.  
 
 
Chapter 4: Results 
 
102 
  
 
Figure 4- 50: Concentration of vincamine and epivincamine in young and old leaves. Different 
lower-case letters on top of the column for each period of time (1, 4, 8, 14 days) indicate significant 
differences (P≤0.05) by the least significant difference (LSD) test. The mean value corresponds to the 
average value of six independent analyses. Error bars correspond to the standard deviation. 
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Figure 4- 51: Concentration of vincadifformine in young and old leaves. Different lower-case letters 
on top of the column for each period of time (1, 4, 8, 14 days) indicate significant differences (P≤0.05) 
by the least significant difference (LSD) test. The mean value corresponds to the average value of six 
independent analyses. Error bars correspond to the standard deviation. 
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Figure 4- 52: Concentration of methoxyvincamine of young and old leaves. Different lower –case 
letters on top of the column (for each period of time) indicate significant differences (P≤0.05) by the least 
significant difference test. The mean value corresponds to the average value of six independent 
analyses. Error bars correspond to the standard deviation. 
These data reveal that the levels and time responses of increase of 9-methoxyvincamine, mino-
vincinine and minovincine on the one hand and the decrease of vincamine and vincadifformine 
on the other hand strongly vary, depending on the growth regulators applied. For better 
illustration and to recognize the specific effects of a certain treatment, the importance and 
significant details were extracted from Figure 4-50: 4-52 and displayed appropriately in the 
following chapters. 
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Quantitative changes in response to H2O2  
As outlined, the effects of the different growth 
regulators vary, especially when focussing on 
the time frames. In order to get a better overview 
with respect to the time depending changes, the 
corresponding data for each growth regulator 
applied are analyzed and evaluated separately.  
H2O2 induced a transient increase of the 
vincamine concentration in young leaves. In old 
leaves, such increase in the vincamine 
concentration was not detectable (Figure 4-50a). 
After two weeks, nearly one-third of vincamine 
had been disappeared in young and, and even 
two third in old leaves. 
A similar response was detectable for 
vincadifformine: during the first week after the 
application of H2O2, the alkaloid concentration 
significantly increased, followed by a massive 
decrease. Such transient accumulation was 
observed for young as well as for old leaves. It is 
worth mentioning that the final decrease of the 
vincadifformine concentration was very intense. 
After two weeks, in young as well as in old 
leaves only half of the vincadifformine 
accumulated in the controls is present in the 
stressed plants. When calculating this decline on 
the basis of the maximal level of vincadifformine 
– due to the initial increase – this drop off is far 
more pronounced: after two weeks, nearly two-
thirds of the alkaloid had been disappeared in 
young leaves; and in old leaves hardly 80% had 
been gone (Figure 4-51a). 
Figure 4- 50a: Changes in concentration of vincamine 
and epivincamine in young and old leaves in response 
to H2O2 as presented in a Figure 4-50. 
Figure 4-51a: Changes in concentration of 
vincadifformine in young and old leaves in 
response to H2O2 as presented in a Figure 4-51. 
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In contrast to vincamine and vincadifformine, 
the concentration of all other indole alkaloids 
did not change significantly in response to the 
H2O2, apart from methoxyvincamine, mino-
vincine, and minovincinine.  
In the case of methoxyvincamine, which is 
assumed to be derived from vincamine (Figure 
4-18), a significant increase in its concentration 
was observed in young as well as in old leaves 
only 14 days after the treatment (Figure 4-
52a).  
This increase exactly coincided with the cor-
responding decreases of its putative precursor vincamine (Figure 4-50/52a). In this context, it 
has to be noted that the increase in the concentration of methoxyvincamine in response to the 
MeJA treatment is also accompanied by a corresponding decrease of vincamine, however, these 
changes already occurred after 8 days (Figure 4-50a, and Figure 4-50/52a, respectively). The 
fact that both reverse changes exactly coincided although the effective time of the responses 
caused by the different growth regulators strongly differed, convincingly supports the 
biosynthetic pathway mentioned in Figure 4-18.  
 
Figure 4-50/52a: The reverse changes in the concentration of vincamine and its putative 
metabolite –methoxyvincamine- in young and old leaves in response to H2O2. The data are 
extracted from Figure 4-50 and 4-52. 
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Figure 4-52a: Changes in concentration of methoxy-
vincamine in young and old leaves in response to H2O2 
as presented in a Figure 4-52. 
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While vincamine and vincadifformine are present also in significant amounts already in 
unstressed plants, minovincinine and minovincine could only be determined after stress 
induction. Interestingly, the time frame of the stress responses is equal to that outlined for the 
generation of methoxyvincamine (Figure 4-53).  
 
 
Figure 4- 53: Concentration of minovincinine and minovincine in young and old leaves treated 
with H2O2.  ** In the control plants, both alkaloids are below the limit of the detection. Accordingly their 
concentration was set to be zero. The mean value corresponds to the average value of three 
independent analyses. Error bars correspond to the standard deviation. 
Minovincinine and minovincine, which putatively are derived from vincadifformine, 
significantly accumulate only 14 days after the H2O2 treatment. This increment co-occurs with 
the decrease of vincadifformine (Figure 51/53a), and thus supports the biosynthetic pathway 
for minovincinine and minovincine mentioned in Figure 4-18.  
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Figure 51/53a: The reverse changes in the concentration of vincadifformine and the putative 
metabolites minovincinine and minovincine in young and old leaves in response to H2O2. When 
the compounds were below the limit of detection, their concentration is set to zero and mentioned as **. 
The data are extracted from Figure 4-51 and 4-53. 
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It is worth mentioning that – in the same manner as outlined for the reverse changes in the 
vincamine and methoxyvincamine concentration – also the accumulation of minovincinine and 
minovincine and the corresponding decrease in the vincadifformine content in response to the 
H2O2 treatment occurred retarded compared to the corresponding effects induced by MeJA, 
which already were detectable 8 to 9 days after the treatment (see below). Yet, also in this both 
cases, the generation of the putative metabolites coincides with the decline of its precursor, i.e., 
vincadifformine.  
Quantitative changes of indole alkaloids in response to MeJA 
As already accomplished for the results related 
to the application of H2O2 also the data from the 
treatments with MeJA were presented with 
respect to their time dependency. In comparison 
to the control, the content of vincamine slightly 
was increased during the first days. Then, 
between day 4 and 8, it significantly decreased in 
young as well as in old leaves (Figure 4-50b). In 
the course of this decline nearly one-fourth of the 
alkaloid disappeared in young leaves, and in old 
leaves, almost half of the vincamine vanished, 
putatively due to its conversion to methoxy-
vincamine (Figure 4-52b). 
Subsequently, the vincamine concentration 
increased again, presumably due to a massive 
biosynthesis of this alkaloid. When referring this 
increase to control plants, it corresponds to a 
20% higher concentration. Yet, when calculating 
it on the basis of the minimum level of vincamine present at 8 days, this enhancement is much 
more pronounced: whilst the second week of after the treatment, the vincamine concentration 
in increased by about 50% and hardly 70% in young and old leaves, respectively (Figure 4-
50b).  
Similarly, in old leaves MeJA induced an initial rise of the vincadifformine concentration (about 
30%); but such increase was not detectable in young leaves (Figure 4-51b). Subsequently, a 
Figure 4-50b: Changes in concentration of 
vincamine and epivincamine in young and old 
leaves in response to MeJA as presented in a 
Figure 4-50. 
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transient decline was observed, resulting in a 
minimal content of vincadifformine at about 8 
days after the treatment in young as well as in old 
leaves.  
When referring these data to the related contents 
of the control plants, the vincadifformine 
concentration in the young leaves of the treated 
plants was only one half, whereas in old leaves 
the level of treated and control plants is very 
similar after one week. However, when calculat-
ing the extent of this reduction on the basis of the 
initial high level, almost half of the vinca-
difformine concentration in old leaves had 
disappeared, presumably converted to mino-
vincine and minovincinine (Figure 4-54). 
Finally, the concentration of vincadifformine re-
increased again, and the highest level was reached two weeks after the treatment. Whereas in 
old leaves this final level is far higher in stressed leaves than that of the controls, in young 
leaves no significant difference was detectable. Nevertheless, when calculating the increase in 
young leaves on the basis of the minimum level of the vincadifformine present at 8 days, the 
concentration of this alkaloid increased by about 40 %. 
The concentration of methoxyvincamine, which is assumed to be derived from vincamine 
(Figure 4-18), significantly increases in young as 
well as in old leaves 8 days after the treatment 
(Figure 4-52b). This increase very exactly 
coincides with the corresponding decreases of its 
putative precursor vincamine (Figure 4-50/52b).  
 
Figure 4-51b: Changes in concentration of vinc- 
difformine in young and old leaves on response to 
MeJA as presented in a Figure 4-51. 
Figure 52b: Changes in concentration of 
methoxyvincamine in young and old leaves in 
response to MeJA as presented in a Figure 4-52. 
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Figure 50/52b: The reverse changes in the concentration of vincamine and its putative metabolite 
methoxyvincamine in young and old leaves in response to MeJA. The data are extracted from 
Figure 50 and 52. 
Minovincinine and minovincine, which putatively are derived from vincadifformine, 
significantly increased only after 8 days after the MeJA treatment (Figure 4-51/54b). 
 
Figure 4- 54: Concentration of minovincinine and minovincine in young and old leaves treated 
with MeJA.  ** In the control plants, both alkaloids are under the limit of the detection; accordingly, their 
concentration was assumed to be zero. The mean value corresponds to the average value of three 
independent analyses. Error bars correspond to the standard deviation.  
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Figure 51/54b: The reverse changes in the concentration of vincadifformine and is putative 
metabolites minovincinine and minovincine in young and old leaves in response to MeJA. The 
compounds are under the limit of the detection are set to zero and mentioned as **. The data are 
extracted from Figure 4-51 and 4-54. 
Quantitative changes of indole alkaloids in response to SA 
Salicylic acid (SA) is another important signaling molecule in plants. It has been well 
documented that SA is involved in the defense responses related to the systemic acquired 
resistance (SAR) by activating certain defense-related genes (Thomma et al., 2001; 
Hasanuzzaman et al., 2017). Previous studies have shown that exogenous addition of 
SA induced indole alkaloid production in C. roseus within a very short time period (Pan et al., 
2010). In contrast, the application of SA to suspension cultures and seedling had no effect on 
the concentration of indole alkaloids in C. roseus (Aerts et al., 1996; Guo et al., 2013). Other 
authors reported the opposite effect: when SA is applied to seedlings or suspension cultures, 
respectively, the content of alkaloid increased (Godoy-Hernández and Loyola-Vargas, 1997; 
El-Sayed and Verpoorte, 2004). Accordingly, also SA was applied to V. minor plants in this 
study.  
The treatment of V. minor with SA during the blooming time resulted in a transient increase of 
the vincamine and vincadifformine accumulation in the leaves. Yet, in old leaves, this increase 
of vincamine concentration is only visible when referred to the controls (Figure 4-50c).  
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In contrast to the relatively slight changes in the 
vincamine content (Figure 4-50c), the SA 
treatment caused massive changes in that of 
vincadifformine, i.e., 4 days after SA 
applications, in old leaves, its concentration is 
nearly doubled in comparison to the untreated 
controls. But then, it strongly is reduced again. 
After about one week, the vincadifformine 
concentration is even lower than that of the 
controls. In young leaves, initial increase, as 
well as the subsequent decrease, is far less 
intense (Figure 4-51c). 
It is noteworthy to mention that – in contrast to 
the treatment with MeJA and H2O2 – apart from 
one unique sample  (Appendix: Figure A-66) – 
neither methoxyvincamine nor minovincine 
and minovincinine had been produced in 
response to the SA treatment.  
Obviously, SA does not induce a conversion of 
vincamine to methoxyvincamine and of vinca-
difformine to minovincine and minovincinine, 
respectively.  
Figure 4-51c: Changes in concentration of vinca-
difformine in young and old leaves on response to 
SA as presented in a Figure 4-51. 
Figure 4-50c: Changes in concentration of vincamine and 
epivincamine in young and old leaves in response to SA 
as presented in a Figure 4-50. 
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4.4.5 Effect of inhibitors on the MeJA induced conversion of indole alkaloids 
As outlined in the scientific background (section 2.3.4.2), various inhibitors of oxidative 
enzymes are described, which mainly act on enzymes that are induced by the jasmonic acid 
induction pathway (Morgan and Shanks, 1999; Guo et al., 2011). In this manner, the application 
of naproxen changed the alkaloid composition of C. roseus suspension culture (Guo et al., 
2011), and  the combination of naproxen with H2O2 increases the total alkaloid content  of V. 
minor hairy root culture (Verma et al., 2014b) . Accordingly, also naproxen was applied to V. 
minor plants in this study.  
 
Figure 4- 55: Impact of naproxen on the alkaloid spectrum of V. minor. The plants were sprayed 
with naproxen two times during the experiment and collected at 9 days. 
These results suggest that naproxen primarily has no pronounced effect on the composition and 
concentration of the indole alkaloids present in V. minor plants (Figure 4-55). In principle, this 
outcome could have been predicted, since only those oxidative enzymes, which putatively are 
induced by MeJA, should be inhibited by naproxen. In the case of the indole alkaloids of V. 
minor, these are the enzymes involved in the MeJA induced conversion of vincamine to 9-
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methoxyvinamine, and of vincadifformine to minovincine and minovincinine, respectively 
(Figure 4-18). Consequently, naproxen has to be applied to plants, in which the corresponding 
hydroxylation steps, i.e., the conversion of vincadifformine and vincamine are implemented by 
MeJA. Accordingly, in a further experimental approach naproxen was sprayed together with 
MeJA (Figure 4-56).  
 
Figure 4- 56: Impact of the concomitant application of naproxen and MeJA on the alkaloid 
spectrum V. minor. The plants were sprayed two times during the experiment and collected at 9 days. 
As predicted, the MeJA induced changes in the alkaloid pattern of V. minor could be suppressed 
by the inhibition of the oxidative enzymes involved by naproxen. It has to be mentioned that 
the inhibition of the MeJA induced conversion of vincamine to 9-methoxyvinamine, and of 
vincadifformine to minovincine and minovincinine, respectively (Figure 4-56). This 
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suppression is very efficient and only traces of the transformation products had been produced 
after three days (Figure A-69), and completely inhibited at 9 days (Figure 4-56). From this, it 
could be deduced, that naproxen very efficiently inhibits the corresponding cytochrome P450 
enzymes in V. minor. This feature might help to identify the corresponding enzymes. Yet, we 
have to consider that the outcome of this experiment could also be caused by another 
mechanism involved. It could not be excluded that naproxen – in contrast to a direct inhibition 
of the enzymes – also might act indirectly, e.g., by suppressing the transduction of the MeJA 
signal. The related coherences are discussed in detail in chapter 5 (Discussion 5.2).  
In addition of naproxen, also, resveratrol which is also known to inhibit corresponding P450 
enzymes (Chan and Delucchi, 2000; Fan and Mattheis, 2001; Laden and Porter, 2001; Piver et 
al., 2001; Kutil et al., 2014), was applied to V. minor plants to modulate the alkaloid 
biosynthesis in V. minor. Yet, based on the knowledge that resveratrol is taken up from the soil 
and translocated into the leaves (Tucker Serniak, 2016; Radwan (2017), pers. Communication; 
and a corresponding experiment was done for barley plants (Appendix; Figure A-67)), in a first 
approach, resveratrol was added 4 times to V. minor via the irrigation water.  
Analogously to the experiments with the application of naproxen, also in the case of resveratrol, 
no major changes in the alkaloid pattern had been observed, i.e., no conversion of vincadiffor-
mine to minovincine or vincamine to is induced.  Accordingly, in a further experiment, MeJA 
and resveratrol had been applied concomitantly.   
 
Figure 4- 57: Concentration of vincamine in young and old leaves. Different lower –case letters on 
top of the column for each period of time (1, 4, 8, 14 days) indicate significant differences (P≤0.05) by 
the least significant difference (LSD) test. The mean value corresponds to the average value of six 
independent analyses. Error bars correspond to the standard deviation. Vincamine corresponds to the 
sum of vincamine and epivincamine. 
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Treatment of V. minor with resveratrol resulted only in minor differences in the vincamine 
content (Figure 4-57). Whereas no clear trend could be estimated in the young leaves, in the 
older ones, the application of resveratrol in all cases resulted in a slightly higher concentration 
of vincamine (Figure 4-57). This means that vincamine is not massively converted to 9-
methoxyvinamine. This is underlined by the finding, that the latter one is present in the 
resveratrol-treated plants in the same amount as in the controls (see Appendix; Figure A-68). 
In the same manner, resveratrol had no major effect on the concentration of vincadifformine 
(Figure 4-58) and a conversion to neither minovincinine nor minovincine could be excluded. 
This is confirmed by the finding that both of the putative conversion products are absent in 
the resveratrol-treated plants (see Appendix; Figure A-68). 
 
Figure 4- 58: Concentration of vincadifformine in young and old leaves. Different lower–case letters 
on top of the column for each period of time indicate significant differences (P≤0.05) by the least 
significant difference test. The mean value corresponds to the average value of six independent 
analyses. Error bars correspond to the standard deviation. 
As already mentioned for naproxen, also the application of resveratrol primarily has no 
pronounced effect on the composition and concentration of the indole alkaloids present in V. 
minor plants, since the reactions sensitive for this inhibitor are absent. Consequently, also 
resveratrol has to be applied to plants in which the conversion of vincadifformine to 
minovincine is induced. Accordingly, in a further experiment, MeJA and resveratrol had been 
applied concomitantly.   
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Figure 4- 59: Changes in the alkaloid spectrum of old leaves due to the application of MeJA and 
in combination with resveratrol to V. minor plants after nine days of the treatment. 
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In analogy to the outcome related to the naproxen application also the concomitant spaying of 
MeJA and resveratrol results in a very effective suppression of the MeJA induced conversion 
of the indole alkaloids (Figure 4-59).  
The data mentioned in this chapter clearly 
confirm the scheme outlined in Figure 4-18 and 
verify the previous results, i.e., that MeJA 
treatment massively changes the pattern of the 
indole alkaloids in V. minor as outlined above: 
the concentration of vincadifformine and 
vincamine massively are reduced whereas the 
content of minovincine and minovincinine 
(putatively derived from vincadifformine), and 
that of 9-methoxyvincamine (putatively derived 
from vincamine), drastically are enhanced. 
However, when MeJA and the inhibitors 
resveratrol or naproxen respectively, are applied 
together, the conversion of vincadifformine and 
vincamine does not occur (Figure 4-18a). This 
fascinating effect could be caused either 
indirectly by a suppression of MeJA related 
induction or directly by an inhibition of the enzymes responsible for the conversion of 
vincamine and vincadifformine, respectively. Indeed, due to its antioxidative properties, 
resveratrol is known to reduce various stress-related effects (Shin et al., 2009; He and Yan, 
2013; Pociecha et al., 2014). Thus – in principle – this stilbene might be able to generate 
antagonistic effects with respect to the impact of MeJA. However, two major points favor the 
second option, i.e., the inhibition of the modifying enzymes by resveratrol or naproxen, 
respectively. First, resveratrol and naproxen are described to inhibit or substrate of various 
cytochrome P450 enzymes, i.e., monooxidases, hydroxylases etc. (Miners et al., 1996; Chan 
and Delucchi, 2000; Laden and Porter, 2001; Piver et al., 2001; Basheer et al., 2016); secondly, 
the same results have been achieved, for the co-application of MeJA with both inhibitors, which 
reveal a quite different structure, but in contrast to resveratrol, is has no pronounced 
antioxidative capacity. 
Figure 4-18a:  Resveratrol inhibits the conversion 
of indole alkaloids in V. minor in response to MeJA 
treatment as outlined in Figure 4-18. 
? 
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Summing-up - 4.4.4-4.4.5 Effect of growth regulators and inhibitors on the alkaloid 
concentration 
1- H2O2 induced a transient increase of the vincamine and vincadifformine 
concentrations followed by massive decrease in their content after two weeks. The 
time frame of the accumulation of 9-methoxyvincamine, minovincinine and 
minovincine coincided with the corresponding decline of its putative precursor (i.e., 
vincamine and vincadifformine) with underlines the assumption that vincamine is 
converted to 9-methoxyvincamine, and vincadifformine to minovincinine and 
minovincine, respectively. 
2- MeJA induced a significant decrease in vincamine and vincadifformine 
concentrations, between day 4 and 8, putatively due to its conversion to 9-
methoxyvincamine, minovincine and minovincinine. Subsequently, the vincamine 
and vincadifformine concentrations increased again presumably due to a massive 
biosynthesis of these alkaloids. 
3- SA treatment resulted in a transient increase of the vincamine and vincadifformine 
accumulation in the leaves. Obviously, SA does not induce a conversion of vincamine 
to methoxyvincamine and of vincadifformine to minovincine and minovincinine, 
respectively. 
These results show that the levels and time responses of increase of 9-
methoxyvincamine, minovincinine and minovincine on the one hand and the 
decrease of vincamine and vincadifformine on the other hand strongly vary, 
depending on the growth regulators applied. 
4- Inhibitors of oxidative enzymes :The MeJA induced changes in the alkaloid pattern 
of V. minor could be suppressed by the application of resveratrol or naproxen. Up to 
now, it is not known, whether the conversion of vincadifformine and vincamine is 
suppressed indirectly, i.e., by blocking the signal transduction or by a direct inhibition 
of the oxidative enzymes involved. 
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Chapter 5: Discussion 
This thesis was aimed to comprehend the effects of methyl jasmonate (MeJA) and other growth 
regulators on the pattern of indole alkaloids of Vinca minor with a special emphasis on the 
appearance of the novel, so far unknown indole alkaloids. The intention was to investigate 
whether or not the application of growth regulators could be a novel strategy to modify the 
composition of active components in medicinal plants. The results presented in this work 
vividly demonstrate that such approach indeed leads to massive qualitative as well as 
quantitative variations in the content of bioactive compounds. In consequence, this outcome 
highlights that the utilization of growth regulators, especially of MeJA, could be a promising 
tool for altering and diversifying the composition of active substances in medicinal plants.  
For comprehensively evaluating of this issue, two major aspects have to be considered: first, up 
to now, any altering and optimization of medicinal plants were focussed only on quantitative 
changes, and secondly, any changes in the composition, e.g., induced by various environmental 
impacts, were generally considered as a negative issue. The deliberate alteration of the 
composition of active ingredients by influencing the growth conditions illustrates a novel 
strategy, revealing a high potential of process innovation (Figure 5-1). 
Due to the fact that most of the active compounds of well-known medicinal plants already had 
been extensively studied, the enthusiasm for using these plant extracts for the discovery of novel 
pharmaceutical leads had recently been declined massively (Raskin et al., 2002; Poulev et al., 
2003). Moreover, today, the identification of new valuable and efficacious requires the 
extraction of various kilograms of plants material (Li et al., 2018; Chen et al., 2018; Ayoub et 
al., 2018; Liu et al., 2018; J Zhang et al., 2018). In this context, the presented approach seems 
to be a promising alternative (Figure 5-1).   
Up to now, the environmental impacts on the composition of active ingredients of medicinal 
plants had mostly been assessed negatively: the lack of reproducibility reported for more than 
40% of related plant extracts is considered as one of the major drawbacks in using plants in 
pharmaceutical discovery (Cordell, 2000). Moreover, the biochemical profiles of plants 
harvested at different times and locations vary greatly (Poulev et al., 2003; Atanasov et al., 
2015). Indeed, with respect to defensive compounds, such variability is not surprising, and it is 
well known that in addition to quantitative changes, stress may also alter the composition of the 
relevant compounds (Rijhwani and Shanks, 1998; Rodriguez et al., 2003; Poulev et al., 2003; 
Wojakowska et al., 2013; Tang et al., 2015; Sampaio et al., 2016). This especially accounts for 
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the production of phytoalexins in response to 
pathogen attack, representing a typical 
biological stress (Ahuja et al., 2012; Daniel, 
2017). In consequence, the quantity, as well 
as the composition of healthy and non-
stressed plants, could be quite different than 
those of the plants elicited by various 
biological and abiotic stress situations. 
However, up to now, these coherences have 
not been taken into account adequately, 
when searching for novel pharmacological 
active natural products.  Accordingly, it 
seems to be obvious to exert these 
coherences and to develop alternative 
approaches to harness the stress-related 
alterations to deliberately vary the 
composition of active compounds of 
medicinal plants. The next level of a 
corresponding implementation is to mimic 
the related stress or developmental situation 
by the application of growth regulators or 
inductors (Figure 5-1). Consequently, in this 
thesis, MeJA salicylic acid, and hydrogen 
peroxide were used to induce characteristic 
stress responses to the impacts on the 
secondary metabolism.  
The application of MeJA and hydrogen peroxide leads to massive changes in the pattern of 
indole alkaloids of Vinca minor, including the appearance of the novel, so far unknown indole 
alkaloids. Accordingly, MeJA treatment on Vinca plants was proved to be an appropriate and 
promising approach for identifying novel pharmacological products (Figure 5-1).   
Based on the structural similarities, it is postulated that as response of the MeJA treatment 
vincamine is converted to methoxyvincamine and vincadifformine to minovincine and mino-
vincinine (Figure 4-18). These modifications require oxidative enzymes (Rodriguez et al., 
Figure 5- 1: Schematic overview of the novel 
approach to study the effects of stress and growth 
regulators as promising tools for phytochemical 
drug discovery. 
Chapter 5: Discussion 
 
122 
  
2003; Giddings et al., 2011). It seems to be very likely that these reactions are catalyzed by 
cytochrome P450 enzymes (Rodriguez et al., 2003; Giddings et al., 2011). This assumption is 
supported by the fact that the MeJA induced modifications could be suppressed by the 
application of resveratrol or naproxen, representing typical inhibitors or substrates for oxidative 
enzymes. In the following chapters, the different aspects of the various novel insights are 
discussed in detail.   
5.1 Indole alkaloids in mature, healthy V. minor plants 
Up to now, tremendous high number of data on the monoterpenoid indole alkaloids (MIAs) of 
V. minor and their pharmaceutical effect is available (Proksa et al., 1988; Vas and Gulyás, 2005; 
Grujić et al., 2015). The alkaloids of Vinca minor had been studied thoroughly by several 
research groups in Europe. Up to now, more than 60 indole alkaloids have been extracted, 
isolated from lesser periwinkle and structure elucidated (Taylor, 1965; Aynilian et al., 1974; 
Proksa and Grossmann, 1991; Appendix Table A-1). Although different studies frequently 
reveal quite different compositions of indole alkaloids of V. minor, in all cases, the major 
alkaloid in the leaves was reported to be vincamine. In general, this eburnamine-type MIA 
accounts for 25-65% of the total alkaloids from V. minor (Proksa and Grossmann, 1991; 
D'Amelio Sr. et al., 2012; Hasa et al., 2013). Vincamine is a poorly soluble potent 
neuroprotector and cerebral vasodilator, which frequently is employed to treat CNS disorders 
(Vas and Gulyás, 2005; Hasa et al., 2013). Hasa et al. 2013, reported that the oral bioavailability 
of vincamine from a standardized dry extract of Vinca minor L. is sevenfold higher compared 
to pure vincamine. As in this certain case, more than 99 % of the alkaloids are represented by 
the main compound vincamine, the author suggests that the better pharmacological effectivity 
of this standardized extract, would be due to an enhanced bioavailability. Hasa et al. (2013) 
postulated that the reason for this effect might be due to an interaction of the alkaloids with 
other compounds, e.g., flavonoids, which - in addition to vincamine – are also present in the 
corresponding standardized extracts. However, when inspecting the corresponding TIC of the 
standardized extract, no hints for the presence of these compounds can be found. Nonetheless, 
also in other cases, the differences in bioavailability have been attributed to specific interactions 
resulting in a so-called  'phytocomplex', e.g., for khellin and the corresponding crude extracts 
from Ammi visnaga (Eder and Mehnert, 2000). The authors deduced that the enhanced 
bioavailability of the co-administrated compound is either due to an enhanced solubility of the 
'phytocomplex' or an increased rate of its absorption. Accordingly, the use of dried standardized 
extracts could be an attractive alternative to the administration of purified vincamine for 
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treatment of memory disorders or as a CNS stimulant. However, such approach requires exact 
conditions for the standardization procedure.  
It is well known that the amount of Lesser Periwinkle’s alkaloids, and particularly that of 
vincamine, varies to a large extent as a function of the climate, the general growth conditions 
and the season of herb harvesting (Boyadzhiev et al., 2002). In general, the content of alkaloids 
reaches its maximum at the flowering stage (Farahanikia et al., 2011). In addition to these 
investigations employing the genuine plants, much further research had been performed using 
a related tissue and organ cultures (Verma et al., 2012; Verma et al., 2014a; Verma et al., 
2014b). Indeed, these approaches have no direct relevance for pharmaceutical aspects, but they 
could help to understand and elucidate biosynthetic pathways and their regulation. 
Notwithstanding, for the discovery of novel plant drugs, the investigation of genuine plants are 
inevitable, since the synthesis of bioactive secondary metabolites frequently depends on the 
interactions with the environment, e.g., abiotic and biotic stress factors. Moreover, the 
production of natural products is restricted to certain tissues or organs due to tissue-specific 
gene expression patterns of the enzymes responsible for the secondary metabolism. These 
coherences may explain, why most cell or tissue cultures, representing dedifferentiated cells, 
commonly reveal only very low levels of secondary metabolites and thus exhibit only a little or 
no pharmacological activity (Littleton, 2007). In addition, the vincamine content in the mature 
leaves of V. minor was about 0.13%  (Proksa and Grossmann, 1991), whereas the corresponding 
tissue culture contained only about one third (0.041%; (Hou et al., 2011)). Nevertheless, in very 
few cases cultured plant cells produce secondary metabolites and are used as potential sources 
for phytopharmaceuticals. Further problems concerning the production of metabolites by cell 
cultures are related to their low growth rate, various problems in scaling-up and the instability 
of selected cell lines (Whitmer et al., 2003). Considering all these coherences, this thesis was 
based on an investigation of genuine, mature Vinca minor plants. 
As known for other alkaloids, the content of MIAs content in V. minor varies seasonally 
(Kaczmarek and Lutomski, 1965) Plants collected between the middle of April and June 
contained the most content of alkaloids with hypotensive activity, and therefore are most 
suitable for pharmaceutical purposes. Moreover, Boyadzhiev et al. (2002) reported that the 
vincamine content strongly depends on the growth and climatic conditions, and putative stress 
situations and the highest content of alkaloid was detected at the beginning of flowering and at 
fruiting time (Girre, 1971). Furthermore, Mathe (1965) reported that the total alkaloid and 
vincamine contents of the leaves were higher when the V. minor plants were grown under 
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sunny, shadeless conditions, rather than in shaded areas.  Thus, although these plants prefer to 
grow in shaded areas, they should be grown in open fields to increase the vincamine yield. 
Accordingly, in this study, which is aimed to elaborate a new approach for phytochemical drug 
discovery, only mature V. minor plants of defined physiological status were used. Furthermore, 
to investigate the effect of MeJA treatment and of application of another growth regulator on 
the composition of alkaloids, only plants cultivated between April and June were employed. 
When analyzing these intact and healthy plants, always four main alkaloids, i.e., vincamine, 
vincadifformine, and strictamine and 10-hydroxycathafoline were detected. These alkaloids 
represent the three major groups of MIAs (Figure 5-2).  
 
Figure 5- 2: The major indole alkaloids determined in V. minor control plants leaves. 
Whereas vincamine, vincadifformine, and strictamine already had been reported several times 
to be present in V. minor  (Proksa and Grossmann, 1991; D'Amelio Sr. et al., 2012), the forth 
alkaloid was described to occur for the first time in this plant. Based on a comprehensive 
structure elucidation (corresponding NMR data are mentioned in the appendix, Figure A-2: A-
9) this alkaloid was identified as 10-hydroxycathofoline. In this context, it is worth mentioning 
that this alkaloid is absent in young leaves and occurs only in traces in old leaves, which are 
harvested in late summer. On the first sight, these facts seem to approve the occurrence of 
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seasonal variation as reported by Balsevich et al. (1982). However, it has to be taken into 
consideration, that such variation, e.g., the absence of 10-hydroxycathofoline, also could be due 
to differences in the developmental and or maturation stage of the plants analyzed.  
The same coherences pertain to the other main alkaloids. Whereas – as outlined in result chapter 
(4.2) in detail - vincamine represents the major alkaloid in old leaves of V. minor. In contrast, 
in young leaves, vincadifformine is the alkaloid exhibiting the highest concentration. 
Accordingly, the total content of vincamine strongly increases whilst leaf maturation, whereas 
that of vincadifformine remains mostly constant. Obviously, the accumulation of these both 
alkaloids is controlled differentially. 
In general, metabolism and metabolic actions are impacted multifariously, including 
developmental, ontogenetic, spatiotemporal, and environmental factors (Kursar et al., 2009; 
Barton and Koricheva, 2010; Kooke and Keurentjes, 2012; Richards et al., 2015; Wiggins et 
al., 2016) Figure 5-3. 
 
Figure 5- 3: The multifactorial regulation of plant metabolism. The interplay between temporal, 
spatial, environmental, and genetic factors determines the quantitative and qualitative profile of a plant’s 
metabolome (Kooke and Keurentjes, 2012). 
Koricheva and Barton, (2012) proposed a model to explain the variation and temporal changes 
especially in secondary metabolite patterns and its concentration by introducing the terms 
proximate and ultimate causes. According to Koricheva and Barton, (2012), proximate causes 
comprises all mechanistic-based processes, such as developmental and environmental 
influences that impact on the generation of chemical diversity, whereas the ultimate causes are 
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related to evolutionary, phylogenetic issues. As this thesis is focussed on putative approaches 
to impact the concentration of secondary metabolites, i.e., alkaloids, only the issue of proximate 
causes will be discussed in detail.  
a) Proximate causes of temporal changes in SM concentrations 
The increase or decline of the content of a certain secondary metabolite in plant tissues always 
results from the difference in its gain and its loss. This balance is always determined by the 
rates of biosynthesis of a certain substance, its allocation, and its modification or degradation, 
respectively (Figure 5-4), which, in turn, might be impacted to a different extent by 
developmental, ontogenetic, spatiotemporal, and environmental factors (Figure 5-3). 
 
 
 
 
 
 
 
 
 
Figure 5- 4: Proximate causes of temporal changes in content and composition of secondary 
metabolites  
Impact on biosynthesis 
In Mentha × piperita (Lamiaceae), a plant used as model system for the study of monoterpene 
metabolism, the rate of biosynthesis was shown to be the principal factor for increasing 
monoterpene contents in young leaves, whereas rates of monoterpene losses through 
volatilization or catabolism were negligible (Gershenzon et al., 2000). Moreover, this study 
showed that monoterpene biosynthesis in M. piperita is restricted to an early period in leaf 
development. This is in accordance with the finding that the activities of the enzymes 
responsible for monoterpenes biosynthesis and the expression of the corresponding genes in M. 
piperita had very similar developmental profiles (McConkey et al., 2000).  
If the biosynthesis of a certain secondary metabolite occurs predominantly in early in leaf 
development and stops before leaf expansion is completed, the total content of this natural 
content of a certain 
secondary metabolite 
biosynthesis 
     
modification 
degradation 
transport 
catabolism allocation 
anabolism 
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product remains constant, whereas its concentration (based on leaf area, dry or fresh weight) 
will strongly decrease in the course of leaf maturation (Koricheva, 1999). In this sense, in leaves 
of a tropical tree Inga umbellifera (Fabaceae) flavonoids are synthesized only until an 
intermediate expansion stage whereas the leaf biomass continues to increase until the leaf is 
fully mature; as result,  the flavonoid concentrations decline although the total content of 
flavonoids per leaf remains the same (Brenes-Arguedas et al., 2006). In contrast, in another 
Inga species, i.e., in I. goldmanii, such significant dilution in the flavonoid concentration is not 
detectable. In this plant, the synthesis of flavonoids proceeds throughout the entire leaf 
development, indicated by a continuous increase in the total content of flavonoids. In 
consequence, although growth related increase of biomass and leaf area occurs, flavonoid 
concentrations is not diluted or results in a much lesser extent than in I. umbellifera (Brenes-
Arguedas et al., 2006; Wiggins et al., 2016). 
The results related to the contents of indole alkaloids in V. minor presented in this investigation, 
reveal that both of the options mentioned above could be realized in on plant: the concentration 
of vincadifformine is markedly lower in old leaves than in young ones, putatively due to a 
corresponding dilution of the alkaloid by the massive gain of biomass per leaves. In contrast, 
the concentration of vincamine is significantly enhanced in old leaves, verifying a considerable 
rate of vincamine biosynthesis whilst leaf maturation. 
Impact on allocation 
In addition, to alteration in the rate of biosynthesis, temporal changes in secondary metabolite 
contents may also be due to allocation processes, i.e., their transport from one plant tissue or 
organ to another. A famous example for such coherence is the decrease in the concentrations of 
pyrrolizidine alkaloids in older leaves of Cynoglossum officinale (Boraginaceae). As any 
catabolism of this compounds was ruled out, the decline of the alkaloid content could only be 
due to its translocation from the mature leaves - acting as a physiological source - into young 
developing leaves (Vandam et al., 1995). In analogy, in Senecio species (Asteraceae), 
pyrrolizidine alkaloids are synthesized in roots and are translocated - in the form of the 
corresponding alkaloid N-oxide - into the sink organs like flowers, seeds, and fruits (Hartmann 
and Dierich, 1998). This translocation of alkaloids into the sink organs always is realized via 
the phloem. However, in some cases, translocation of alkaloids is also performed via the xylem. 
However, all substances transported within the xylem will not be translocated into sink organs, 
but instead only into those tissues exhibiting significant rates of transpiration, i.e., 
predominantly into the leaves (Nowak and Selmar, 2016). The best example for such allocation 
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is the transport of nicotine. This pyrimidine alkaloid is synthesized in tobacco roots and 
subsequently translocated via the xylem. This allocation results in its accumulation in the 
transpiring leaves, whereas only traces of nicotine are translocated from the root into the typical 
physiological sink organs, e.g. the flowers, seeds or fruits (Nowak and Selmar, 2016). In 
consequence, the extent of accumulation of nicotine in the leaves predominantly is affected by 
the respiration rate of the leaves, which in turn strongly depends on the temperature and 
humidity and thus on varying seasonal situations.  
Indole alkaloids of V. minor are also present in the in the roots (Proksa and Grossmann, 1991),  
fruits, and flowers (Appendix Figure A-70). However, each organ exhibits a distinct spectrum 
of terpenoid indole alkaloids, (MIAs), especially when comparing leaves and roots. Similarly, 
in C. roseus also different patterns of indole alkaloids were reported for various tissues (e.g., 
the bisindole alkaloids are restricted to the aerial parts of the plant and do not occur in the roots).  
In C. roseus, the distribution of the different types of alkaloids nicely correlates with the 
occurrence of the specific enzymes responsible for their biosynthesis, and the expression of the 
corresponding genes, respectively (Laflamme et al., 2001). For example, vindoline is 
accumulated exclusively in the laticifer and idioblast. In addition to the enzymes responsible 
for catalysis of the late steps of vindoline biosynthesis indeed are associated exactly in these 
cells. In contrast, the enzymes catalyzing the biosynthesis of minovincinine and 
hörhammericine, which are characteristic for the root tissue, indeed only are present in this 
organ (Laflamme et al., 2001). Accordingly, based on this congruences, it is deduced for C. 
roseus that the biosynthesis of a certain alkaloid takes place in that tissue, in which it is 
accumulated; in consequence, major contributions of allocation are thought to be very unlikely 
(St-Pierre, 1999; Shukla et al., 2006).  
However, on cellular level, various transport steps of MIAs are realized, since – at least in C. 
roseus - MIA biosynthetic is compartmented at cellular as well as subcellular levels: the 
enzymes involved in the MIAs biosynthesis are located in different cell types and their 
interaction requires intercellular translocation of intermediates (Burlat et al., 2004; Guirimand 
et al., 2011). 
In conclusion, the transport of indole alkaloids in C. roseus is assumed to occur at an 
intercellular level rather than between different organs. However, no sound statements can be 
deduced with respect to a putative translocation of MIAs from leaves or roots into reproductive 
organs. Up to now, less information on the occurrence of indole alkaloid biosynthesis in the 
fruits and seeds of C. roseus was reported (Eilert et al., 1985). Yet, if we deduce that in analogy 
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to other alkaloidal plants the alkaloids accumulated in these sink organs are – at least in part - 
synthesized in source organs and are translocated via phloem into the fruits and seeds. Vivid 
examples for such courses of events are the pyrrolizidine alkaloids in Senecio (Hartmann and 
Dierich, 1998), also the quinolizidine alkaloids in Lupins (Wink and Witte, 1984; Lee et al., 
2007; Frick et al., 2017) and tropane alkaloids in solanaceous plants (e.g. Hyoscyamus niger; 
(Hashimoto et al., 1991). 
In the case of a putative translocation of MIAs in the phloem of V. minor, these alkaloids are 
exposed to the same constraints as the other types of alkaloid: the phloem is reported to be 
slightly basic (pH 8; (Tammes and van Die, 1964; Nowak and Selmar, 2016)). Accordingly, 
most of the alkaloids will be present as unprotonated free bases, which – in general – are able 
to pass see biomembranes. In contrast, the xylem is acidic, a milieu in which most alkaloids are 
protonated and in result are not anymore able to pass biomembranes. In consequence, the 
alkaloids would be trapped in the xylem according to the ion-trap mechanism outlined first by 
Matile, (1976). Only the constantly charged quaternary alkaloids will not be affected by this 
process. To prevent a bleeding of secondary and tertiary alkaloids, they are converted to 
corresponding N-oxides (Nowak and Selmar, 2016), which are not able to diffuse through 
membranes. Only in the case of a phloem transport of very alkaline alkaloids the generation of 
such transport metabolites is not required since these alkaloids are protonated even in the 
slightly alkaline phloem. In this manner, the occurrence of quinolizidine alkaloid in the phloem 
of Lupins is coherently explained. In contrast, MIAs reveal much lower alkaline properties and 
consequently, in order to be translocated from source to sink organs via phloem, special 
transport metabolites like N-oxides should be required. In this sense, further investigations on 
the occurrence of indole alkaloid N-oxides would be helpful in order to elucidate whether or 
not MIAs are translocated within V. minor plants. Nevertheless, the presence of some 
corresponding N-oxides and some quaternary indole alkaloids in V. minor (Votický et al., 1979; 
Proksa et al., 1989) and other members of  Apocynaceae (Cao et al., 2012; Zhang et al., 2013) 
are the first hint that also – at least some – MIAs also are translocated from source to sink 
organs. As consequence, also putative changes in the extent of such translocation which in turn 
could also be affected by developmental stages and environmental conditions, have to be taken 
into consideration when evaluating and assessing corresponding changes in the alkaloid content 
in various organs. 
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Impact on modification or degradation 
The third factor which might be responsible for changes in the content of SMs is related to the 
conversion of the natural product. The extent of such modifications might range from slight and 
minor modifications (e.g., Steinegger and Bernasconi, 1964; Waller and Skursky, 1972) up to 
a complete degradation (e.g., Kalberer, 1965). 
An entire breakdown of natural products is known for various classes of natural compounds: 
cyanogenic glucosides are converted to primary metabolites during the seedling development 
of Hevea brasiliensis (Selmar et al., 1991), cyanogenic lipids are degraded whilst seedling 
development of Ungnadia speciosa (Selmar et al., 1990), and canavanine is metabolized in 
seedlings of Canavalia ensiformeis (Rosenthal, 1970). In addition, many papers are available 
reporting also a degradation of alkaloids, e.g., of a major share of pyrrolizidine alkaloids is 
metabolized during germination of Crotalaria scassellatii (Wink and Witte, 1985; Toppel et 
al., 1988), and caffeine and related purine alkaloids are degraded in the leaves of Coffea arabica 
(Ashihara et al., 1996). In some cases, the observed degradation correlates with certain changes 
in developmental stages, e.g., seed germination, whereas for other plants an ongoing 
degradation has been reported (Kalberer, 1965; Mothes et al., 1965; Waller and Nowacki, 
1978).  
If a permanent degradation co-occurs with a significant rate of biosynthesis, a classical turn 
over situation results. However, if either biosynthesis or degradation prevail, this outbalance 
results in an increase or a decline of the alkaloid content. In this sense, as outlined above, the 
alkaloids stored in the seeds are mobilized during germination (Waller and Nowacki, 1978; 
Wink and Witte, 1985).  In contrast, the seeds of C. roseus virtually no alkaloids are present, 
and during germination, alkaloids are synthesized and reach a maximum at the third week 
(Mothes et al., 1965). Subsequently, they almost disappear within the fourth and eighth week 
of seedling development, before they finally reappear in older plants (Mothes et al., 1965). Such 
observations seem to indicate a dynamic role for the alkaloids in C. roseus, a statement, which 
was verified by the results of Daddona et al. (1976). In the same sense, also in tobacco plants 
such extensive breakdown of nicotine and the re-entry into primary plant metabolites have been 
observed (Leete and Bell, 1959; Robinson, 1974). 
Whereas reports on a complete degradation or a steady turn-over of alkaloids are relatively rare, 
the modification of alkaloids seems to be far more common. Nevertheless, albeit in the course 
of their biosynthesis nearly alkaloidal basic structures are modified all, i.e., each of the 
synthesized compounds in the metabolic pathway serves as a precursor for the subsequent one, 
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these phenomena are not considered as “modification of alkaloids”. However, if a certain 
alkaloid is accumulated temporarily and later on, e.g., at a specific developmental stage, is 
modified, it is implemented in this classification. In this sense, the growth-related dimerization 
of vindoline and catharanthine into anhydrovinblastine in leaves of C. roseus  (Naaranlahti et 
al., 1991) has to be evaluated as a modification of accumulated alkaloids. In the same manner, 
the alkaloid transformations in Genista aetnensis during a growing season reported by 
Steinegger and Bernasconi, (1964) have to be rated as SM-modifications: during plant 
development, the level of sparteine decreases while that of retamine increases, caused by the 
oxidation. In parallel, methylcytisine is demethylated to cytisine and further on transformated 
to anagyrine (Steinegger and Bernasconi, 1964).  In analogy, also methylation demethylation 
may also play an important role in mobilization and translocation of ricinine (Skursky et al., 
1969): in mature castor bean leaves, ricinine accumulated. In the course of senescence, it is 
converted to N-demethyl ricinine, which is translocated in the xylem via the transpiration 
stream (Waller and Skursky, 1972). In this sense, also the MeJA induced modifications of 
indole alkaloids presented in this thesis, are vivid examples of typical modifications of 
alkaloids. 
Apart from ordinary and plain conversions, alkaloids might be modified by the formation of 
complexes with molecules of different classes of plant secondary metabolites. In this context, 
the stacking interaction of caffeine and chlorogenic acid in coffee or caffeine and catechin in 
tea represents the most popular examples (Colon and Nerin, 2014; D'Amelio et al., 2015). In 
addition to such simple stacking interaction, alkaloids may also modify by covalent bonds, e.g., 
by the attachment of a glucose moiety, as it is reported for glycoalkaloids in Solanum species 
(van Gelder et al., 1988) and indole alkaloid glycosides isolated from Uncaria tomentosa 
(Kitajima et al. 2000) and C. roseus roots (Kitajima et al., 2000; Wang et al., 2012). 
In conclusion it could be stated that not just the total content of alkaloids, but also their 
composition may change through plant development; a phenomenon which also is reported for 
many other secondary metabolites, such as monoterpene, phenolics and flavonoids 
(Gershenzon et al., 2000; Salminen et al., 2001; Salminen et al., 2004; Sampaio et al., 2016; 
Wiggins et al., 2016). 
Impact of environmental and developmental cues and challenges 
In addition to the ontogenetic changes mentioned above, also environmental factors, e.g., 
changes in temperature, the availability of light (photoperiod), water and nutrients and various 
stress situations affect the composition and extent of the secondary metabolites. These, in fact, 
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are determined by rates of biosynthesis of natural products, its allocation, and its modification 
or degradation, respectively Figure 5-4. As each of this process might be influenced in a certain 
manner either by environmental or by developmental factors, the entire situation with respect 
to the elucidation of putative impacts of the various factors and the related regulation 
mechanisms is very complex. Indeed, in principle, it is possible to verify an active turn over or 
putative translocation of a certain substance by using radioactively labeled compounds. In the 
same manner, by applying labeled biogenetic precursors the extent of biosynthesis could be 
evaluated, conceivably in combination with related studies on the expression of biosynthetic 
enzymes. However, it is very unlikely to comprehensively consider all these processes 
adequately and to identify the various different effects of all environmental and developmental 
factors. Accordingly, most studies just concentrate on the overall changes and do not distinguish 
between the certain impacts on biosynthesis, allocation and metabolic degradation. Moreover, 
in general, only a few of the numerous environmental and developmental factors, which are 
impacting the secondary metabolism, could be investigated in parallel. These coherences 
always have to be considered when certain changes and modification should be evaluated. 
In principle, these difficulties are inherent and fundamental in nearly all corresponding 
investigations, which might be outlined by a few examples: In annual and short-lived 
herbaceous plants, seasonal and ontogenetic changes are confounded, such as leaf expansion 
usually occur within a relatively short time interval during the season (e.g. a few weeks in spring 
in temperate ecosystems). Nevertheless, the seasonal change (different temperature, the ratio of 
light/dark) strongly influences plant development, especially induction of flowering and in 
consequence production of seeds and change in source-sink properties. For instance, the rate of 
purine alkaloids biosynthesis in tea leaves (Fujimori et al., 1991),  and indole alkaloid 
brachycerine biosynthesis in Psychotria brachyceras was varied between different seasons and 
seedling development (Gregianini et al., 2004).   
Moreover, plants interact with various and complex biotic and abiotic factors, like temperature, 
light, water availability, pest, and herbivores. Yet, these numerous environmental factors 
frequently are influencing and impacting each other. In this sense, for example, a high 
irradiation is frequently accompanied with elevated temperatures, high irradiation often 
parallels with UV-radiation, and elevated temperatures co-occur with higher evaporation rates 
(Kleinwächter and Selmar, 2014). Moreover, some parameters, such as drought, impact also on 
the entire ecosystem and might be associated with a higher herbivore pressure, but a lesser 
number of pathogens. 
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In conclusion, neither an unequivocal differentiation between putative effects on biosynthesis, 
allocation or metabolic degradation of a certain compound by developmental or by 
environmental factors could be made.  
b) Ultimate causes of temporal changes in SM production 
Although - as outlined above – the proximate causes of temporal changes of SMs are very 
complex and difficult to cover comprehensively – their basis are relatively well understood 
(Koricheva and Barton, 2012). In contrast, the comprehensions of the ultimate causes, which in 
principle cover the evolutionary aspects, are still heavily debated. Two types of hypotheses 
have been put forward to explain the evolution of patterns of seasonal and ontogenetic variation 
in SM production. The first hypothesis considers the above patterns to be by-products of 
resource allocation constraints. Since, young leaves are more susceptible to herbivores and 
pathogens than mature leaves (Coley, 1983, 1983; Coley and Kursor, 1996), it is postulated that 
plants would benefit by allocating more resources to defend those organs (Feeny, 1992). The 
second hypothesis explains the evolution of temporal changes in SMs mainly with regard to 
adaptive responses to the selection pressure imposed by herbivores.   
In this context, however, it is neglected that the presence of a certain substance might reveal 
various consequences. Meanwhile, there are many examples of such multifunctionality of 
natural products. For instance, flavonoids (e.g. lutein and zeaxanthin) absorb harmful UV-light, 
and also protect the chloroplast from the high light intensities and thus against light-induced 
damage, but in addition, they may act as radical scavengers, too (Demmig-Adams and Adams, 
2002). C. roseus habituated to the fungal-rich tropical rainforest. C. roseus accumulates a 
complex variety if indole alkaloids, which seems to be protective not only against fungal 
pathogens but also are active in repelling potential herbivores (van der Heijden et al., 2004). 
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5.2 The effect of growth regulators on the alkaloid biosynthesis in V. minor leaves 
Poulev et al. (2003) reported that the application of various growth regulators strongly enhances 
the pharmacological efficiency of corresponding plant extracts and might be a promising new 
approach in drug discovery. Meanwhile, it is well established that elicitation induces major 
qualitative and quantitative biochemical changes in the chemical composition of the plant’s 
natural products (Poulev et al., 2003; Ncube et al., 2012; Wojakowska et al., 2013; Wang et 
al., 2015; Shakya et al., 2017). These changes seem to be specific for each growth regulator, 
resulting in quite different chromatographic fingerprints of the extracts obtained from untreated 
or induced plants. Moreover, the corresponding changes may strongly vary with respect to the 
plant species investigated (Poulev et al., 2003). 
Up to now, many investigations on the impact of elicitation by different growth regulators on 
the monoterpenoid indole alkaloids (MIAs) biosynthesis have been performed (Aerts et al., 
1994; Zhao et al., 2001a; Rodriguez et al., 2003; Sottomayor et al., 2004; Gregianini et al., 
2004; Tang et al., 2009; Wei, 2010; Giddings et al., 2011; Wang et al., 2011). These studies 
clearly illustrated that methyl jasmonate (MeJA), hydrogen peroxide (H2O2) and salicylic acid 
(SA) have a great impact on MIAs biosynthesis. Unfortunately, there are many contradictions 
Conclusions and implication 
Based on the insights mentioned above, it can be concluded:  
Any changes in the content and the composition of natural compounds always results 
from the balance of biosynthesis, allocation and degradation. These three processes are 
influenced differentially by developmental and environmental factors. Thus, their overall 
impact on the spectrum and content of the secondary metabolites might be very complex 
and multifarious.  
These considerations open novel doors for manifold and deliberate approaches to change 
and adapt the secondary metabolism, intended to improve and optimize the search for 
novel pharmacological active compounds. 
With respect to environmental factors, the generation of various stress situations and the 
concomitant consideration of the developmental stage of the plant seems to be the most 
promising approach. In this sense, the augmentation of capabilities combined with higher 
reproducibility should be achieved by the employment of growth regulators or signal 
transducers involved in the control of stress responses. 
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with respect to the effect of the underlying elicitation processes (Aerts et al., 1994; Aerts et al., 
1996; Godoy-Hernández and Loyola-Vargas, 1997; El-Sayed and Verpoorte, 2005; Pan et al., 
2010). Nonetheless, the authors considered these approaches as promising strategies for MIAs 
production and proposed forthcoming investigations, to elucidate the putative effects of MeJA, 
H2O2, and SA on modulating the composition of MIAs biosynthesis in V. minor. Based on the 
coherences unveiled in this study, many of these inconsistencies could be - at least in part - 
elucidated and will be discussed comprehensively in the next section. Owing to the 
considerations mentioned above, it is vital to consider the physiological status of the plants 
investigated. By doing so, the effects of MeJA or other signal molecules could be segregated 
from the effects of endogenous jasmonates produced due to natural stress situations or due to 
aging and senescence processes. 
Implementing these considerations, in this thesis - as outlined in details in results section - it 
could be shown for the first time that the application of growth regulators and signal transducers 
(e.g. MeJA and H2O2) not only altered the overall content but also resulted in massive 
modification of the alkaloid pattern. Based on reverse changes in their concentration, it was 
deduced that vincadifformine is transformed first to minovincinine and finally to minovincine. 
In the same manner, vincamine is converted via 9-hydroxyvincamine to 9-methoxyvincamine 
(Figure 4-18, Figure 5-5). The discovery of 9-methoxyvincamine as a novel natural product 
further outlines that even well-known, extensively studied plants such as V. minor, might be an 
auspicious source for the discovery of novel phytochemical drugs when certain stress situation 
are deliberately induced.  
Methyl jasmonate (MeJA) is a part of numerous signal transduction chains, including the 
elicitation of phytoalexins (Tamogami et al., 1997; Konan et al., 2014), the enhancement of 
protective secondary metabolites in response to various environmental factors such as insect 
attacks (Okada et al., 2015), or abiotic stress situations (Ahmad et al., 2016). In addition, MeJA 
is involved in the induction of senescence (He et al., 2002; Qi et al., 2015). Accordingly, the 
application of MeJA will induce many different metabolic events, which cannot be attributed 
to only one unique stress situation. Moreover, this elicitation, i.e., the impact of the MeJA 
application, is strongly affected by the physiological status of the plants (Wasternack et al., 
2013; Wasternack, 2014; De-Ollas and Dodd, 2016). Notwithstanding, elicitation generally 
causes qualitative as well as quantitative changes in the content of bioactive secondary 
metabolites (Poulev et al., 2003; DeGeyter et al., 2012; Wojakowska et al., 2013; Tang et al., 
2015; Sampaio et al., 2016). 
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Figure 5- 5: Modification of indole alkaloids in V. minor after MeJA-treatment (in red: compounds, 
which for the first time had been demonstrated to be present in V. minor).   
As outlined, these alterations could be due to changes in all three metabolic processes outlined 
above, i.e., the biosynthesis, allocation, and degradation of MIAs and, generally are related and 
due to changes in the expression of the corresponding enzymes (Rodriguez et al., 2003; Wei, 
2010; Giddings et al., 2011; Wang et al., 2011). Unfortunately, in the literature frequently, only 
the biosynthetic aspect is considered (Aerts et al., 1994; Gershenzon et al., 2000; Pan et al., 
2010; Xing et al., 2011; Xiang et al., 2015). 
The results presented in this thesis clearly show that the modifications are the main cause of the 
temporal changes in the content and composition of indole alkaloids in V. minor leaves Figure 
5-5. In principle, there might be various reasons for these modifications, e.g.,  they might reveal 
a defensive role against various environmental stress situations such as drought, herbivore or 
pathogen attack (Poulev et al., 2003; Sampaio et al., 2016). Moreover, they might be required 
for translocation, e.g., for the transport from source to sink organs (Nowak and Selmar, 2016), 
or in the course of senescence from dying into young leaves (Waller and Skursky, 1972).  
Indeed, an unequivocal confirmation for the occurrence of such conversions should be provided 
by classical pulse-chase experiments using 13C or 14C labeled alkaloids, which could be 
generated by feeding the corresponding labeled precursors (tryptophan) to V. minor plants 
before MeJA treatment. However, the inverse changes in their concentration immediately 
suggest that vincadifformine is converted first to minovincinine and finally to minovincine. In 
the same manner, vincamine is thought to be converted to 9-methoxyvincamine (Figure 4-18b).  
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With respect to any modifications, especially 
oxidative ones, the corresponding reactions very 
often are catalyzed by cytochrome P450 
enzymes (Rodriguez et al., 2003; Wei, 2010; 
Giddings et al., 2011; Wang et al., 2011). This 
assumption is supported by the inhibition of 
these modifications when the plants 
concomitantly are treated with MeJA and 
resveratrol or naproxen, respectively. As 
outlined in the next chapter, resveratrol as anti-
oxidant competitive substrate and naproxen as 
oxygenase inhibitor hamper the activity of the 
enzymes induced by the MeJA treatment. 
Accordingly, the corresponding changes 
outlined in Figure 4-18b are suppressed.  
The complexity of the signal transducing effects 
of jasmonic acid is vividly demonstrated by the 
putative contradictory findings in C. roseus. 
Whereas in hairy root cultures it leads to a 
significant increase in the content of indole alkaloids and to a shift in their composition 
(Rijhwani and Shanks, 1998; Rodriguez et al., 2003), it seems to have no effect on the indole 
alkaloid accumulation in mature C. roseus leaves (Pan et al., 2010). Moreover, the response of 
developing seedlings of C. roseus to MeJA varies strongly (Aerts et al., 1994). Schluttenhofer 
et al. (2014) tried to explain these contradictions by the involvement of the WRKY transcription 
factors, which are known to be key regulators of many syndromes in plants, including the 
processes induced by drought or salt stress, and also the responses related to the jasmonate 
signal transduction (Phukan et al., 2016). The authors showed that the MeJA related induction 
of the strictosidine synthase, the key enzyme of indole alkaloid biosynthesis, is correlated with 
corresponding changes in the expression of WRKYs. However, as the WRKYs also regulate 
various stress-related temporary downstream steps in modifications of the main alkaloidal 
structures, the diverse responses may interfere, resulting in a complex physiological situation 
(Schluttenhofer et al., 2014). Many further approaches are required to elucidate the observed 
changes in the pattern of indole alkaloids in V. minor.  
Figure 4-18b:  Effects of MeJA in the conversion of 
major indole alkaloids in V. minor as outlined in 
Figure 4-18 (SLS, secologanin synthase; STR, 
strictosidine synthase; TDC, tryptophan de-
carboxylase). : the decrease in vincamine and 
vincadifformine concentrations at 8 days followed 
by increase after 14 days. : the increase in 
minovincine, minovincinine and methoxyvincamine 
at 8 days followed by massive decrease at 14 days. 
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Hydrogen peroxide (H2O2) is a stress-related by-product of cellular metabolism. In plants, it 
is produced in large amounts chloroplasts whilst photorespiration and in peroxisomes in the 
course of the ß-oxidation of fatty acids (Slesak et al., 2007; Mubarakshina et al., 2010; Corpas, 
2015). Moreover, hydrogen peroxide acts as an important substrate for many peroxidases, e.g., 
those involved in the lignin biosynthesis. Apart from these processes, in which relatively large 
concentrations of H2O2 are involved, it also represents an important signal molecule. Growing 
evidence suggests that H2O2, sometimes in combination with other reactive oxygen species 
(ROS), plays a versatile role in eliciting plant defense and various developmental processes 
(Quan et al., 2008; Saxena et al., 2016). In this sense, ROS regulate cell proliferation and 
differentiation, programmed cell death, seed germination, root hair growth and pollen tube 
development, senescence, etc (Singh et al., 2016). In principle, H2O2 accumulation is 
maintained at a very low level because of the existence of an antioxidant system in plants, which 
are responsible for eliminating the excess of H2O2, and thereby keeping the level of H2O2 in a 
dynamic balance. This “redox homeostasis” is achieved by various enzymes and several 
chemical scavengers. The enzymatic antioxidant system includes ascorbate peroxidases, 
superoxide dismutases, catalases, glutathione peroxidases, and glutathione reductases. The 
most abundant antioxidant molecules are tocopherol, ascorbic acid, glutathione and many 
secondary metabolites, including MIAs (Matsuura et al., 2014).  
Various studies have shown that the exogenous application of H2O2 to plants caused a rapid 
production of endogenous H2O2 and thereby to a destruction of the homeostatic redox status 
(Allan and Fluhr, 1997; Zhao et al., 2001a; Tang et al., 2009) and thus, to oxidative stress5.  
In response to many abiotic stress situations, one of the major effects is the generation of an 
“over-reduced status” in the chloroplasts (Wilhelm and Selmar, 2011; Kleinwächter and 
Selmar, 2014). The stress-related stomata closure massively diminishes the CO2-influx into the 
leaves. In consequence, far less reduction equivalents (NADPH+H+) are consumed via the 
Calvin cycle. Although the various energy dissipating mechanisms are up-regulated, the 
reduction status of the chloroplasts increases massively (Selmar and Kleinwächter, 2013; 
Kleinwächter and Selmar, 2015). As result, electrons from the photosynthetic electron transport 
chain will directly be conveyed to oxygen, generating superoxide radicals, which subsequently 
have to be detoxified by superoxide dismutase (Selmar et al., 2017). Indeed, the major share of 
the H2O2 is detoxified by ascorbate peroxidase, nevertheless, the overall content of ROS 
                                                          
5 Oxidative stress is the condition in which the production of reactive species exceeds antioxidant 
defenses thereby disturbing the redox balance. 
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strongly is enhanced (Matsuura et al., 2014). In addition, H2O2 is generated in many other cell 
organelles by various reactions (Slesak et al., 2007; Mubarakshina et al., 2010; Corpas, 2015). 
Accordingly, oxidative stress, i.e., the generation of ROS, is a common outcome of biotic and 
abiotic stresses, and may lead to several responses, including antioxidant systems activation 
and secondary metabolites elicitation, processes that may be interconnected for successful 
protective responses Figure 5-6. In summary, H2O2 represents a versatile molecule already acts 
as an important signal molecule at normal levels. However, due to its massive increase under 
abiotic or biotic stress conditions, it induces oxidative stress.  
Due to its unique properties, i.e., its stability, diffusibility and lesser reactivity, H2O2  should be 
differentiated from the rest of the ROS molecules (Quan et al., 2008), predestining it as a good 
signaling molecule. Accordingly, in plants, non-toxic levels of H2O2 act as key factor in 
intracellular signalling, e.g., to regulate numerous physiological and biological processes and 
their regulation and triggering (Sena and Chandel, 2012), such as growth, hypoxic signal 
transduction, autophagy, and stem cell proliferation and differentiation (Holmström and Finkel, 
2014; Reczek and Chandel, 2015). Moreover, H2O2  is involved in the elicitation of biotic and 
abiotic stress responses (Reczek and Chandel, 2015; Mittler, 2017) and interferes with various 
hormonal signaling pathways to regulate plant growth and stress tolerance.  
One of the best-characterized mechanisms, by which H2O2 act as signal molecules is the 
oxidation of cysteine residues within redox-sensitive proteins  (D'Autréaux and Toledano, 
2007). At toxic concentrations H2O2 is involved in programmed cell death (Dat et al., 2003): 
when large amounts of H2O2 react with metal cations (Fe
2+ or Cu+), in the course of this Fenton 
reaction high concentrations of the extremely reactive hydroxyl radical (OH•) are formed, which 
cause irreversible oxidative damage. Accordingly, the particular signaling effect of H2O2 or its 
typical chemical action depends on its concentration (Figure 5-6). 
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Figure 5- 6: Involvement of H2O2 in regular metabolism and in stress responses. Excess hydrogen 
peroxide generates oxidative stress by producing hydroxyl radicals. Moreover, H2O2 is also acting 
indirectly as a second messenger in responses to various stress situations. In addition, hydrogen 
peroxide is interfering with several other signal molecules (crosstalk). In consequence, H2O2 is part of 
the induction and regulation system to protect plants from the stresses and in regulating plant growth 
and development. In general, the concentration of H2O2 is maintained at a basic level by the concomitant 
action of a series of antioxidant systems. 
Zhao et al. (2001a) reported that both, exogenous H2O2 treatment and elicitor-induced 
H2O2 overproduction are associated with related changes in alkaloid production. The author 
suggested a close relationship between the oxidative burst and indole alkaloid biosynthesis in 
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elicited C. roseus cell cultures. Up to now, there are only a few reports, in which a direct impact 
of oxidative stress on the concentration of MIAs are displayed. In this context, Tang et al. 
(2009), documented an identical time course of the vinblastine and H2O2 in seedlings of C. 
roseus in response to oxidative stress. In the same sense, several reports mentioned that in 
stressed C. roseus, the increase in the concentration of vinblastine and serpentine correlates 
with that of H2O2 and an enhancement of the peroxidase activity present in vacuoles of 
mesophyll cells (Knobloch et al., 1982; Loyola-Vargas et al., 1992; Sottomayor et al., 2004). 
From these coherences, it was postulated that the peroxidase catalyzed the oxidation of 
ajmalicine into serpentine as well as the oxidative coupling of vindoline and catharanthine are 
part of an antioxidative system responsible for the detoxification of H2O2 under stress 
conditions (Sottomayor et al., 2004). Analogously, the indole alkaloids in Camptotheca 
acuminata are also assessed as antioxidative compounds, based on the consumption of H2O2 
when camptothecin is oxidatively converted to 10-hydroxycamptothecin in response to 
hydrogen peroxide elicitation (Pi et al., 2010). Moreover, in the hairy root of V. minor, H2O2 
caused a significant enhancement of total alkaloid content (Verma et al., 2014b). In conclusion, 
it is argued that the indole alkaloids in combination with the vacuolar peroxidases represent an 
effective system to detoxify stress related H2O2 in levels in green plants. 
As mentioned above, H2O2  may act directly as a substrate in the oxidative system and thereby 
modulate MIAs via peroxidase catalyzed reaction (Zhao et al., 2001b; Sottomayor et al., 2004; 
Tang et al., 2009) or it could act indirectly via impacting the signal transduction. In the latter 
case, the signal molecule may change the concentration and spectrum of MIAs by inducing 
enzymes involved in biosynthesis, allocation or modification. Moreover, it may interfere with 
other signal molecules, such as JA, SA, ethylene, Ca++, NO etc. (for review see (Dat et al., 
2000; Saxena et al., 2016) and thereby alter signal transduction. In this sense, H2O2 accumulated 
in response to high light in tobacco plant up-regulate genes involved in the hypersensitive 
response, vesicular transport, posttranscriptional processes, biosynthesis of ethylene and 
jasmonic acid, proteolysis, mitochondrial metabolism, and cell death, and was accompanied by 
a very rapid up-regulation of several signal transduction components (Vandenabeele et al., 
2003).  
With respect to its physicochemical properties, H2O2 is considered as an ideal signaling 
molecule: it is the most stable ROS, reveals a selective reactivity, and a high diffusibility. 
Moreover, it interacts with thiol-containing proteins. In consequence, it activates different 
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signaling pathways as well as various transcription factors that in turn regulate gene expression 
and cell-cycle processes (Møller et al., 2007; Slesak et al., 2007).   
A major problem in the understanding of the complex action of H2O2 is related to spatial 
compartmentation. On the one hand, the impact of H2O2 is described to related to its site of 
origin, i.e.,  if produced in peroxisomes, it induces transcription of processes related to protein 
repair responses, while H2O2 production in chloroplasts leads to early signal responses, 
including transcription factors and biosynthetic genes involved in production of secondary 
messengers (Sewelam et al., 2014).  On the other hand, hydrogen peroxide is highly diffusible. 
Accordingly, the balance between hydrogen peroxide production and its removal determines its 
actual concentration and thus the mode and extent of its action, i.e., the extent and efficiency of 
signaling processes and/or that of oxidative damage (Møller et al., 2007). 
The application of hydrogen peroxide resul-
ted in a similar change of the MIAs pattern 
as the treatment with MeJA, i.e., the conver-
sion of vincamine to 9-methoxyvincamine 
and of vincadifformine to minovincinine and 
minovincine (Figure 4-18c). However, in the 
case of H2O2 treatment, in the beginning, the 
concentration of both putative precursors 
(vincamine and vincadifformine) increased 
before they - concomitantly with the increase 
of the products (9-methoxvincamine, mino-
vincinine, and minovincine) - decreased 
again (Figure 4-18c). Obviously, in addition 
to the impact of jasmonic acid, the elicitation 
by H2O2 resulted in V. minor first in an initial 
increase of MIAs biosynthesis leaves, before 
the same conversions are induced. On the 
first glance, these modifications could be 
related to peroxidase catalyzed reactions 
with H2O2 as outlined above for serpentine and vinblastine.  However, according to the results 
from the concomitant application of signal transducers and enzyme inhibitors, a direct 
contribution of H2O2 in the conversion of vincamine and vincadifformine to 9-
Figure 4-18c:  Effects of H2O2 in the accumulation 
and modification of indole alkaloids in V. minor as 
outlined in Figure 4-18. : the transient increase 
in vincamine and vincadifformine concentrations till 
8 days followed by massive decrease after 14 days. 
: the increase in minovincine, minovincinine and 
methoxyvincamine at 14 days. 
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hydroxyvincamine and to minovincine (Appendix, Figure A-71) could be ruled out: the 
simultaneous application of H2O2 with naproxen
6 resulted in a complete inhibition of the 
conversion. As this inhibitor does not affect peroxidases, a contribution of peroxidases is very 
unlikely. Moreover, as outlined below in detail, the outcome of resveratrol and naproxen 
application indicates the involvement of cytochrome P450 enzymes.  
These results suggest that indole alkaloids may be involved in plant defense, i.e., against 
pathogens or to repel herbivores. The animal attack is frequently associated with wounding, 
which in turn depends on the mode of herbivory, e.g., by chewing or sucking actions. The 
related differences in tissue destruction induce various modifications of a plant’s wound 
responses (Wu and Baldwin, 2009). MeJA, ethylene (ET), and reactive oxygen species (ROS 
e.g. H2O2), which are involved in activation of the various wounding-responsive genes, mediate 
the signaling of the wounding response and pathogenesis-related genes (Jacobo-Velázquez et 
al., 2015). According to Jacobo-Velázquez et al. (2015), ROS (e.g. H2O2) play a key role as 
signaling molecules for the wound-induced activation of the primary and secondary 
metabolism, whereas ET and MeJA are thought to be essential for the modulation of the ROS 
levels. In this sense, an initial response to wounding, ROS, and ET are simultaneously 
produced. After that, the later one, i.e., ET, induces the biosynthesis of JA, which, in turn, plays 
a key role in modulating the ROS levels, especially that of H2O2, afterward regulates the 
expressions of numerous genes involved in the wounding responses (Jacobo-Velázquez et al., 
2015). Moreover,  hydrogen peroxide modulates the intensity of the various signaling pathways 
(Ma et al., 2015), resulting in a complex so-called cross-talk of the different signal transducers 
(Saxena et al., 2016).   
In consequence, like MeJA, also H2O2 can be utilized to modulate the pattern of MIAs in V. 
minor and thus to alter the pharmacological properties of corresponding plant extracts. Since 
hydrogen peroxide also induces the generation of MeJA, e.g., via lipid peroxidation, a strict 
differentiation between the effects of both signal transducers could not be made. However, the 
time course of the alterations is quite different. 
 
 
 
                                                          
6 In animals, naproxen inhibits cyclo-oxygenase. In Plants, endogenous jasmonate production is 
inhibited by the inhibition of alleneoxide synthetase, a cytochrome P450 enzymes (Pan et al., 1998). 
Naproxene does not inhibit peroxidases (Tam et al., 1995). 
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The effect of inhibitors of oxidative enzymes   
As mentioned above, the conversion of vincamine and vincadifformine are thought to be 
catalyzed by cytochrome P4507 enzymes (CYPs), not least because of the similarities to related 
modifications of the indole alkaloids elucidated for C. roseus, (Figure 5-7; (Rodriguez et al., 
2003; Giddings et al., 2011). 
 
Figure 5- 7: Involvement of cytochrome P450 enzymes in the biosynthesis of tabersonine-derived 
alkaloids in C. roseus. Most of the biosynthetic steps in the roots are still uncharacterized at the genetic 
level and are represented by dashed arrows. However, most of the reactions are known to be catalyzed 
by cytochrome P450 enzymes (Hotze et al., 1995; Irmler et al., 2000; Collu et al., 2001; Facchini and 
Luca, 2008; Giddings et al., 2011). 
                                                          
7 In general,  CYPs catalyze regio- and stereoselective oxidative attack of non-activated carbons at 
physiological conditions (Akashi et al., 1999). They are responsible for various general reactions in 
plant primary as well as secondary metabolism, e.g., hydroxylations (Rodriguez et al., 2003; Giddings 
et al., 2011). However, few enzymes exhibit less common unusual activities (Mizutani and Sato 2011; 
Guengerich and Munro 2013) including successive oxidation of a single carbon (Helliwell et al. 2001; 
Carelli et al., 2011), rearrangement of carbon skeletons (Akashi et al., 1999). 
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In the aerial parts of C. roseus, the alkaloid tabersonine is transformed into vindoline, whereas 
in the roots it is converted to 19-O-acetylhörhammericine (see Figure 5-7; Laflamme et al., 
2001; O'Connor and Maresh, 2006). Both, the hydroxylation at the 16-position of tabersonine, 
which ultimately leads to vindoline, and the conversion of tabersonine to form lochnericine are 
catalyzed by P450-dependent enzymes (Furuya et al., 1992; Shanks et al., 1998). Moreover, 
tabersonine is converted to 19-hydroxytabersonine by the action of a P450-dependent 19-
hydroxylase (Morgan and Shanks, 1999; Giddings et al., 2011; Figure 5-7). Previous studies 
reported that many of the cytochrome P-450 enzymes involved in alkaloid biosynthesis are 
inducible by MeJA (Pauli and Kutchan, 1998; Morgan and Shanks, 1999; Rodriguez et al., 
2003; Giddings et al., 2011). 
To determine the enzyme activities of P450 is problematic, it requires the close collaboration 
with an appropriate NADP reductase and the availability of the specific substrate. Thus, 
unfortunately, a reliable and reproducible quantification of the enzyme activity has not yet been 
developed. An alternative approach to verify the involvement of a CYP is based on the 
reduction of their enzyme activity via the application of corresponding inhibitors or competitive 
substrates, respectively. The use of oxygenase inhibitors has proved useful for the study of the 
tabersonine branchpoint (Morgan, Shanks 1999) and catharanthine biosynthesis (Morgan and 
Shanks, 1999; Guo et al., 2011; Guo et al., 2013) in C. roseus. Similar studies have examined 
the biosynthetic pathways of taxol  (Srinivasan et al., 1996), brassinolides  (Winter et al., 1997) 
and benzylisoquinoline alkaloids  (Sugimoto et al., 1997). In contrast, in hairy root cultures of 
V. minor, oxygenase inhibitors (e.g. naproxen) had no effect, neither on total alkaloid nor on 
vincamine content. However, the combination of naproxen with H2O2 increases the total 
alkaloid content (Verma et al., 2014b). In plants, naproxen and other nonsteroidal-anti- 
inflammatory drugs are described to hampers the endogenous jasmonate production by the 
inhibition of the alleneoxide synthetase, a typical cytochrome P450 enzyme catalyzing the key 
reaction in the biosynthesis of jasmonic acid (Staswick et al., 1991; Nojiri et al., 1996; Pan et 
al., 1998; Froehlich et al., 2001; Hu et al., 2010). In conclusion, naproxen is known to be a 
substrate for various cytochrome P450 enzymes (Miners et al., 1996; Tracy et al., 1997). 
Accordingly, it was employed in this study to inhibit the enzymes putatively responsible for the 
stress-related modifications of MIAs in V. minor. 
Resveratrol, a stilbene, which is well known for its antioxidative and health protective 
properties is also described to act as competitive substrate for methyltransferases as well as for 
P450 enzymes and thereby inhibit the turnover of the genuine substrates of these enzymes (e.g. 
P450 hydroxylase; Piver et al., 2001; Martínez‐Márquez et al., 2016). Accordingly, apart from 
naproxen, also this stilbene was used to modify the biosynthesis of MIAs in V. minor. 
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When inhibitors for P450 enzymes, either resveratrol or naproxen, respectively, were applied 
together with MeJA, the common MeJA induced conversion of vincadifformine and vincamine 
does not occur. This fascinating effect could be caused either indirectly by a suppression of 
MeJA related signaling pathway or directly by an inhibition of the enzymes responsible for the 
conversion of vincamine and vincadifformine, respectively. Up to now, no data on the inhibition 
of the signal transduction downstream jasmonic acid are known. Yet, one key reaction within 
the synthesis of the jasmonic acid itself is catalyzed also by a P450 enzyme, i.e., the allene 
oxide synthase (Pan et al., 1998). However, as high amounts of MeJA had been applied 
exogenously, a putative inhibition of endogenous biosynthesis of jasmonic acid should not 
influence the corresponding induction.  
In addition to the inhibition by naproxen also 
resveratrol, which is described as a 
competitive substrate for cytochrome P450 
enzymes, also blocks the conversion of 
vincadifformine to minovincine as well as 
the hydroxylation of vincamine. 
Accordingly, it could be assumed that these 
reactions indeed are catalyzed by P450 
enzymes. This assumption strongly is 
supported by the fact that in C. roseus the 
congruent reactions are known to be 
catalyzed by such cytochromes (Figure 5-7; 
4-21d). The further investigation of this 
fascinating issue corresponds to a promising 
and auspicious scientific approach. 
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Salicylic acid (SA) is further important plant growth regulator that modulates various processes 
in plant growth and development  (Pancheva and Popova, 1998; Scott et al., 2004),  and leaf 
senescence (Abreu and Munné-Bosch, 2007). However, the predominant significance of SA is 
related to systemic acquired resistance; i.e., it mediates plant defense against pathogens and 
some sucking insects (Walling, 2009; Kästner et al., 2014), and increases systemically the 
resistance and plant fitness (Traw et al., 2007). Accordingly, SA represents an important factor 
in the interaction of plants with their environment.  
In contrast to the impact of MeJA and H2O2 on indole alkaloid modifications, SA treatment 
resulted in an initial and transient increase of the vincamine and vincadifformine accumulation 
in the leaves. A similar response was observed by Pan et al. (2010), who reported that 
exogenously applied SA to C. roseus also caused a transient increase in indole alkaloid content.  
SA does not induce the conversion of vincamine to methoxyvincamine and of vincadifformine 
to minovincine and minovincinine, respectively. When SA has applied again after four days, 
the content of vincadifformine decreased significantly. It appears that at least high 
concentrations of salicylic acid resulted in an inhibition of various reactions involved in the 
synthesis of MIAs, or in an induction of their catabolism. A related finding was reported by 
Guo et al. (2013), who showed that salicylic acid does not act as elicitor for tabersonine 
biosynthesis. However, when SA is applied to seedlings or suspension cultures, respectively, 
the content of alkaloid increased (Godoy-Hernández and Loyola-Vargas, 1997; El-Sayed and 
Verpoorte, 2004). In contrast, other investigation could not verify such impact of SA on the 
indole alkaloid metabolism: the application of SA to suspension cultures of C. roseus (Guo et 
al., 2013) as well to seedling of C. roseus (Aerts et al., 1996) and to leaves of Psychotria 
brachyceras (Gregianini et al., 2004) had no effect on the concentration of indole alkaloids. 
Gregianini et al. (2004) tried to explain these putative contradictions by suggesting that the 
significance of indole alkaloids might not be restricted to general interaction with pathogens 
but might mainly be assigned to general wound responses and to protection against UV light, 
which probably is mediated by jasmonic acid. The corresponding multifarious interactions 
between the different growth regulators might explain the inconsistent findings outlined. 
As mentioned above, SA is mainly associated with the establishment of systemic acquired 
resistance and its levels increase after pathogen infection (Menke et al., 1999), but also in 
processes related to wounding and to the resistance against insects. As highlighted above, 
various evidence indicates that the signal pathways related to SA are not linear, but are 
integrated through a network of cross-talking connections to coordinate various different 
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responses. In this sense, especially the substantial communication between the JA and SA signal 
transductions seem to be vital. Nevertheless, JA and SA signal cascades might activate different 
sets of plant defense genes (Thomma et al., 1998) or in some cases, they even act 
antagonistically (Felton et al., 1999; Leon-Reyes et al., 2010). Exogenous application of SA or 
its derivatives, such as aspirin, blocks both JA biosynthesis and thus the effect of JA in wound 
signalling (Doherty et al., 1988; Pena-Cortés et al., 1993; Doares et al., 1995; Kunkel and 
Brooks, 2002; Leon-Reyes et al., 2010). Thus, depending on the type of induction, there might 
exist different control pathways or partial response superposition (Baron and Zambryski, 1995; 
McConn et al., 1997; Maleck, 1999; Pieterse et al., 2012).  
According to the results presented in this thesis, the exogenous application of SA might act as 
antagonist for the endogenous JA signal by inhibiting the allene oxide synthase 
(AOS)  (Sivasankar et al., 2000; Norton et al., 2007), which catalyzes the first step in the 
biosynthesis of jasmonic acid. In addition, experiments with Arabidopsis revealed that JA-
responsive marker genes are highly sensitive to suppression by exogenous application of SA. 
This suggests that the significance and the accumulation of indole alkaloids might not be 
restricted to interaction with pathogens, but might also be assigned to general wound responses, 
which probably might be mediated by JA. In contrast, Mur et al. (2006) reported that 
in Arabidopsis, a treatment with low concentrations of JA and SA resulted in a synergistic effect 
on the JA- and SA-responsive genes. These different observations strongly suggest further 
research to study the interactive effect of MeJA and SA, especially at low and different 
concentrations on the in the indole alkaloid accumulation and modulation in V. minor plants. 
The complex interaction of signal molecules 
Elicitation is vastly complex because of an almost infinite number of intertwined events. 
Additionally, all these events might differ with respect to temporary and spatial variations. 
Moreover, these processes strongly are impacted by the environment (Shakya et al., 2017; 
Figure 5-8). Furthermore, all these alterations depend on the physiological and developmental 
stage of the plant, their growth cycle and nutritional status, as well as the specificity and 
concentration of elicitors, which, in turn, massively influence the final responses (Shakya et al., 
2017). Thus, it is nearly impossible to establish a universal and absolute model, which 
comprises all elicitation mechanisms. Nevertheless, to increase the basic understanding of these 
processes, corresponding schemes are required, in which the particular components, such as 
calcium flux, a burst of reactive oxygen species (ROS), and phosphorylation by mitogen-
activated protein kinase (MAPK) are outlined (Seybold et al., 2014). As mentioned above, these 
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reactions might initiate further signaling events, i.e., the activation of transcription factors and 
the induction of plant secondary metabolism (Trewavas and Malhó, 1998; Naoumkina et al., 
2008; Schluttenhofer and Yuan, 2015; Pan et al., 2016). 
 
Figure 5- 8: The molecular mechanism of elicitation at the cellular level: Recognition of elicitors by 
plasma membrane‐bound receptors results in ion fluxes, Ca2+ burst, cytoplasmic acidification, ROS 
burst, activation of NADPH oxidases, of mitogen-activated protein kinases (MAPKs) and of G-proteins. 
These events interfere with other signaling pathways, e.g., those involving salicylic acid, jasmonic acid, 
cAMP, which in turn might activate transcription factors and thus gene expression, which modulates – 
apart from many other processes – also the secondary metabolism (Shakya et al., 2017). 
In conclusion, after the signaling molecules are produced, various signal transduction 
mechanisms are activated and the primary, as well as the secondary metabolisms, are modulated 
in the stressed plants. With respect to defense reactions, a wide array of processes might be 
induced. After being infected by a pathogen, the major defense reaction is the so-called 
hypersensitive response; i.e., the cells die. Due to the ongoing de-compartmentation, tanning 
reaction causes the typical browning processes, which hamper most infections. In the areas 
around the center of the infection, i.e., the cells surrounding the necrotic tissue, further defense 
reactions are generally induced. When focusing on the underlying mechanisms, it has to be 
considered that in principle there are two different basic strategies (VanEtten et al., 1994), either 
the defense substances are constitutively present in the plants or they are synthesized in 
response to the infection. In the first case, they are denoted as phytoanticipins, the latter ones 
are classified as phytoalexins.   
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When phytoanticipins are constitutive accumulated in the plants, they either might be already 
active, like alkaloids, saponins or various phenolic compounds, or they are activated postmortal 
from pre-existing precursors like polyphenols, cyanogenic glucosides or glucosinolates. When 
the integrity of the cell is destroyed, i.e., due to insects feeding or penetration by fungal hyphae, 
the precursors come into contact with their degrading enzymes. In this sense, the hypersensitive 
reaction is due to the enzymatic oxidation of polyphenols and cyanogenic glucosides or 
glucosinolates are hydrolyzed and toxic aglycones are released. The latter process frequently is 
denoted as a biological bomb (Matile, 1980; Tomas-Barberan and Gil, 2008; Iriti and Faoro, 
2009). In contrast to the phytoanticipins, the phytoalexins are synthesized de novo from primary 
metabolites in response to the pathogens attack (Jeandet, 2015; Pusztahelyi et al., 2015), or 
upon UV radiation (Marti et al., 2014).  
It is worth mentioning that the processes responsible for the induction of both defense strategies, 
the hypersensitive reaction and the synthesis of phytoalexins are more or less identical: in the 
first phase of host-pathogen interaction, due to the cellulolytic enzymes released from the 
pathogens, fragments of the plant cell wall are liberated. These signal molecules denoted as 
elicitors, are recognized by corresponding receptors (Figure 5-8), and the various signal 
transduction cascades are induced. Apart from many other events, also glucanases, chitinases, 
and other hydrolases are produced, which degrade the cell walls of the attacking pathogens. 
The corresponding fragments also operate as elicitors and the entire elicitation process is 
enhanced and accelerated. Interestingly, the decision whether the hypersensitive reaction is 
initiated or the cells remain alive and the other protective reactions are induced, depends on the 
concentration on elicitors and on the velocity of its generation (Fritig et al., 1987). In the same 
sense, the subsequent generation and accumulation of reactive oxygen species (ROS) and of 
nitric oxide (NO) determines the mode and outcome of the defense mechanism. Accordingly, 
active oxygen species might be part of the hypersensitive response, or they are responsible 
directly for the death of the cells from the host as well as from the pathogens. Moreover, in 
lower concentrations, they might act as secondary messenger and thus are part of the signal 
transduction chains. These coherences clearly display the tremendous complexity of the entire 
issue. Accordingly, a comprehensive conception of the elicitation of secondary metabolism by 
various signal transducers does not only require – as outline above - the consideration of the 
specific developmental and physiological status of the plants, but also the concentration of the 
signal molecule applied.   
The situation is even more complex when the multifarious interactions of the different 
phytohormones and numerous growth regulators are considered. Up to now, we are far away to 
understand and conceive all these reciprocal interferences, frequently denoted as cross-talk. In 
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this context, the various interaction of jasmonic acid (JA) and salicylic acid are a fascinating 
example, which vividly displays the entire complexity of this issue (Pieterse et al., 2009).  As 
outlined in Figure 5-9, in the course of a typical host-pathogen interaction, SA-dependent 
resistance against biotrophic pathogens and JA-dependent defense against necrotrophic 
pathogens and herbivory have been documented (Bostock, 2005; Stout et al., 2006). For 
example, induction of the SA pathway in  Arabidopsis by the biotrophic oomycete 
pathogen Hyaloperonospora arabidopsidis strongly is suppressed by JA-mediated defense 
reactions that were activated upon feeding by caterpillars of white Pieris rapae (Koornneef et 
al., 2008). Although many reports describe an antagonistic interaction between SA- and JA-
dependent signaling, also many synergistic interactions have been described as well (Mur et al., 
2006). In this sense, the treatment with low concentrations of JA and SA resulted in Arabidopsis 
in a synergistic effect on the activation of JA- and SA-responsive genes. However, at higher 
concentrations the related effects were antagonistic. This, in turn, demonstrates that the 
outcome of the SA-JA interactions strongly dependents on the actual concentration of each 
growth regulator (Mur et al., 2006). Since their concentrations also are impacted by the various 
anabolic as well catabolic reactions, Koornneef et al. (2008), outlined that – apart from the 
actual concentration - timing and sequence of initiation of SA and JA signaling are very 
important factors for the outcome of the SA-JA signal interaction.  
The complex interaction between SA and JA also plays a major role in the induction of systemic 
acquired resistance (SAR): SA, as well as JA or its derivatives, are translocated as within the 
plant from one organ to another (Farmer, 2001; Durrant and Dong, 2004; Attaran et al., 2009). 
Yet, this relocation of growth regulators causes a further level of complexity, since also 
nonpathogenic microorganisms existing on the leaves or in the rhizosphere might induce SAR 
and the related translocation of growth factors (Attaran et al., 2009; Beneduzi et al., 2012). In 
this context, beneficial soil-borne microorganisms, such as mycorrhizal fungi and plant growth 
promoting rhizobacteria, are of special interest. In analogy to SAR, the related induced reactions 
frequently are denoted as induced systemic resistance (ISR; Figure 5-9 ; (van Loon et al., 1998; 
Pozo and Azcón-Aguilar, 2007). This means that the interaction with various beneficial 
microorganisms could cause a systemic activation of several responses related to the various 
defense reactions. In this sense, the growth of several rhizobacteria triggers the synthesis of SA 
and thus the SA-dependent SAR pathway. In addition, at least in Arabidopsis thaliana, the 
induced systemic resistance (ISR) is mediated by a SA-independent pathway, which is triggered 
by jasmonic acid (JA) and ethylene. A similar mechanism is described for the induction of 
defense reactions due to non-pathogenic microorganisms growing on leaves; (Bargabus et al., 
2002). The increase of resistance due to the induction of ISR frequently is denoted as “priming” 
(Heil, 2001; Choudhary et al., 2007). Whereas SAR is predominantly effective against 
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biotrophic pathogens that are sensitive to SA-induced defense mechanisms, ISR was shown to 
be effective mostly against pathogens and insects that are sensitive to the primarily JA- and ET-
induced defense reactions (Ton et al., 2002; van Oosten et al., 2008). Combination of ISR and 
SAR can increase protection against pathogens that are resisted through both pathways besides 
extended protection to a broader spectrum of pathogens than ISR or SAR alone (Choudhary et 
al., 2007).  
 
Figure 5- 9: Interactions and modifications of the SA and JA depending signaling.  
Whereas the responses related to the systemic acquired resistance (SAR) are caused by pathogen or 
herbivore attack, those involved in induced systemic resistance (ISR) are triggered by non-pathogenic 
microorganisms, predominately by microbes growing in the rhizosphere. Both phenomena, which 
mandatorily involve SA and JA signaling, lead to an increased resistance against future attacks by 
pathogens or herbivores. A corresponding enhanced defense status could also be induced by 
transferring the airborne signaling molecule methyl jasmonate (MeJA) and methyl salicylate (MeSA) 
from infected organs of one plant to distant leaves either of the same plant or the same species 
respectively, or to plants of another species, growing in the near vicinity. This figure is modified from 
(Farmer, 2001; Taiz and Zeiger, 2010; Pieterse et al., 2009; Pieterse et al., 2012). 
Additionally, the growth factors can be readily modified into derivatives revealing altered 
biological activity and physicochemical properties, opening the door for another layer of 
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regulation (Pieterse et al., 2009). The best examples for such derivatives are the volatile methyl 
ester of SA and JA, which are proposed to be relevant for long-distance signalling from infected 
or injured organs to distant leaves either of the same plant or of individuals growing in the near 
vicinity (Farmer, 2001; Attaran et al., 2009; Tamogami et al., 2012). In this sense, methyl 
salicylate is produced by infected plants increases the resistance of neighboring, uninfected 
tobacco plants, e.g., by inducing the expression of the defense gene PR1 in uninfected plants 
(Shulaev et al., 1997). Meanwhile, further compounds, which act as airborne plant-to-plant 
signals, have been identified, e.g., MeJA is liberated from infected big sagebrush plants 
(Artemisia tridentata), which induced the accumulation of defense-related proteinase inhibitors 
in the leaves of tomato plants growing in the near vicinity (Farmer and Ryan, 1990). In the 
acceptor plants, the methyl-esters are hydrolyzed to yield either SA or JA, which in turn, 
induces the observed reactions. Considering these coherences, the experimental approach 
employed in this thesis indeed corresponds to a “natural situation”  
In conclusion, there is an unimaginable high degree of variability of putative interactions and 
interferences between the JA and SA pathways. Accordingly, all changes in the kinetics of 
phytohormone biosynthesis and signaling in the course of the interactions of a plant might alter 
the biochemical defense responses and thus, the final outcome of the plant-herbivore or plant-
pathogen interactions. These coherences may also explain the great variation and the 
contradictory results in the previous literature experiments, in which MeJA or SA are applied 
to indole alkaloid-containing plants, e.g., Aerts et al. (1996) and El-Sayed & Verpoorte (2004) 
reported a quite different and entirely contradicting effects when C. roseus seedlings have been 
treated with SA. However, we have to consider that these results are actually not equivalent, 
since the authors applied quite a different concentration of SA and, moreover, employed quite 
different times of incubation. Consequently, it is hardly surprising that the outcome of the 
defense response is completely different. 
The stressed induced modification of indole alkaloids requires a novel classification of 
defense reactions 
As outlined above, the known defense mechanisms are classified by two different types: in the 
case phytoalexins, the active substances are synthesized de novo from primary metabolites 
whereas the phytoanticipins are constitutively present in the plants (VanEtten et al., 1994). The 
latter one either are active per se, i.e., the defense is directly due to the accumulated substance, 
or these substances are activated after cell death, i.e., by hydrolysis of the precursors (Matile, 
1980; Tomas-Barberan and Gil, 2008; Iriti and Faoro, 2009). However, the results displayed in 
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the thesis, revealed that due to a stress-related elicitation, the MIAs are just slightly modified 
in vital, elicited cells. Yet, since they are not synthesized de novo, they do not represent classical 
phytoalexins and should be classified as phytoanticipins. However, their modifications do not 
occur postmortally but require a living, elicited cells. Hence, this type of defense compounds 
features characteristics of phytoalexins as well as of phytoanticipins, we have to introduce a 
new category, either within the class phytoanticipins by adding a sub-category of “substances 
modified in vital cells after elicitation” or within the class of phytoalexins as those being 
synthesized from complex precursors. Alternatively, a third main category apart from 
phytoanticipins or phytoalexins could be introduced. In this case, an appropriate denotation 
could be phytoelicitins. 
Independently to the semantic problem, the modification of MIAs presented in this thesis 
vividly expound the large complexity and the high dynamic of plant defense reactions and the 
difficulty to incorporate and characterize them by simple classifications. In this context, it has 
to be noted that corresponding problems in the assessments or typecasting of a certain mode of 
defense represent a well-known issue, e.g., with respect to defense compounds: in grape wine, 
reveratrol is produced as typical phytoalexins in response to biotic elicitation (Chang et al., 
2011), but after successful defense of the pathogens, this stilbene is glucosylated and the 
corresponding glucoside, i.e., piceid, is stored in the vacuole and has to be considered as typical 
phytoanticipin with respect to a next infection. In the same manner, in tobacco plants, scopoletin 
is produced as phytoalexin in response to fungal or mosaic virus elicitors and accumulated as 
glycoconjugates without deleterious effects to the plant cell. Conjugation is also thought to 
provide a pool of inactive forms that can be rapidly transformed to active molecule via specific 
β-glucosidases in a secondary infection occurring in such tissues (Chong et al., 1999; Costet et 
al., 2002).  
Furthermore, some compounds such as momilactone are known to be de novo synthesized in 
response to pathogen attack as a typical phytoalexin in leaves (Cartwright et al., 1981), but are 
constitutively present as phytoanticipin in another part of the same plant (Kato et al., 1973; Lee 
et al., 1999). In the same sense, nicotine which is accumulated in the roots and leaves of N. 
attenuata as typical phytoanticipin, is – in addition - also de novo synthesized as phytoalexin 
in response to an attack by the larvae of Manduca sexta (Winz & Baldwin, 2001; Steppuhn et 
al., 2004). 
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Conclusions and implication 
Based on the insights mentioned above, it can be concluded:  
The application of growth regulators or signal transducers involved in the signal 
transduction of stress responses could modulate the composition of secondary 
metabolites.  Accordingly, elicitation could be a suitable, novel tool for further 
searches for pharmacologically active plant natural products. Such approach might 
open new doors to improve and facilitate phytochemical drug discovery. 
In addition, also the application of enzyme inhibitors could be used as alternative 
approach to study but also to modify the biosynthetic pathway of certain secondary 
metabolite.  
With respect to the biosynthesis of MIAs, the identification of the cytochrome P450 
enzymes responsible for the stress induced conversion of indole alkaloids is an 
attractive topic for further studies.  
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5.3 Proposed biosynthetic pathway in the V. minor 
 As outlined above, the major indole alkaloids 
from V. minor belongs to three different classes, 
i.e., the eburnamine/vincamine-, the aspido-
spermine- and the akuammiline-group. Yet, all 
different structures are derived from strictosidine, 
resulting from the condensation of tryptamine and 
secologanin (Figure 5-10; Thamm et al., 2016). 
The tremendous high variation in the indole 
alkaloid structures is due to modifications of the 
secologanin moiety, resulting in two different 
basic structures, i.e., the aspidosperma and the 
corynanthe/strychnos type (Figure 5-11). 
Moreover, the aspidosperma type skeleton could 
be rearranged, yielding in two different classes, 
representing the eburnamine/vincamine or the 
aspidospermine group. 
 
Figure 5- 11: The main groups of indole alkaloid in V. minor. The iridoid moiety, which results from 
various rearrangements of the secologanin skeleton, is displayed in bold. 
Figure 5- 10: Biosynthesis of strictosidine 
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In addition, also in the case of the aspidosperma alkaloids, one C-atom (C-22) of the rearranged 
secologanin moiety could be removed (Saxton, 1983a). Meanwhile, in many cases, the detailed 
routes of biosynthesis are elucidated; e.g., the aspidospermidine skeleton results from the 
attachment of C-21 to Nb and the β position of the tryptamine nucleus (the so-called β-
condensation), followed by further cyclization between C-16 and C-2, leading to the 
aspidospermidine skeleton (Saxton, 1983a).  In contrast, the eburnamine/vincamine skeleton is 
due to the attachment of C-21 to Nb and C-2 (α condensation), followed by cyclization between 
C-16 and Na, leads to the (Saxton, 1983b).  
With respect to the alkaloid biosynthesis in V. minor only limited information are available; 
nonetheless, it is known that also in this plant the MIAs are derived from the assembly of a 
secologanin and tryptamine (Thamm et al., 2016). Scott (2002) proposed that geissoschizine is 
an early transformation product of strictosidine (Figure 5-12), which is thought to be an 
intermediate leading to all different MIAs and that strictamine results from an intramolecular 
oxidative coupling between the C7 and C16 atoms of geissoschizine followed by deformylation 
(Figure 5-12; Scott, 2002; Ren et al., 2016). In addition, geissoschizine is postulated to be the 
precursor of stemmadenine that represents the putative intermediate leading to tabersonine 
(Qureshi and Scott, 1968b, 1968a) and vincadifformine. However, the detailed biosynthetic 
pathway is still not characterized (Qu et al., 2018). Giddings et al. (2011) reported that in hairy 
root culture of C. roseus tabersonine is converted to vincadifformine via 6,7-reductase; 
nevertheless, also this step is uncharacterized at the genetic and enzymatic level. 
Vincamine still exhibits a C10 aspidosperma unit; accordingly, it could be originated from 
vincadifformine by a series of reactions which involve the cleavage of bonds to both, the α and 
β positions of the indole (Wenkert and Wickberg 1965; Dewick 2009). This assumption was 
supported by feeding 14C-labelled tabersonine to V. minor plants, which converted it to 14C-
vincamine (Kutney et al., 1971). Kellner et al. (2015) suggested that the 2,3-epoxides 
tabersonine might be a common intermediate for the assembly of the eburnamine alkaloids such 
as vincamine by a non-enzymatic rearrangement. This assumption seems to be supported by 
approaches in the chemical semi-synthesis of vincamine from tabersonine or vincadifformine 
(Zsadon et al., 1979; Saxton, 1983a; Szabó et al., 1998; Li et al., 2017). However, up to now, 
any enzyme or gene, respectively, involved in the biosynthetic pathway of vincamine in V. 
minor have not been identified yet. 
In contrast, many enzymes and related genes are characterized in C. roseus (Giddings et al., 
2011; Qu et al., 2015; Kellner et al., 2015): in hairy root culture of C. roseus, vincadifformine 
could be transformed  to minovincinine by the action of a cytochrome P450 enzymes, which 
specifically hydroxylates the 19-C of vincadifformine (Morgan and Shanks, 1999; Giddings et 
al., 2011).  
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Figure 5- 12: Proposed biosynthetic pathway of indole alkaloids in V. minor. Based on the findings 
for C. roseus (Scott, 2002; Dewick, 2009; Giddings et al., 2011; Qu et al., 2018) and the deductions 
mentioned in the text, for the first time a corresponding pathways for the MIAs in V. minor under normal 
conditions (black) and under stress conditions (red) is presented. SLS: secologanin synthase; STR: 
strictosidine synthase; TDC: tryptophan decarboxylase; SGD: strictosidine β-glucosidase; GS: 
geissoschizine-synthase).
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Moreover, Edge et al. (2018) reported that in C. roseus, in the course of vindoline biosynthesis, 
tabersonine is hydroxylated at 16-position (i.e. 6-position of indole ring) by a cytochrome P450 
depending tabersonine-16 hydroxylase (Schröder et al., 1999), followed by an O-methylation 
catalyzed by the 16-hydroxytabersonine-16-O-methyltransferase (Levac et al., 2008). These 
results are in accordance with the finding outlined in the actual thesis, that in V. minor - under 
normal, unstressed conditions - the hydroxylation and methylation occur at 6-position indole 
ring, yielding in 11-methoxy-vincamine (see above Figure 5-12). 
According to the published biosynthetic pathway for MIAs  in C. roseus (Scott, 2002; Dewick, 
2009; Giddings et al., 2011; Qu et al., 2018), a corresponding scheme for V. minor is proposed 
in Figure 5-12, in which also the results and insights from this thesis are incorporated. To 
highlight the stress-induced changes, the alkaloids, which are exclusively accumulated in 
response to the MeJA treatment, are displayed in red. In this sense, it becomes obvious that - in 
analogy to C. roseus - also in V. minor the 6-position of indole ring is hydroxylated and O-
methylated under regular conditions. Accordingly, in C. roseus, tabersonine is converted to 
vindoline8, whereas in V. minor vincamine is converted to11-methoxyvincamine4. In contrast, 
under stress conditions, vincamine is hydroxylated and O-methylated at the 4-position of indole 
ring, resulting in 9-methoxyvincamine. In analogy, vincadiffformine is hydroxylated at 19-
position to form minovincine and subsequently oxidized to minovincine after MeJA treatment 
in V. minor leaves.  
Based on the knowledge that resveratrol represents an effective inhibitor for cytochrome P450 
enzymes - either due to its action as competitive substrate or as non-competitive inhibitor - 
(Piver et al., 2001; Liu et al., 2013; Martínez‐Márquez et al., 2016; El-Sherbeni and El-Kadi, 
2016) this stilbene was employed in this thesis to modulate the alkaloids composition in stressed 
V. minor. As expected, the stressed induced changes in indole alkaloid composition were fully 
suppressed by the application of resveratrol to V. minor plants. In contrast, resveratrol applied 
via irrigated water had a minor effect on the composition of MIAs in the V. minor control plants. 
In principle, this could be due to three different effect:  
1)  there are no cytochrome P450 enzymes involved in the biosynthesis of the standard 
MIAs, present in accumulated plants 
2)  the concentration of resveratrol in the leaves are too low for an effective inhibition,  
3)  there are no changes detectable since the rate of alkaloid biosynthesis is too low. 
                                                          
8 In vindoline, the 6-position of indole ring corresponds to the 16-position of standard numbering of the 
alkaloid, whereas in vincamine the 6-position of indole ring accounts for the 11-position of the alkaloid. 
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The first possibility, i.e., that there are no cytochrome P450 enzymes involved in the 
biosynthesis of MIAs in the V. minor control plants, seems to be very unlikely, since it is well 
known that in C. roseus many steps of the biosynthesis of the MIAs accumulated in the leaves 
and roots are catalyzed by cytochrome P450 enzymes, e.g., the hydroxylation at the 16- or  19- 
positions of tabersonine, (Furuya et al., 1992; Shanks et al., 1998; Morgan and Shanks, 1999; 
Giddings et al., 2011). In contrast, the second possibility, i.e., that the concentration of 
resveratrol in the leaves are too low for an effective inhibition, could not be rejected out of 
hand; however we have to consider that the concentration of resveratrol applied in this work 
via the irrigation water reflects the same concentration, which was used by Tucker Serniak, 
(2016) to study allelopathic effects of resveratrol as well as that found in leachates of Fallopia 
japonica, which had been employed to horizontal natural product transfer (Fan et al., 2009; 
Tucker Serniak, 2016; Radwan, personal communication). Accordingly, it could be assumed 
that resveratrol is taken up from the soil by the roots and accumulated in ample amounts in the 
leaves as reported earlier (Henry et al., 2005; Fan et al., 2009; Tucker Serniak, 2016). The most 
likely reason for the absence of a resveratrol effect on the composition of the MIAs in control 
plants concerns the low rate of biosynthesis within the plants during the treatment. 
These coherences clearly point out, that in the future a putative effect of resveratrol on the 
composition of the MIAs in control plants and the elucidation of its biochemical background 
represent a promising and auspicious strategy. In addition, an alternative approach employing 
resveratrol is related to the horizontal natural product transfer: Fallopia japonica roots which 
contains large amounts of resveratrol and its glucoside (polydatin), respectively (Chen et al., 
2013) could be used to modulate the MIAs V. minor. The application of F.  japonica roots, 
either as a mulching powder or via their aqueous extracts in the irrigation water seems to be an 
appropriate strategy to deliberately - but naturally - change to alkaloids composition in V. minor 
plants.  
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5.4 New strategies in phytochemical drug discovery 
Naturally occurring compounds play an essential role in drug discovery. From 1981 to 2014, 
70% of all new approved therapeutic agents are traceable back to natural products (David et al., 
2015; Newman and Cragg, 2016). The exploration of natural biodiversity has led to the 
identification of a remarkable variety of chemical entities that reveal highly selective and 
specific biological activities and unique modes of action (Cragg and Newman, 2013). Bio-
prospecting of natural sources is still of great interest for the discovery of new scaffolds; only 
1% of tropical species have been investigated for their biological activities (Gurib-Fakim, 2006; 
Long et al., 2014). Yet, routine and classical drug discovery programmes are based on plant 
natural products have mainly utilized secondary metabolites, which are often constitutive 
defense metabolites (Hostettmann et al., 2005). Accordingly, the dynamic stress response of 
plants is usually not considered, although it is known that many phytoalexins also reveal strong 
bioactivities (Hammerschmidt, 1999). Consequently, in addition to the required analyses of so 
far non-investigated plants, a further approach to comprehensively using the entire potential of 
plants as valuable resources for pharmacological purposes has to be introduced: only when the 
ability of plants to respond to biotic and abiotic stress is adequately considered, the entire 
spectrum of natural products could be captured.  
Dereplication-guided isolation of new indole alkaloids  
To detect and identify bioactive compounds, efficient and innovative strategies are needed to 
significantly reduce the time-line of bioactive natural product discovery. All evidence suggests 
Conclusions and implication 
Based on the insights mentioned above, it can be concluded:  
The biosynthesis of MIAs in V. minor seems to be analogous to that of the 
alkaloids in C. roseus.  
Stress induced by MeJA application alters to composition of MIAs via an 
induction of specific hydroxylation and O-methylation.  
The key enzymes responsible for these changes and thought to be specific 
cytochrome P450 depending hydroxylases.  
The identification and characterization of these enzymes should increase our 
understanding of the complex biochemical and ecological aspects of indole 
alkaloids; moreover, it will provide helpful tools to boost the discovery of new 
drugs or toxins. 
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that the most promising workflows for the chemical profiling of natural products should 
involve, at least in part, a dereplication procedure. Historically, the first definition of the term 
“dereplication” was given by Beutler et al. (1990) as “a process of quickly identifying known 
chemotypes”. Accordingly, such approach also should be suitable for the high number of 
samples resulting from various elicitation procedures as outlined in detail below.  
The goal of dereplication approaches was to evaluate the activity of a wide range of terrestrial 
and marine plant extracts and to rapidly identify compounds responsible for this activity without 
investing time in traditional bioassay-guided fractionation or full structure elucidation 
procedures (Hubert et al., 2017). These methods are challenging to develop because they 
require high chromatographic resolution for detailed natural product profiling as well as high 
throughput for rapid quantification or fingerprinting analyses (Hubert et al., 2017). In this 
respect, techniques such as LC-MS, mainly, have played key roles over the last three decades. 
The recent introduction of ultra-high pressure liquid chromatography (UHPLC) system coupled 
to ultra-high resolution time of-flight analysis in both the mass spectrometry (UHR-TOF-MS) 
and tandem MS (MS/MS) modes has represented an important breakthrough for the profiling 
of complex mixtures, such as natural extracts (Wolfender et al., 2010). In comparison to 
conventional HPLC, UHPLC allows a remarkable decrease in analysis time as well as an 
increase in peak capacity, sensitivity and reproducibility (Eugster et al., 2011). TOF-MS 
provides sensitive detection, high mass-resolution and high mass-accuracy for the rapid 
assignment of molecular formulae of natural products: a key piece of information for metabolite 
identification and dereplication. UHPLC-TOF-MS provides reproducible and highly 
informative datasets for MS-based metabolomics (Wolfender et al., 2009). The most important 
aspect of this approach is the quick identification of known substances in order to concentrate 
the efforts on the discovery of new ones.   
In this context, LC-MS with high accuracy and sensitivity has become a valuable method in 
dereplication guided isolation of novel MIAs (Aguiar et al., 2010; Xu et al., 2012; Y Liu et al., 
2015; J Liu et al., 2015; Pan et al., 2015; Akhgari et al., 2015; Kumar et al., 2016; J-G Zhang 
et al., 2018). In this thesis, a simple, sensitive, reproducible UHPLC–ESI–MS/MS method was 
developed in positive ion mode for the dereplication of MIAs in V. minor. UHPLC profiling 
enabled the separation of a very high number of compounds and the detection of minor 
constituents. The high mass accuracy data generated by UHR-TOF-MS provides molecular 
formula information for all MIAs detected in stressed leaves sample of V. minor. The diagnostic 
fragmentation pathways were established with the help of MS/MS spectra of diagnostic 
fragment ions of isolated and NMR based identified compounds. Vincadifformine and 
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vincamine classes of MIAs showed two types of fragment ions, namely due to loss of 
substituents, which were attached with the terpene moiety and RDA fragment ions. The 
established diagnostic fragmentation pathways were applied for identification and 
characterization of other MIAs in the extract of stressed plants which were absent in the control. 
Extracted ion recording was used to detect the compounds with the same molecular ion, minor 
and co-eluting components.  
About 20 alkaloids were tentatively detected and characterized in the extract of stressed leaves 
of V. minor. 9-hydroxyvincamine, 9-methoxyvincamine and 9-methoxyepivincamine were 
identified as novel alkaloids isolated and characterized for the first time. Moreover, other 
alkaloids had been described to occur in V. minor for the first time (e.g. ercinamine and 10-
hydroxycathofoline). 
The isomeric compounds of vincamine, methoxyvincamine, hydroxyvincamine, and 
vincaminine were successfully distinguished by MS/MS analysis. The present information 
showed the utility of the accurate mass measurements, which will also speed up dereplication 
of MIAs. It is important to mention that the 1H and 13C chemical shifts deviated significantly 
from literature data, probably due to the protonation of the basic nitrogen atoms by TFA or 
protonation of formic acid during HPLC fractionation. This illustrates that metabolite 
dereplication using carbon chemical shifts might be hampered in cases where the compounds 
act as weak acids or bases. 
In conclusions, dereplication including the approaches outlined above seems to be an 
appropriate tool to analyze the complex profiles of extracts from elicitor-treated cells.  
Stress induction for lead drug discovery 
As outlined, it is well known that plants generate a large number of new, stress-induced natural 
products, which also might reveal high therapeutic value (Atkinson and Urwin, 2012; 
Wolfender and Queiroz, 2012). However, up to now, the various environmental impacts on the 
composition of active ingredients of medicinal plants had mostly been assessed negatively, 
mainly with respect of the abundant variations in the content of the active compounds. In this 
sense, the lack of reproducibility is considered as one of the major drawbacks in using plants in 
pharmaceutical discovery (Cordell, 2000). When considering the basic metabolic coherences in 
metabolism of plants exposed to various abiotic stress situations (Kleinwächter and Selmar, 
2015), the observed differences in the concentration the various secondary plant metabolites in 
plants harvested at different times and locations become obvious (Poulev et al., 2003; Atanasov 
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et al., 2015). Moreover, the biosynthesis of various defensive compounds, such as phytoalexins 
is strongly impacted by plant pathogens (Ahuja et al., 2012). 
Indeed, the consideration of all putative biotic and abiotic stress situations is quite impossible; 
however, due to the comprehensive knowledge of the underlying signal transduction 
mechanisms, the usage of certain elicitors, phytohormones and growth regulators represent 
effective tools for novel approaches. 
Indeed, meanwhile, various elicitors already are frequently used to enhance the production of 
secondary metabolites. However, this strategy is strictly limited to increase the content of those 
compounds, which already have been present in the non-treated plants (Ferrari, 2011). 
Moreover, with respect to quality improvement of vegetables and fruits, e.g., by increasing the 
content of glucosinolates and flavanoid in broccoli (Ku and Juvik, 2013), or the enhancement 
of flavonoids in apple skin (Awad and Jager, 2002), the application of growth regulators is well 
established.  However, up to now, corresponding approaches are not employed in drug 
discovery, e.g., to induce or enhance putative phytoalexins or phytoelicitins (see 5.2 page 160-
161). This disregarding is peculiar, since the impact of elicitation on the bioactivity of many 
plant species is well established (Poulev et al., 2003) as well as on the composition of the 
relevant compounds (Rijhwani and Shanks, 1998; Rodriguez et al., 2003; Poulev et al., 2003; 
Wojakowska et al., 2013; Tang et al., 2015; Sampaio et al., 2016). Accordingly, the induction 
and the utilization of natural elicitation mechanisms should be introduced in forthcoming 
approaches in drug discovery.  
We have studied the effect of different growth regulators or the inducers on the MIAs 
biosynthesis in V. minor to induce the production of new alkaloids through the activation of 
biosynthetic pathways encoded by genes that are silent under normal condition. Consequently, 
in this thesis, methyl jasmonic acid (MeJA), salicylic acid (SA), and hydrogen peroxide were 
used to induce characteristic stress responses and to impact the biosynthesis of indole alkaloids. 
As outlined, the application of MeJA and hydrogen peroxide resulted in massive changes in the 
pattern of indole alkaloids of V. minor, i.e., the appearance of novel, so far unknown indole 
alkaloids, whose bioactive properties are under study. Accordingly, the MeJA treatment of 
Vinca plants unequivocally proved that the elicitation by the application of growth regulators 
represents an appropriate and promising approach for identifying novel natural products, which 
might represent valuable pharmacological remedies.  
Regulation of the biosynthesis of target bioactive compound 
In addition to the application of elicitors, the treatment of the plant cell with enzyme inhibitor 
could be used as an additional approach to induce or modify the biosynthetic pathway of the 
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certain secondary metabolite by affecting the related metabolic fluxes. Such approach might be 
aimed to reduce the content of unfavorable compounds by inhibiting the enzymes involved in 
their biosynthesis, or, alternatively, to increase the concentration of the desired substances by 
inhibiting metabolic processes utilizing the same precursors. 
In this sense, in C. roseus catharanthine 
formation was enhanced by minimizing the 
concurrent metabolic flux of its precursor, 
i.e., 4,21-dehydrogeissoschizine, to 
serpentine synthesis by using naproxen. 
This cyclooxygenase inhibitor strongly 
inhibited the biosynthesis of serpentine. As 
consequence, the metabolic flux to 
catharanthine biosynthesis was strongly 
enhanced, resulting in an elevated 
catharanthine concentration (Figure 5-13; 
Guo et al., 2011). In another approach, the 
same authors demonstrated the high 
potential of such strategies by influencing 
the fluxes in alkaloid biosynthesis at three 
different sites (Guo et al., 2013) to increase 
the vinblastine concentration. 
In addition to the application of naproxen, which increased the metabolic flux to catheranthine, 
a second inhibitor, i.e., benzotriazole (Figure 5-13), which specifically inhibits the 
cyclooxygenase that generates lochnericine, was added to the cell cultures of C. roseus. In 
consequence, the metabolic flux from tabersonine into the lochnericine was strongly reduced, 
resulting in an elevated production of vindoline. Furthermore, into the medium, H2O2 was 
added, which is known to increase the generation of vinblastine by eliciting the peroxidase that 
is required for the condensation of vindoline and catharanthine at the final step of the vinblastine 
biosynthesis (Figure 5-13). In contrast, in hairy root cultures of V. minor, inhibitors (e.g. 
naproxen) had no effect, neither on total alkaloid nor on vincamine content. However, the 
combination of naproxen with H2O2 increases only the total alkaloid content (Verma et al., 
2014b). Therefore, the identifying of the enzymes involved in the alkaloid biosynthesis and 
ample understanding of the various signal transduction pathways in the modulation of 
secondary metabolites are vital for the further optimization of plant production systems. 
Figure 5- 13: Modulation of the vinblastine bio-
synthesis according to Guo et al. 2013. 
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According to Hasa et al. (2013), there is tremendous demand for novel indole alkaloid-based 
pharmaceuticals derived from V. minor extracts. As the vincamine present in the remedies from 
Vinca minor reveal a much higher oral bioavailability than pure vincamine, it is argued that 
certain, so far unknown, phyto-complexes might be involved in the bioavailability. 
Accordingly, there is a high demand for preparations from V. minor, which reveal strongly 
enhanced vincamine concentrations. Based on the coherences mentioned and the results 
outlined in this thesis, a corresponding auspicious approach could be based on the simultaneous 
application of growth regulators (MeJA or SA) and resveratrol as a potential inhibitor of certain 
cytochrome P450 enzymes. In consequence, due to the general elicitation, the overall content 
of alkaloids should be massively enhanced, but, due to the inhibition of hydroxylases 
responsible for the conversions outlined in Figure 4-18, no stress related derivatives of the basic 
MIAs will be formed and, accordingly, the vincamine concentration will increase. With respect 
to the potential activity of the related remedies, this approach might be even more advantageous, 
since resveratrol is known to be heath beneficial anyway, as it improves memory performance 
in association with improved glucose metabolism in the brain and might enhance the action of 
vincamine  (Witte et al., 2014; Hui et al., 2018). Accordingly, the presence of both, high 
concentrations of vicamnine, and resveratrol, or its metabolites, in a standardized extract of V. 
minor could indeed be a promising approach to improve the bioactivity of V. minor.  
 
 
 
 
 
 
 
 
 
 
 
Conclusions and implication 
Based on the insights mentioned above, it can be concluded:  
Dereplication-guided isolation of new indole alkaloids could promote the discovery of novel 
drugs in extracts from elicitor-treated cells. 
The quantity as well as the composition of alkaloids accumulated in healthy and non-stressed 
plants could be altered massively by elicitation employing various growth regulators, e.g., 
MeJA, SA, H2O2. Corresponding approaches, which up to now only had been considered as a 
negative topic, are auspicious strategies to search for novel pharmacological active natural 
products. 
The biosynthesis of certain bioactive compounds could be deliberately altered by the 
application of specific enzyme inhibitors, such as naproxen or resveratrol. Especially the 
combination of elicitation and the application of specific enzyme inhibitors seems to be a 
promising strategy for modulating the composition of biologically active natural products of 
a certain plant. 
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Chapter 6: Conclusion and future prospects 
6.1 Conclusion 
The scope of the current study was to investigate the impact of the application of growth 
regulators as a novel strategy to modify the composition of active components in medicinal 
plants. Accordingly, mature Vinca minor (Apocynaceae) plants of defined physiological status 
were used as a model system to investigate the effect of elicitation with methyl jasmonate 
(MeJA) and other growth regulators. The results presented in this work vividly demonstrate 
that such approach indeed leads to massive qualitative as well as quantitative variations in the 
content of bioactive compounds. In this context, MeJA and H2O2 treatment induces oxidative 
enzymes in V. minor, as suggested by the shifts in alkaloid distribution from vincamine to 9-
methoxyvincamine and from vincadifformine first to minovincinine and finally to mino-
vincine. The identification of the enzymes involved appears to be an attractive topic for further 
studies. In addition, the discovery of 9-methoxyvincamine as a novel natural product further 
implies that even well-known extensively studied plants such as V. minor might be an 
auspicious source for the generation of novel phytochemical drugs when grown under defined 
stress conditions. In consequence, this outcome highlights that the utilization of growth 
regulators or signal transducers, especially of MeJA, and the consideration of different 
developmental stages could be a promising tool for altering and diversifying the composition 
of active substances even in well investigated medicinal plants.  
6.2 Future prospects 
The current study represents an initial attempt to employ the growth regulators or signal 
transducers for the identification of novel pharmacologically active compounds and to 
optimization the corresponding phytochemical drugs. Moreover, it provides new tools for basic 
plant biology. In conclusion, some possible strategy can be identified as follows: 
• The application of growth regulators might induce the biosynthesis, accumulation, and 
modulation of substances of therapeutic interest also in those plants, which- due to the 
absence of bioactivities – up to now, are only poorly studied. Accordingly, such 
approach might open new doors to improve and facilitate phytochemical drug discovery 
by providing an opportunity to explore minor constituents of poorly or extensively 
studied pants that can yield new bioactivities after chemical or biological manipulations. 
• Dereplication-guided isolation from elicitor-treated plant extract could accelerate the 
efficient identification of new drug leads. In addition, developing a metabolomics 
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method for finding stress metabolites provides a good way to target the isolation of 
compounds of interest based on the MS characteristics of the stressed plant chemical 
profile. 
• Evaluation of biological activities of the modulated plant extracts. 
• The application of enzyme inhibitors could be used as an alternative approach to study 
and to modify the biosynthetic pathway of the certain secondary metabolite in the plant 
of interest. 
• With respect to the biosynthesis of MIAs, the identification of the cytochrome P450 
enzymes responsible for the stress-induced conversion of indole alkaloids is an 
attractive topic for further studies. As the identification and characterization of these 
enzymes should increase our understanding of the complex biochemical and ecological 
aspects of indole alkaloids; moreover, it will provide helpful tools to boost the discovery 
of new drugs or toxins. 
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Appendix 
Table A- 1:Chemical structures of indole alkaloids isolated before from V. minor. 
≠ Compound 
Molecular 
formula/MW 
R References 
A) The Eburnamine-Vincamine Group  
 
1 Vincamine  
Syn. Minorine 
 
C21H26N2O3 
354.448 
R=R3=H; R1=OH,  
R2=COOCH3 
(Proksa and 
Grossmann, 
1991) 
2 16-Epivincamine 
Syn. Isovincamine 
 
C21H26N2O3 
354.448 
R=R3=H; R1= COOCH3;  
R2=OH 
(Taylor and 
Farn-Sworth, 
1974) 
3 (±)-Eburnamonine 
Syn. Vincamone, 
(-)-Eburnamonine, 
Vincanorine 
C19H22N2O 
294.396 
R=R3=H; R1, R2=O (Mokry et al., 
1963; Proksa 
and Grossmann, 
1991) 
4 Vincaminol C20H26N2O2 
326.43 
R=H; R1=OH 
R2=CH2OH,  
(Kováčik and 
Kompiš, 1969) 
5 Vincine 
Syn. 11-Methoxy-
vincamine 
C22H28N2O4 
384.47 
R=OCH3; R1=OH;  
R2=COOCH3; R3=H 
(Trojánek et al., 
1961) 
6 (-)-Eburnamine C19H24N2O  
296.41 
R=R1=R3=H; R2=OH (Proksa and 
Grossmann, 
1991) 
7 (+)-Apovincamine C21H24N2O2  
336.43 
R=R3=H; R2=COOCH3; 
∆14, 15 
(Robakidze, 
2003) 
8 (+)-Eburnamenine C19H22N2  
278.39 
R=R3=H; R1=H, ∆14, 15 (Mokrý et al., 
1967) 
9 (+)-Isoeburnamine 
 
C19H24N2O 
296.41 
R=R2=R3=H; R1=OH (Mokrý et al., 
1967) 
10 11-Methoxy-
eburnamonine 
C20H24N2O2 
324.422 
R=OCH3; R1, R2=O, 
R3=H 
(Doepke et al., 
1968) 
11 11, 12-Methoxy-
eburnamonine 
C21H26N2O3 
354.448 
R=OCH3; R1,R2=O, R3=H (Taylor and 
Farn-Sworth, 
1974) 
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≠ Compound 
Molecular 
formula/MW 
R References 
12 Vincaminine 
Syn. 19-Oxo-vincamine,       
Vincareine 
C21H24N2O4 
368.43 
R= H; R1=OH;  
R2=COOCH; R3= O 
(Cekan et al., 
1962) 
13 Vincinine 
Syn. 19-Oxo-11-
methoxy-vincamine 
C22H26N2O5 
398.45 
R=OCH3; R1=OH;  
R2=COOCH; R3= O 
(Cekan et al., 
1962) 
14 Hydroxyvincamine C21H26N2O4 
370.447 
R= H; R1= R3=OH;  
R2=COOCH3  
(Taylor and 
Farn-Sworth, 
1974) 
B) Aspidospermine group 
 
15 (-)-Vincadifformine 
(±)-Vincadifformine 
 
 
C21H26N2O2 
338.44 
R=R1=R2=H (Plat et al., 
1962; Proksa 
and Grossmann, 
1991) 
16 (-)-Methoxy-
vincadifformine 
C22H28N2O3 
368.47 
R=OCH3; R1=R2=H (Doepke and 
Meisel, 1968) 
17 (-)-Minovincinine C21H26N2O3 
354.44 
R=R1=H; R2=OH (Plat et al., 
1962) 
18 Minovincine C21H24N2O3 
352.44 
R=R1=H; R2=O (Plat et al., 
1962) 
19 Methoxy-minovincine C22H26N2O4 
382.45 
R=OCH3; R1=H; R2=O (Plat et al., 
1962) 
20 (-)-Minovine 
Syn. N-methyl-
vincadifformine 
C22H28N2O2 
352.47 
R=R1= R2=H 
N1-CH3 
(Plat et al., 
1962) 
21 5-Oxominovincine C21H22N2O4 
366.41 
R=H; R1=R2=O (Taylor and 
Farn-Sworth, 
1974) 
22 (-)-Tabersonine 
 
C21H24N2O2  
336.43 
R=R1=R2=H;   
∆14, 15 
(Robakidze, 
2003) 
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≠ Compound 
Molecular 
formula/MW 
R References 
23 (-)-Vincatine 
(oxindole alkaloid) 
 
C22H30N2O3  
370.49 
 
(Doepke and 
Meisel, 1966; 
Doepke et al., 
1969) 
 
24 (+)-N-Methyl-
aspidosperimidine 
 
C20H28N2 
296.45 
R=CH3; 
R1=H 
(Mokrý et al., 
1967) 
25 (+)-1,2-Dehydro-
aspidospermidine 
Syn. Eburenine 
(root) 
C19H24N2 
280.41 
 ∆1, 2  (Mokrý et al., 
1967) 
 
26 (+)-Quebrachamine C19H26N2 
282.42 
R=R1=R2=H (Mokrý et al., 
1967) 
27 (±)-N-Methyl-
quebrachamine 
 
C20H28N2 
296.45 
R=R2=H, R1=CH3 (Mokry and 
Kompis, 1963) 
28 (+)-Vincadine 
(leaves, root) 
C21H28N2O2 
340.46 
R=R1=H, R2=COOCH3 (Mokry et al., 
1962) 
29 (+)-Vincaminoreine 
(leaves, root) 
C22H30N2O2 
354.49 
R=H, R1=CH3, 
R2=COOCH3 
(Trojanek et al., 
1960) 
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≠ Compound 
Molecular 
formula/MW 
R References 
30 (+)-Vincaminorine 
(leaves, root) 
C22H30N2O2 
354.49 
R=H, R1=CH3, 
R2=COOCH3 
(Cekan et al., 
1960) 
31 Vincaminoridine C23H32N2O3 
384.51 
R=OCH3, R1=CH3, 
R2=COOCH3 
(Mokrý and 
Kompiš, 1963) 
C) The akuammiline group: alkaloids with a 7,16 bond 
32 
Strictamine 
Syn. Vincamidine 
(leaves) 
C20H22N2O2 
322.40 
R=R2=H; ∆1, 2 
(indolenine) 
(Mokrý et al., 
1967) 
33 Picrinine 
(leaves) 
C20H22N2O3 
338.40 
R=R2=H;  
2,5-epoxy 
(Grossmann et 
al., 1973) 
34 Deacetylakuammiline C21H24N2O3 
352.43 
R=H; R2=CH2OH; ∆1, 2 
(indolenine) 
(Savaskan et al., 
1972) 
35 10-Methoxydeacetyl-
akuammiline 
C22H26N2O4 
382.45 
R=OCH3; R2=CH2OH; ∆1, 
2 (indolenine) 
 
 
(Savaskan et al., 
1972) 
D) secoakuammilan group: alkaloids with a 7,16 bond 
 
  
36 Vincoridine C21H24N2O3 
352.43 
R=H, R1=O (Mokrý and 
Kompiš, 1963) 
37 Vincovine 
(-)-Vincorine 
C22H28N2O3 
368.47 
R=OCH3, R1=H 
 
(Mokry et al., 
1962) 
E) The quebrachidine group: Alkaloids with a 5,17 bond and a 7,16 bond 
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Molecular 
formula/MW 
R References 
38 Vincamedine C24H28N2O4 
408.49 
R=CH3, R1= H, 
R2=R3=CH3COO  
(Trojanek et al., 
1960) 
39 (-)-Vincamajine 
N-Methylquebrachidine 
O-Deacetylvincamedine 
 
C22H26N2O3 
366.45 
R=CH3, R1=H, R2=OH,   
R3=CH3COO  
 
(Tulyaganov 
and 
Nigmatullaev, 
2000) 
 
41 10-Methoxyvellosimine 
 
C20H22N2O2 
322.40 
R=OCH3, R1= CHO (Taylor and 
Farn-Sworth, 
1974) 
42 Tombozine 
Syn. Vellosiminol 
C19H22N2O 
294.398 
R=H, R1= CH2OH (Raynaud et al., 
1970; 
Tulyaganov 
and 
Nigmatullaev, 
2000) 
 
43 Vincanidine C19H20N2O2 
308.37 
R=OH, R2= CHO (Tulyaganov 
and 
Nigmatullaev, 
2000) 
44 Vincanine C19H20N2O 
292.37 
R=H, R2=CHO (Tulyaganov 
and 
Nigmatullaev, 
2000) 
45 (-)-Akuammicine 
 
C20H22N2O2 
322.40 
 
R=H,  
R2= CH3COO 
(Tulyaganov 
and 
Nigmatullaev, 
2000) 
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Molecular 
formula/MW 
R References 
 
46 Majdine C23H28N2O6 
428.48 
R=OCH3 (Tulyaganov 
and 
Nigmatullaev, 
2000) 
47 Vinerine 
 
C22H26N2O5 
398.45 
R=H (Tulyaganov 
and 
Nigmatullaev, 
2000) 
48 Vineridine 
 
C22H26N2O5 
398.45 
R=H (Tulyaganov 
and 
Nigmatullaev, 
2000) 
 
49 Ervine 
 
C21H24N2O3 
352.43 
R=H (Tulyaganov 
and 
Nigmatullaev, 
2000) 
50 Reserpinin 
 
 
 
 
C22H26N2O4 
382.45 
R=OCH3 
 
 
(Tulyaganov 
and 
Nigmatullaev, 
2000) 
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Molecular 
formula/MW 
R References 
51 Reserpine (Root + leaves) 
C33H40N2O9 
608.68 
 
(Lyapunova and 
Borisyuk, 1961; 
Lyapunova, 
1964) 
52 (-)-Vincarubine 
(bisindole alkaloid) 
C43H50N4O6 
718.88 
 
(Proksa et al., 
1986) 
53 (-)-Vinoxine 
(leaves, root) 
 
C20H24N2O3 
340.42 
 
(Mokrý et al., 
1967) 
54 Vinomine C19H22N2O3 
326.394 
Structure is not available 
in the literature 
(Meisel and 
Doepke, 1971) 
55 Vintsine Structure is not available in the literature (Chekan, 1964) 
56 Vincesine C22H32N2O4 
 
Structure is not available 
in the literature 
(Doepke and 
Meisel, 1966) 
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≠ Compound 
Molecular 
formula/MW 
R References 
57 4-Methyl-
akuammicinium 
chloride 
(quaternary alkaloid) 
C21H25N2O2 .Cl 
372.89 
 
(Proksa et al., 
1989) 
58 4-Methyl-
raucubaininium chloride 
(quaternary alkaloid) 
C22H29N2O3 .Cl  
404.93 
 
(Proksa et al., 
1989) 
59 4-Methyl-strictaminium 
chloride 
(quaternary alkaloid) 
C21H25N2O2 .Cl  
372.88 
 
 
 
 
 
 
 
(Proksa et al., 
1989) 
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≠ Compound 
Molecular 
formula/MW 
R References 
60 N1-methyl-2β,16β-
dihydroakuammicine 
N4-methochloride 
(quaternary alkaloid) 
C22H29N2O2 .Cl  
388.93 
 
(Votický et al., 
1979) 
 
61 
Epipleiocarpamine-N4-
oxide 
C20H22N2O3 
338.40 
 
(Votický et al., 
1979) 
62 Vincoside 
 
C27H34N2O9 
530.57 
 
(Nishibe et al., 
1996) 
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Figure A- 1: comparison between UV spectrum of vincamine standard and compound (2) in V. minor 
alkaloid extract  
Spectral View -  PDADetector 1
[nm]Wavelength
200 250 300 350
[AU]
A
b
so
rb
a
n
ce
0
1
2
3
4
5
Current Spectrum at 12.02 min
vincamine
Appendix 
 
204 
  
 
Figure A- 2: UV, MS and MS-MS spectrum of 10-hydroxycathafoline (1). 
 
161.0836
177.0969
321.1600
353.1865
1. +MS, 7.46-7.84min #1670-1757, -Peak Bkgrnd
2182. UV, 7.42-7.74min #892-930
355.2024
3. +MS, 10.17-10.60min #2296-2399, -Peak Bkgrnd
208
312
4. UV, 10.13-10.50min #1217-1261
0
1
2
3
5x10
Intens.
0
10
20
Intens.
[mAU]
0.0
0.5
1.0
1.5
6x10
Intens.
0
10
20
30
40
Intens.
[mAU]
50 100 150 200 250 300 350 m/z
200 220 240 260 280 300 320 340 360 Wavelength [nm]
50 100 150 200 250 300 350 m/z
200 220 240 260 280 300 320 340 360 Wavelength [nm]
161.0836
177.0969
321.1600
353.1865
1. +MS, 7.46-7.84min #1670-1757, -Peak Bkgrnd
2182. UV, 7.42-7.74min #892-930
355.2024
3. +MS, 10.17-10.60min #2296-2399, -Peak Bkgrnd
208
312
4. UV, 10.13-10.50min #1217-1261
0
1
2
3
5x10
Intens.
0
10
20
Intens.
[mAU]
0.0
0.5
1.0
1.5
6x10
Intens.
0
10
20
30
40
Intens.
[mAU]
50 100 150 200 250 300 350 m/z
200 220 240 260 280 300 320 340 360 Wavelength [nm]
50 100 150 200 250 300 350 m/z
200 220 240 260 280 300 320 340 360 Wavelength [nm]
MS 
compound 1 
10-hydroxycathafoline 
355.2024 
[M+H]+ 
 
355.2025 
[M+H]+ 
 
MS2 
Appendix 
 
205 
 
 
fsu10_11658S
a.010.001.1r.esp
C
h
em
ica
l S
hift (p
p
m
)
8
.5
8
.0
7
.5
7
.0
6
.5
6
.0
5
.5
5
. 0
4
.5
4
.0
3
.5
3
.0
2
.5
2
.0
1
.5
1
.0
0 0.1
0
.2
0
.3
0
.4
0
.5
0
.6
0
.7
0
.8
0
.9
1
.0
1.44
3.55
1.64
1.23
1.27
4.89
1.59
2.68
7.71
5.67
3.08
4.32
1.68
1.18
1.06
1.03
1.13
0.99
1.27
9
1
2
2
6
2
1
6
3
D
M
S
O
-d
6
5
<
''>
1
4
<
'>
1
1
1
7
M
e
th
o
x
y
2
1
<
''>
2
1
<
'> 5
<
'>
6
<
'>
1
9
1
8
W
a
te
r
6
<
''>
1
4
<
''>
  
C
h
e
m
ic
a
l S
h
ift (p
p
m
)
6
.5
0
6
.4
5
6
.4
0
6
.3
5
0
.9
6
1
.0
1
1
.0
2
9
1
1
1
2
6.33.
6.33.
6.41.
6.41.
6.42.
6.43.
6.46.
6.47.
Figure A- 3: 1H NMR spectrum (700 MHz, DMSO-d6) of 10-hydroxycathofoline x formic acid (1). 
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Figure A- 4: 13C NMR spectrum (175 MHz, DMSO-d6) of 10-hydroxycathofoline x formic acid (1). 
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Figure A- 5: 1H-1H-COSY-NMR spectrum (700 MHz, DMSO-d6) of 10-hydroxycathafoline (1) x formic 
acid. 
 
 
 
 
 
 
 
 
 
 
 
Figure A- 6: 1H-1H-TOCSY- NMR expansion spectrum (700 MHz, DMSO-d6) of 10-hydroxycathafoline 
(1) x formic acid. 
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Figure A- 7: 1H-1H-ROESY-NMR spectrum (700 MHz, DMSO-d6) of 10-hydroxycathafoline (1) x formic 
acid. 
 
Figure A- 8: 1H-13C-HSQC-DEPT-NMR spectrum (700 MHz, DMSO-d6) of 10-hydroxycathafoline (1) x 
formic acid. 
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Figure A- 9: 1H-13C-HMBC NMR spectrum (700 MHz, DMSO-d6) of 10-hydroxycathafoline (1) x formic 
acid. 
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Figure A- 10: UV, MS and MS-MS spectrum of vincamine (2). 
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Figure A- 11: 1H NMR spectrum (700 MHz, CHCl3-d) of vincamine (2) xTFA.  
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Figure A- 12: 13C NMR spectrum (175 MHz, CHCl3-d) of vincamine (2) xTFA.  
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Figure A- 13: 1H-1H-COSY-NMR spectrum (700 MHz, CHCl3-d) of vincamine (2) xTFA. 
 
Figure A- 14: 1H-1H-ROESY-NMR spectrum (700 MHz, CHCl3-d) of vincamine (2) xTFA. 
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Figure A- 15: 1H-13C-HSQC-DEPT-NMR spectrum (700 MHz, CHCl3-d) of vincamine (2) x TFA. 
 
Figure A- 16: 1H-13C-HMBC-NMR spectrum (700 MHz, CHCl3-d) of vincamine (2) xTFA.  
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Figure A- 17: UV, MS and MS-MS spectrum of strictamine (3). 
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Figure A- 18:  1H-NMR spectrum (700 MHz, CHCl3-d) of strictamine (3) xTFA. 
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Figure A- 19: 13C-NMR spectrum (175 MHz, CHCl3-d) of strictamine (3) xTFA.  
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Figure A- 20: 1H-1H-COSY-NMR spectrum (700 MHz, CHCl3-d) of strictamine (3) xTFA. 
 
Figure A- 21:1H-1H-TOCSY-NMR spectrum (700 MHz, CHCl3-d) of strictamine (3) xTFA. 
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Figure A- 22: 1H-1H-ROESY-NMR spectrum (700 MHz, CHCl3-d) of strictamine (3) xTFA. 
 
Figure A- 23: 1H-13C-HSQC-DEPT-NMR spectrum (700 MHz, CHCl3-d) of strictamine (3) xTFA. 
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Figure A- 24: 1H-13C-HSQC-NMR spectrum (700 MHz, CHCl3-d) of strictamine (3) xTFA. 
 
Figure A- 25: 1H-13C-HMBC-NMR spectrum (700 MHz, CHCl3-d) of strictamine (3) xTFA. 
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Figure A- 26:. UV, MS and MS-MS spectrum of vincadifformine (4). 
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Figure A- 27:  1H NMR spectrum (700 MHz, CHCl3-d) of vincadifformine (4) xTFA.  
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Figure A- 28:13C NMR spectrum (175 MHz, CHCl3-d) of vincadifformine (4) xTFA.  
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Figure A- 29:1H-1H-COSY-NMR spectrum (700 MHz, CHCl3-d) of vincadifformine (4) xTFA. 
 
Figure A- 30: 1H-1H-TOCSY-NMR spectrum (700 MHz, CHCl3-d) of vincadifformine (4) xTFA.  
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Figure A- 31: 1H-1H-ROESY-NMR spectrum (700 MHz, CHCl3-d) of vincadifformine (4) xTFA.  
 
Figure A- 32: 1H-13C-HSQC-DEPT-NMR spectrum (700 MHz, CHCl3-d) of vincadifformine (4) xTFA. 
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Figure A- 33:1H-13C-HMBC-NMR spectrum (700 MHz, CHCl3-d) of vincadifformine (4) xTFA.  
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Figure A- 34: UV, MS and: MS-MS spectrum of 9-methoxyvincamine (5). 
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Figure A- 35: 1H- NMR spectrum (700MHz, CHCl3-d) of 9-methoxyvincamine (5) xTFA. 
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Figure A- 36: 13C-NMR spectrum (175MHz, CHCl3-d) of 9-methoxyvincamine (5) xTFA. 
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Figure A- 37: 1H-1H-COSY NMR spectrum (700 MHz, CHCl3-d) of 9-methoxyvincamine (5) xTFA. 
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Figure A- 38: 1H-1H-TOCSY NMR spectrum (700 MHz, CHCl3-d) of 9-methoxyvincamine (5) xTFA. 
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Figure A- 39: 1H-1H-ROESY NMR spectrum (700 MHz, CHCl3-d) of 9-methoxyvincamine (5) xTFA. 
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Figure A- 40: 1H-13C-HSQC-NMR spectrum (700 MHz, CHCl3-d) of 9-methoxyvincamine (5) xTFA.  
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Figure A- 41: 1H-13C-HMBC NMR spectrum (700 MHz, CHCl3-d) of 9-methoxyvincamine (5) xTFA.  
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Figure A- 42: UV, MS and MS-MS spectrum of minovincinine (6). 
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Figure A- 43: 1H- NMR spectrum (700 MHz, DMSO-d6) of minovincinine (6) x formic acid. 
 
 
u
b
e
_
1
1
4
6
7
S
a
.0
1
0
.0
0
1
.1
r.e
s
p
C
h
e
m
ic
a
l S
h
ift (p
p
m
)
9
.5
9
.0
8
.5
8
.0
7
.5
7
.0
6
.5
6
.0
5
.5
5
.0
4
.5
4
.0
3
.5
3
.0
2
.5
2
.0
1
.5
Normalized Intensity
0
0
.0
5
0
.1
0
0
.1
5
0
.2
0
0
.2
5
0
.3
0
0
.3
5
0
.4
0
0
.4
5
0
.5
0
0
.5
5
0
.6
0
0
.6
5
0
.7
0
2
.7
2
1
.0
7
3
.1
6
1
.0
2
1
.0
7
1
.3
0
1
.2
5
3
.1
9
1
.2
5
2
.0
9
2
.8
2
0
.9
3
1
.0
4
0
.9
3
0
.9
5
0
.8
5
1
8
9
1
1
1
0
D
M
S
O
1
1
5
1
4
<
'>
5
6
<
'>
1
2
1
9
5
2
1
,1
7
(O
v
e
r
la
p
p
e
d
)
3
<
'>
1
4
<
''>
,6
<
''>
,1
5
(O
v
e
r
la
p
p
e
d
)
3
<
''>
9.45..
7.21...
7.20..
7.07..
7.01..
7.00.
6.80...
6.79..
6.78...
3.19.. 3.18..
3.18..
3.17..
3.05..
2.85..
2.84..
2.83..
2.57..
2.55.
2.54..
2.45..
2.33..
2.33...
1.86..
1.85..
1.71..
1.54.. 1.52.
1.50..
1.49..
1.49...
1.48..
0.73..
0.72.
Appendix 
 
237 
 
 
 
 
 
Figure A- 44: 1H-13C-NMR spectrum (175 MHz, DMSO-d6) of minovincinine (6) x formic acid.  
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Figure A- 45: 1H-1H-COSYNMR spectrum (700 MHz, DMSO-d6) of minovincinine (6) x formic acid. 
 
Figure A- 46: 1H-1H-TOCSY-NMR expansion spectrum (700 MHz, DMSO-d6) of minovincinine (6) x 
formic acid. 
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Figure A- 47: 1H-1H-ROESY-NMR pectrum (700 MHz, DMSO-d6) of minovincinine (6) x formic acid. 
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Figure A- 48: 1H-13C-HSQC-DEPT-NMR spectrum (700 MHz, DMSO-d6) of minovincinine (6) x formic 
acid. 
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Figure A- 49: 1H-13C-HMBC-NMR spectrum (700 MHz, DMSO-d6) of minovincinine (6) x formic acid.  
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Figure A- 50: UV, MS and MS-MS spectrum of minovincine (7). 
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Figure A- 51: 1H NMR spectrum (700 MHz, CHCl3-d) of minovincine (7) x formic acid. 
 
Appendix 
 
243 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ube_11035S
a.010.001.1r.esp
C
h
em
ica
l S
hift (p
p
m
)
2
16
2
08
2
00
1
92
1
84
1
76
1
68
1
60
1
5 2
1
44
1
36
1
28
1
20
1
12
1
04
9
6
8
8
8
0
7
2
6
4
5
6
4
8
4
0
3
2
2
4
0
0
.0
0
5
0
.0
1
0
0
.0
1
5
0
.0
2
0
0
.0
2
5
0
.0
3
0
1
9
2
2
2
1
3
8
1
0 11
2
11
6
7
2
4 5
2
0 3
1
7
6
1
5
2
3
9 1
2
1
4
C
H
L
O
R
O
F
O
R
M
-d
206.26..
173.11..
169.00.
158.36.
151.64.
143.77.
129.18..
128.95.
124.04.
123.67
122.23..
115.43..
113.80..
109.37..
65.47.
62.93.
60.16.
54.43..
52.76.
48.14.
46.76.
43.78..
42.07..
35.50.
29.83.
29.69.
29.41.
24.25.
14.89..
14.27.
1.00..
1
8
 
2
3
 
Figure A- 52: . 13C NMR spectrum (175 MHz, CHCl3-d) of minovincine (7) x formic acid. 
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Figure A- 53: 1H-1HCOSY NMR spectrum (700 MHz, CHCl3-d) of minovincine (7) x formic acid. 
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Figure A- 54: 1H-1H-ROESY NMR spectrum (700 MHz, CHCl3-d) of minovincine (7) x formic acid. 
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Figure A- 55: 1H-13C-HSQC NMR spectrum (700 MHz, CHCl3-d) of minovincine (7) x formic acid. 
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Figure A- 56: 1H-13C-HMBC NMR spectrum (700 MHz, CHCl3-d) of minovincine (7) x formic acid. 
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Figure A- 57: UV, MS and MS-MS spectrum of ercinamine (9). 
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Figure A- 58: 1H- NMR spectrum (700 MHz, DMSO-d6) of ercinamine (9) x formic acid. 
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Figure A- 59: 13C- NMR spectrum (175 MHz, DMSO-d6) of Ercinamine (9) x formic acid.  
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Figure A- 60: 1H-1H- COSY-NMR spectrum (700 MHz, DMSO-d6) of ercinamine (9) x formic acid. 
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Figure A- 61: 1H-1H- TOCSY-NMR spectrum (700 MHz, DMSO-d6) of ercinamine (9) x formic acid. 
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Figure A- 62: 1H-1H- ROESY-NMR spectrum (700 MHz, DMSO-d6) of ercinamine (9) x formic acid. 
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Figure A- 63: 1H-13C- HSQC-DEPT-NMR spectrum (700 MHz, DMSO-d6) of ercinamine (9) x formic 
acid. 
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Figure A- 64: 1H-13C- HMBC-NMR spectrum (700 MHz, DMSO-d6) of ercinamine (9)x formic acid. 
 
Figure A- 65: The extracted ion chromatograms (EIC 500-900 m/z) of control and H2O2 treated old 
leaves. It turned out that several unique dimeric alkaloids are present only on the stressed plants. 
Unfortunately, the MS-MS fragmentation is not very intense for solid structures deductions. 
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Figure A- 66: The different response of the plants to salicylic acid (SA) during the experiment. In case 
of SA no significant change in the spectrum of the alkaloids was observed; except for single plant after 
4 and 8 which showed a drastic increase in 9-methoxyvincamine, minovincinine and minovincine and 
decrease in vincamine and vincadifformine. After 14 days, 9-methoxyvincamine was present in very low 
concentration, whereas minovincinine and minovincine were present in high concentration. Since the 
reasons for this particular and unique finding are unknown. 
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Figure A- 67: Uptake of the resveratrol by the barley plant. Resveratrol was applied to the irrigated 
water of barley plant with the same concentration used in Vinca experiment. 
Plant material and application of resveratrol: 
Barley seedlings were sown in vermiculite. Two weeks after germination, resveratrol was added 
during watering as mentioned with Vinca minor. To exclude any contamination with the 
resveratrol-containing substrate (vermiculite), harvesting, was performed by cutting the 
seedlings at 1–2 cm above the ground after one week.  
HPLC analysis of resveratrol: 
After grinding the freeze-dried plant material using a ball mill, 0.6g of the powdered sample 
were extracted with 10 mL methanol and sonicated for 30 min at 50 ºC. After centrifugation 
(10 min; 10,000 x g). The supernatant was pooled and evaporated using a steam air, facilitated 
using a water bath at 45ºC. The dry residue was dissolved in methanol. After sonication, the 
solution was filtered and used for HPLC analysis. 
HPLC was performed using a Nucleosil RP-C18 column by applying a binary gradient, starting 
with 85% A, 15% B. After 10 min the ratio was 76% A, 24% B; subsequently the ratio was 
changed as follows:30 min: 38% A, 62% B; 33 min: 30% A, 70% B; using A: aqueous acetic 
acid (1%) and B: acetonitrile. The flow rate was 0.8 mL/min and the injection volume was 50 
μL. For detection, a PDA detector was applied (304 nm). Identification was made by 
comparison to authentic reference resveratrol. 
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Figure A- 68: The response of the plants to resveratrol during the experiment. In case of resveratrol no 
significant change in the spectrum of the alkaloids was observed. 
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Figure A- 69: Impact of the concomitant application of naproxen and MeJA on the alkaloid spectrum V. 
minor after 3 days. 
 
 
Figure A- 70: HPLC chromatogram of the flowers and fruits of Vinca minor. 
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Figure A- 71: Impact of the concomitant application of naproxen and H2O2 on the alkaloid spectrum V. 
minor. The plants were sprayed two times during the experiment and collected at 9 days. 
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